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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Topical Neomycin

Topical antibiotics are commonly used
to prevent and treat cutaneous infec
tions,1 but their role in the prophylaxis
of surgical wounds is unclear2 and
there is no compelling evidence that
topical antibiotics are effective in the
prophylaxis of postoperative wound
infections.3 None the less, topical neo
mycin or preparations containing neo
mycin continue to be widely used with
consequences such as cutaneous sen
sitization, ototoxicity, nephrotoxicity
and the emergence of antibiotic re
sistant strains.
Contact hypersensitivity to neo
mycin has frequently been reported
and this drug now is considered one
of the most common causes of allergic
eczematous contact dermatitis in the
United States and Europe.4'5 The fre
quency of hypersensitivity is much
greater in patients with chronic in
flammatory dermatoses who receive
treatment over a long period than in
patients who have undergone operation,
in whom the drug is used only briefly.
However, cross-hypersensitivity to other
aminoglycosides does result from
cutaneous sensitization to neomycin
and may restrict the parenteral use of
agents such as gentamicin.
The relative freedom from com
plications when neomycin is applied
topically to the intact skin surface
does not hold when the drug is used
to irrigate the wound or when it is
instilled into the peritoneal or pleural
space in concentrations that are com
parable to those used for systemic
therapy. The absorption of the drug
from a wound or granulating surface
may, at times, be comparable to ab
sorption from an intramuscular injec
tion site.6
Ototoxicity following topical adminis
tration of neomycin has been reported

after infusion of 7.0 g into an empy
ema cavity;7 use of a neomycin pack;
infusion of a septic joint, of fracture
sites and into a sinus; use in peritoneal
dialysis fluid; treatment of decubitus
ulcers; and implantation of a neomycinimpregnated pigskin graft.8'11 Most pa
tients were exposed to irrigation with a
1% solution of neomycin to a total
dose of 4.5 to 360 g. The daily dose
ranged from 2.4 to 40 g. Nephro
toxicity combined with ototoxicity also
has been reported12'14 following irriga
tion of the peritoneal cavity with 10 g
neomycin sulfate, of a bone fracture
with 40 g and following irrigation of a
hip and of the mediastinum. A report
of two further patients by Manuel and
associates in this issue of the Journal
(page 274) emphasizes this problem.
Some patients with ototoxicity and
nephrotoxicity also had respiratory
paralysis.
The likelihood of any of the recog
nized parenteral side effects of neo
mycin occurring during its topical use
on the skin or in surgical wounds de
pends on the amount applied and the
amount absorbed. The greatest risk is
when neomycin is used in the irriga
tion of a closed space or when the
tissues are inflamed. The dose applied
topically should not exceed the safe
parenteral dose of 15 mg/kg body
weight daily. Some workers, including
Manuel and associates, recommend not
more than 400 mg in total daily. In
patients with pre-existing impairment
of renal function the daily dose should
be further reduced to allow for delayed
excretion in the urine. Topical neo
mycin should be used with caution in
patients receiving other aminoglycoside
antibiotics parenterally.
Topical antibiotics can and do pro
duce resistant organisms. Neomycin
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use has been associated with the
emergence of resistant strains of Sta
phylococcus aureus15-18 and in several
instances these resistant strains have
been the cause of severe hospital ac
quired infections.15 The emergence of
resistant strains may occur rapidly
following use of topical neomycin and
may persist after withdrawal of the
drug. A recent increase in gentamicinresistant strains of S. aureus is of even
greater concern.
Since topical neomycin may be
neither safe nor effective in the pre
vention of wound infection, its con
tinued use should be severely re
stricted,19 particularly in terms of the
total daily dose and its use in the
irrigation of “closed” cavities.
H . R ichardson ,

m d , f r c p [c ]

C.B. M u e l l e r , m d , fr c s [c ], facs
Division of medical microbiology
and section of surgery,
McMaster University Medical Centre,
Hamilton, Ont.
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OTalwin* Injectable
pentazocine lactate injection N.F.
INDICATIONS: For preoperative medica
tion, control of postoperative pain, relief
of pain during labor, and other types of
pain requiring a potent analgesic.
PRECAUTIONS: 1. Because Talwin is a
narcotic-antagonist, occasional patients
who are addicted to narcotics may expe
rience withdrawal symptoms and there
fore Talwin should be given with special
caution to such persons. In non-addicted
patients receiving narcotics for a short
period, symptoms believed to be related
to antagonism may be observed. Intoler
ance or untoward reactions are usually
not observed following administration of
Talwin to patients who have received
single doses or who have had limited ex
posure to narcotics. 2. Since sedation,
dizziness and occasional euphoria have
been noted, ambulatory patients should
be warned not to operate machinery,
drive cars, or unnecessarily expose them
selves to hazards. 3. Although laboratory
tests have not indicated that Talwin
causes or increases renal or hepatic im
pairment, the drug should be administer
ed with caution to patients with such im
pairment. Extensive liver disease appears
to predispose to a higher incidence of
side effects (e.g. marked apprehension,
anxiety, dizziness, sleepiness) from the
usual clinical dose, and may be the result
of decreased metabolism of the drug by
the liver. 4. Until furtherexperience is gain
ed w ith the e ffe cts o f Talwin on the
sphincter of Oddi, the drug should be
used with caution in patients with acute
cholecystitis or pancreatitis or in those
about to undergo surgery of the biliary
tract. 5. Because urinary retention has
been observed in afew patients receiving
Talwin, caution is advised in administra
tion of the drug to patients with obstruc
tive uropathy. 6. Since clinical experience
in children under twelve years of age is
limited, the use of Talwin in this age group
is not recommended. 7. Talwin is not re
commended for pregnant women except
for those in active labor because the
safety to the developing fetus has not
been sufficiently established. As with
other strong analgesics, Talwin should be
used with caution in women delivering
premature infants. 8.Talwin should not be
mixed in the same syringe with soluble
barbiturates, chlordiazepoxide, or diaze
pam since precipitation will occur.
ADVERSE REACTIONS: In a grouping
of 5,731 patients receiving Talwin the fol
lowing adverse reactions were noted:
vertigo 7.6%, nausea 7.2%, vomiting 3.9%,
euphoria 2.6%, diaphoresis 2.3%, con
stipation 1.2%, respiratory depression
0.9%, circulatory depression 0.9%, and
urinary retention 0.7%. Each of the follow
ing adverse„reactions, enumerated in
decreasing frequency, occurred in 0.3 to
0.1% of patients: dry mouth, headache,
restlessness, hot sensation (flushed),
nervousness, dreams, paresthesia, drunk
enness, increase in blood pressure, der
matitis, mental depression, disorientation,
nystagmus, blurred vision and cold sen
sation (chills).
Other rarely reported adverse reactions
include hallucinations, tremors and drug
dependency with withdrawal symptoms.
Laboratory tests of blood, liver, and kidney
functions have revealed no significant
abnormalities after administration of Talwin.
However, eosinophilia of variable degree
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was noted 30 to 50 days after daily ad
ministration of 160 mg of the drug.
DOSAGE AND DURATION OFTHERAPY:
1. Adults, excluding patients in labor:
The average recommended single dose
for adults is 30 mg depending on the
needs of the patient. This dose, adminis
tered by intramuscular, subcutaneous or
intravenous injection, may be repeated
every three to four hours. Pain has been
controlled in most patients with not more
than three doses daily. In selected situa
tions, 45 mg to 60 mg administered sub
cutaneously or intramuscularly may be
required.
Talwin has been administered to patients
with chronic pain for over 300 days with
absence of withdrawal symptoms, even
when administration was stopped abrupt
ly. However since, in a few patients, with
drawal symptoms have occurred after
frequent, prolonged use, it may be of
value to reduce the dose gradually when
the drug is no longer needed.
In prescribing Talwin for chronic use by
self-administration, precaution should be
used to insure against unnecessary esca
lation of dosage and to avoid the use of
the drug in anticipation of pain rather
than for its relief.
2. Patients in labor: Although most
patients in labor have received a single
injection of 30 mg intramuscularly, some
have obtained adequate pain relief with
an intravenous injection of 20 mg. This
latter dose may be given when contrac
tions become regular and may be re
peated one or two times at two to three
hour intervals as needed.
HOW SUPPLIED: Ampuls of 1 ml (30 mg),
1V2 ml (45 mg) and 2 ml (60 mg) Talwin.
Each 1 ml contains TALWIN (brand of
pentazocine) as lactate equivalent to 30
mg base and 2.8 mg sodium chloride in
Water for Injection. pH adjusted between
4 and 5 with lactic acid and sodium hy
droxide. Boxes of 25.
Multiple dose vials of 10ml. Each 1ml con
tains TALWIN (brand of pentazocine) as
lactate equivalent to 30 mg base, 2 mg
acetone sodium bisulfite, 1.5 mg sodium
chloride, and 1mg methylparaben, as pre
servative, in Water for Injection. pH ad
justed between 4 and 5 with lactic acid
and sodium hydroxide. Boxes of 1 and 5.
Winthrop Laboratories
Division of Sterling Drug Ltd.**
Aurora, Ontario, L4G 3H6
•Registered Trade Mark
• ‘ Registered User of the Trademark “TALWIN"
owned by Sterling Drug Inc.
Full prescribing information available on request.
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NARCOTICS CAN BE AS HARD
ON THE PATIENT
AS THEY ARE ON THE PAIN.

Whenever you use injectable narcotics
to relieve severe pain, you run the risk of narcotic
side effects. But there’s one pain reliever that pro
vides the same effectiveness as narcotics without
the usual incidence of narcotic side effects.
OTalwin*
Talwin Injectable is a highly effective, non-narcotic pain
reliever that’s hard on the pain, not on the patient.
The respiratory effects of Talwin are not cumulative, and
there is a ceiling effect at a dose of 30 to 40 mg.(1) Repeated

doses of narcotics, on the other hand, have
an additive effect on respiration.
Talwin Injectable does not significantly affect
maternal blood pressure, heart rate®3'45 or
progress of labour/55 so it’s an excellent
obstetrical analgesic.
And Talwin injections cause three times less nausea
and vomiting than meperidine.®
Talwin. You couldn’t ask for a better reason to kick the
narcotic habit.

^TALWIN INJECTABLE
Hard on the pain, not on the patient.
REFERENCES (1) Engineer, S. and Jennett, S. (1972): Respiratory Depression Following Single and Repeated Doses of Pentazocine and Pethidine. Brit. J. Anaesth. 44:795-802. (2) Duncan, S.L.B., et al. (1969): Comparison
of Pentazocine and Pethidine in Normal Labour. Am. J. Obstet. and Gynec. 105:197-202. (3) O’Dwyer, E. (1971): A Comparison of the Analgesics Pentazocine and Pethilorfan in the Relief of Pain During Labour. J. Irish Med. Ass
64:173-176. (4) Weiss, V. et al. (1971): Pentazocine in der Geburtshilfe. Der Anaesthetist. 20:471-473. (5) Filler, W.W. and Filler, N.W. (1966): Effect of a Potent Non-Narcotic Analgesic Agent (Pentazocine) on Uterine Contrac
tility and Fetal Heart Rate. Obstet. and Gynec. 28:224-232. (6) Odell, E.J. et al. (1969): A Double-Blind Single Dose Study of Pethidine and Pentazocine in Domiciliary Obstetric Practice. Midwives Chron. 82:400-404.
Winthrop Laboratories
Division of Sterling Drug Ltd.**
Aurora, Ontario, L4G 3H6

‘ Registered Trademark
“ Registered User of the Trademark “TALWIN" owned by Sterling Drug Inc.
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SI “ Inches” Forward. 2. More Derived Units

A previous editorial in this journal
(March 1979) discussed base SI units
and the two derived units that describe
volume and concentration, concepts of
particular value in biology and med
icine. Even though some of the terms
may be new, these concepts are suf
ficiently familiar to biologists and
physicians that conversion to the SI
system should be accomplished with
out distress or confusion. Your editors
anticipate unease and possible difficulty
in converting terms for pressure and
heat, which SI recommends be re
ported in pascals and joules, re
spectively.
In addition to the seven base units,
the Systeme international d’unites ac
knowledges 15 derived units. These
have been given special names and
symbols and are described in terms of
the base units or other derived units.
Five of the 15 are listed in Table I.
Pressures, Pascals and Problems

The terms for pressure in everyday
use are derived from concepts which
have grown from the combined pro
perties of mass, gravitational force and
area, that is, weight per unit area. In
1643 Torricelli demonstrated that the
atmosphere had weight by using a
bowl and a column of mercury con
tained in an evacuated tube. Upon
climbing a mountain, he also showed
that for every 1000 feet of elevation
there occurred a 1-inch fall in the
mercury column. Perhaps his selection
of mercury was fortuitous, but it has
become the best known and most
useful liquid available for measuring
pressure. Because of mercury’s high
specific density the column is short,
the vapour pressure of mercury is so
small that it may be disregarded, its
fluid properties permit use under many
conditions and its elemental character
provides stability. Stemming from Torri
celli’s observations and because of the
usefulness of mercury, the standard
atmosphere became a reference point

for pressure, conceived as, and later
defined by, the height of a column of
mercury.
In 1848 the metric commission in
France acknowledged 760 mm Hg to be
a standard atmosphere. Referring it to
the CGS (centimetre-gram-second) sys
tem the commission defined the stand
ard atmosphere as 1 013 250.0 dynes/
cm2 (CGS units). Consequently 1 mm
Hg became 1333.22 dynes/cm2 and
was given the name of 1 Torr. Although
dynes per square centimetre (dynes/
cm2) is precisely equivalent to milli
metres of mercury (mm Hg), the CGS
term, useful to physicists and engi
neers, has not been widely accepted by
biologists and physicians. This may be
due to the visual impact created by
mercury sphygomanometers and labo
ratory pressure devices in which the
height of the column gives some spatial
meaning to the number. In special
cases in which pressure is recorded in
centimetres of water (cm HaO), the
figure must be converted to mm Hg
for integration into a comprehensive
portrayal of cardiovascular, pulmonary
or gaseous dynamics. No one familiar
with 5 cm H 20 central venous pres
sure talks about 160 cm H20 as the
systolic blood pressure or 130 cm H20
as an acceptable arterial oxygen pres
sure. The measurement of pressure in
mm Hg has become an integral part of
medical and biologic thinking, and all
of us have been reared on mm Hg (the
Torr) as a visible, useful means of
measuring pressure.
One of the basic tenets of the SI
system is to define all physical quan
tities in terms of the base units or
their derivatives and thus to create a
coherent system. Since neither mm Hg
nor the standard atmosphere are base
units or acceptable derived units, the
SI system has chosen to formalize a
derived pressure unit in MKS (metrekilogram-second) terms. In the Systeme
international, pressure is defined as
force per unit area. For this, the me
tric system uses dynes/cm2 (g/cm»s2)

Table I— Some Derived SI Units

Physical quantity
Force (mass X acceleration)
Energy (force X distance)
Power (energy/time)
Pressure (force/area)
Frequency (cycle/second)

202

Dimensions in
terms of
base units

Name

Symbol

kg •m/s2
kg •m2/s2
kg ■m2/s3
kg/m ■s2
/s

newton
joule
watt
pascal
hertz

N
J
W
Pa
Hz

Dimensions in terms
of other derived
units
J/m
N ■m
J/s
N/m2
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and SI uses newtons per square metre
(N/m 2 [kg/m*s2]). Reference to a
column of mercury has officially ended
and pressure in the SI system is de
fined as the pascal (Pa) — N /m 2 or
kg/m?s2. For easy conversion, remem
ber that 100 mm Hg equals 13.3 kPa
or 1 kPa equals 7.5 mm Hg.
Having considered the above and
realizing that the mission of our
journal is education and enlighten
ment, your editors wonder if the use
of pascals will serve the education
purpose sufficiently well to warrant its
employment. In a few areas of biologic
expression, for example those dealing
with myocardial function or the rela
tion between radius and tension in a
hollow viscus expressed by such laws
as those of Laplace, the MKS units are
not only superior but indispensable.
These rarely enter our everyday
clinical world. Accordingly we feel that
pressure measurements should and
will be reported in the Canadian Jour
nal of Surgery in mm Hg, accompanied
by pascal conversions whenever such
clarity is needed. When appropriate or
required, pressure determinations may
be reported in pascals if the author
chooses, accompanied by mm Hg con
version. Clarity of communication
seems to us to be more important than
purity of the system.
Conflict Concerning the Calorie

Ideas about the nature of heat have
changed slowly since its manifestations
were ascribed to the action of a subtle,
imponderable, weightless fluid called
“caloric”, a useful concept but one
that was unable to explain the heat
that occurred by friction or the changes
in temperature that accompanied the
expansion or contraction of a gas.
The subsequent ability to distinguish
heat from temperature led to the
description of heat as a quantity of
thermal energy and ultimately it was
recognized that heat could be directly
related to motion or work. In 1878
Joule defined the mechanical equi
valent of heat.
Heat is now related to all other
forms of energy through the first law
of thermodynamics which states that
the change of energy in a substance
is the sum of heat energy, Q, ab
sorbed by the substance, and the
energy acquired because of electrical,
mechanical or other work, W, done
on it. Its simple equation is AE =
Q + W. In 1948 the ninth General
Conference of Weights and Measures
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recommended that the unit accepted
for measuring and defining all other
forms of energy, the joule, should also
be used to measure and define amounts
of heat.
For many years, the quantity of heat
was most conveniently and accurately
measured in terms of a change in the
temperature of a known mass of
water, which led to a definition of
units of heat based on the properties of
water. From this approach arose the
gram-calorie, defined as that amount
of heat required to raise the temper
ature of 1 gram of water 1°C. Defini
tions of the quantity of heat ranged
from the gram-calorie to the British
thermal unit before the international
thermal calorie was accepted. Because
the specific heat of water varies with
the temperature of the water, the
thermal calorie was defined at a
specific water temperature — 14.5°C
to 15.5°C. As electrical standards
developed and thermometry was re
fined, it became possible to measure
the electrical energy introduced into a
calorimeter more accurately than heat
could be measured. A thermochemical
calorie was then defined as the heat
energy equivalent to 4.1849 joules. In
SI units, the standard unit of energy,
the joule, is the work done when a
force of 1 newton moves 1 metre in
the direction of the force. In the
familiar first law of thermodynamics
(AE = Q + W) the work term, W,
has been and still is conveniently ex
pressed in joules, whereas the heat
term, Q, has been expressed in calories.
Now the Systeme international recom
mends that both heat and work be ex
pressed in the same terms — the
joule.

Despite limitations of its definition,
the calorie has been accepted as a term
for heat and has remained in use be
cause of its convenience just as the
joule has been the convenient expres
sion for the unit of work. Physicists,
chemists and heat engineers, as well as
biologists, seem reluctant to accept the
joule as the only unit of energy and
continue to use the calorie, even though
it is no longer defined in terms of
properties of water but rather in terms
of the international joule. Biologists
have used both joules and calories as
reporting terms. Those biologists, bio
physicists and physiologists who deal
with organ work and cell work usually
use work terms rather than heat terms.
Muscle contraction, the transport of
ions across membranes and electrical
imbalances are more conveniently ex
pressed in terms of work than of
heat. The nutritionist and the bioenergy
chemist have generally thought in
terms of heat and have used that
terminology. The basal metabolic rate
(which measures no work) has always
been described in heat terms. Since
energy expenditure in animal systems
is inefficient and most is dissipated as
heat, the concept of efficiency, which
relates work to heat as a function of
total energy expenditure, seems to re
quire different terms for reporting the
heat and the work components. In
chemical laboratories where entropic
reactions are considered, work terms
seem inappropriate to describe the loss
of heat, so heat terms are used. Despite
the imprecise definition of the calorie
in the past and its current more pre
cise definition in terms of the joule,
the calorie has remained widely used.
It has been inappropriately extended to

include the chemical energy of foods
(neither heat nor work) and by con
vention all of us eat calories for break
fast and dinner.
Biologic efficiency in the neighbour
hood of 20% to 30% actually means
that a small portion of the energy con
tained in the food we eat appears as
work and the remainder is converted
to heat. Food energy is the chemical
energy contained in molecular bonds
and probably should be reported as
joules, the work term, rather than
calories, the heat term. However, con
vention and common usage have im
bued nutrition science with calories
rather than joules and we believe that
caloric representation of nutritional
concepts is probably still in order, if
appropriate.
To the editors it seems of consider
able advantage, at least for the present,
to separate the reporting of heat from
that of work. It is probably a bit
strained to convert all biologic heat
terms into work terms and to use only
joules. We therefore believe that the
contributors who report biologic pro
cesses which are measured as work
should report these processes in work
terms — the joule, and for those
processes that measure heat or are re
lated to a heat output, the calorie
should be used. Appropriate notation
will be made that one calorie is equi
valent to 4.1840 joules.
C.B. M u e l l e r
Coeditor
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On Understanding Coronary Bypass Surgery

useful in understanding what the oper
ation does for the patient and help
us to assess the value of this procedure.
The traditional hallmarks of suc
cessful CABG, such as patency of,
and high flow rates in, the grafts, may
not be sufficient to supply the subtle
yet important information which is re
quired. The coronary circulation is
unique in that it perfuses the organ
which generates the pressure for such
perfusion. It is analogous to the di
lemma of a man who tries to pull
himself up by his own boot straps,
except for the fact that the cardiac
contractions are phasic. Coronary

The value of coronary artery bypass
grafting (CABG) is undergoing critical
scrutiny because of the vast medical
and socioeconomic dimensions of this
procedure. The prolonging of life by
CABG remains controversial except
for a few selected patients. Relief of
angina pectoris is not disputed, but
even here the considerable placebo ef
fect of the operation and the role of
perioperative infarction of the is
chemic myocardium in the relief of
pain are well recognized.
There are a number of points to be
considered in attempting to identify
the benefits of CABG. Of utmost im

portance is proper preoperative selec
tion of patients, but it is doubtful that
the preoperative studies presently
available are sufficiently precise to
achieve this. The severity of myocar
dial ischemia is estimated by the de
gree of coronary stenosis, yet the
angiographic determination of collate
ral circulation is at best qualitative.
It is not possible to predict the degree
of reversibility of impaired myocardial
contractility, or to know precisely the
distribution of the increased blood
flow delivered through CABG. Thus,
any additional information obtainable
in the intraoperative period should be
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circulation, therefore, occurs mostly in
the diastolic phase; a systolic flow pat
tern indicates perfusion of a myocar
dial segment with poor contraction,
unless it supplies only the low-pres
sure right ventricle. A systolic flow
pattern in a coronary artery bypass
graft, then, may indicate irreversible
myocardial damage or inadequate re
vascularization as may occur when ad
ditional distal stenosis is present.
Likewise, the lack of reactive hype
remia after the temporary occlusion
of a coronary artery bypass graft sug
gests that there is no appreciable
ischemia in the myocardial segment
revascularized. This lack of reactive
hyperemia can occur in several dif
ferent situations and important infor
mation can be gathered by relating
it to other hemodynamic features of
the coronary artery graft. A prelimina
ry systematic attempt to collect such
data appears in this issue of the Jour
nal (page 260). The findings are cor
related with those from preoperative
angiography and it appears that the
two sets of findings may supplement
each other. Future efforts in this area
would require the study, of a greater
number of cases to enable statistical
analysis. The interpretation of the data
has so far relied mostly on the theore
tical and experimental information
gathered in the physiology laboratory
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REVIEW ARTICLE

Le syndrome de Peutz-Jeghers
R ichard B a illo t , m d , L.P. L e G r e s l e y , m d , f r c p [ c ] et
R o bert M. G irard , m d , f r c s [c ]

Le syndrome de Peutz-Jeghers est une
maladie hereditaire associant une
polypose du tube digestif a une
pigmentation mucocutanee caracteristique. Le syndrome est relativement
rare et, a I'occasion de deux nouveaux
cas, les auteurs ont voulu en reviser
les principaux aspects. Mem e si les
manifestations cliniques, genetiques et
pathologiques sont bien connues,
1'evolution naturelle du syndrome est
encore incertaine. La neoplasie maligne
digestive et la mortalite sont plus
faibles que chez les patients porteurs
d'une polypose colique familiale, mais
plus elevees que dans la population en
general. Le traitement chirurgical de la
polypose dans le syndrome de PeutzJeghers doit etre conservateur, mais
la necessity d'une surveillance medicale
a long terme s'impose.
Peutz-Jeghers syndrome is a hereditary
disorder in which gastrointestinal
polyposis is associated with character
istic mucocutaneous pigmentation. The
syndrome is considered to be rare and
the authors' experience with two
patients prompted a review of the
principal features of the disease.
Although much has been learned about
its clinical, genetic and pathologic
features the natural course of the
disease is still uncertain. The mortality
from the disease and its association with
cancer are lower than in patients with
familial polyposis coli but higher than in
the general population. The authors
stress the importance of conservative
surgical management and planned
medical follow-up.

Le syndrome de Peutz-Jeghers est une
entite relativement rare. II n’existe que
tres peu de cas rapportes dans la litterature canadienne et, a I’occasion de
deux nouveaux cas, nous avons pense
reviser les nouveaux aspects du syn
drome.
C’est en 1921 que Peutz1 a decrit
l’association de pigmentations mucocutanees et de polypes intestinaux chez
sept membres d’une meme famille.
Le syndrome fut par la suite remis
en relief par Jeghers, McKusick et
Katz2 en 1949 alors qu’ils apporterent
une contribution de 23 patients. P ar la
suite, Bruwer, Bargen et K ierland3 en
1954 proposerent le terme de syndrome
de Peutz-Jeghers.
L’association clinique telle que decrite par Peutz avait cependant ete
signalee pour la premiere fois en 1881
par un Russe du nom de Skifasowski.4
En 1895, Collier,5 un Anglais, et
Hauser,6 un Allemand, rapportaient
chacun un cas. Le patient de Hauser
etait en plus porteur d’un epithelioma
du rectum. En 1896, H utchinson7 fit
mention de la lentiginose peribuccale
chez un groupe de jumelles. W eber8 en
1919 rapporta qu’une de celles-ci etait
decedee d’intussusception a Page de
20 ans.

presente de nombreux polypes dont un de
2.5 cm au jejunum et, de plus, on soupgonne une intussusception a ce niveau. Un
polype de 4 cm est present a l’angle
splenique et un autre de 2 cm est identifie
quelques centimetres plus bas. Le malade
subit une laparotomie. On retrouva un
point d’intussusception sur le grele (Fig.
1) et des polypes dissemines sur tout l’intestin ainsi qu’un conglomerat a l’angle
splenique (Fig. 2). Le patient eut alors
des enterotomies etagees pour polypectomie et un colectomie segmentaire de
Tangle splenique. Trois ans plus tard, le
patient est asymptomatique et une nouvelle serie digestive a montre quelques
polypes de 1 a 1.5 cm sur le carrefour
gastroduodenal.
Cas no 2.—Une malade agee de 21
ans est admise, en mars 1970, pour des
rectorragies et une chute de l’hemoglobine
a 7 g/dl. A l’examen physique, une lenti
ginose peribuccale est evidente et au ques
tionnaire, on remarque que la malade
presente de vagues malaises digestifs avec

Observations cliniques

Du departement de chirurgie,
Hopital Maisonneuve-Rosemont,
Universite de Montreal, Montreal, PQ
Les demandes de tires a part doivent etre
adressees au Dr R. Girard,
Departement de chirurgie,
Hopital Maisonneuve-Rosemont,
5415, boul. de VAssomption, Montreal,
PQ H IT 2M4

Cas no 1.—Un malade age de 17 ans
s’est presents a la salle d’urgence en
juillet 1975 pour des rectorragies precedees de crampes abdominales. Depuis 1
semaine, le malade eprouve des malaises
digestifs sous forme de coliques localisees
au niveau de la partie superieure de
l’abdomen. Le patient consult* alors apres
avoir remarque la presence de sang
rouge clair dans ses selles et il est immediatement hospitalise pour investigation
digestive. Au questionnaire du malade,
nous avons releve une histoire de douleurs
abdominales presentes depuis environ 6
mois. Une serie digestive pratiquee des
l’admission montre la presence d’un polype
bulbaire de 1.5 cm de diametre. Le grele
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FIG. 1— Cas
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no

1.

Intussusception
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sensation de “trop plein” apres les repas.
Les antecedents de la malade sont perti
nents d’un kyste ovarien et d’un hemangiome enleve au niveau de la levre inferieure.
Du cote paternel, on note qu’une tante
et une cousine avaient aussi des pigmen
tations mucocutanees au niveau du visage.
Une endoscopie est alors pratiquee chez
cette jeune patiente et on constate la
presence de deux polypes oesophagiens
situes a 38 cm et mesurant environ 7 a 8
mm de diametre. A l’estomac, on visualise
une lesion polypoide d’environ 5 a 6 mm
de diametre au niveau de la face anterieure de la grande courbure et un polype
d’environ 1.5 cm au niveau du corps
gastrique.
Une intervention chirurgicale fut done
pratiquee dans les jours qui ont suivi son
admission. On pratiqua alors une gastrotomie ainsi que des enterotomies etagees
pour proceder a 1’exerese des polypes gastriques et duodenaux, et des polypes du
jejunum de plus de 2 cm. Les suites operatoires sont marquees par une occlusion
mecanique sur bride qui fut soulagee par
la section chirurgicale de la bride. Le
rapport pathologique final fut celui de
polype glandulaire hamartomateux de l’estomac, du duodenum, du jejunum ainsi
que de i’ileon.
Huit ans apres l’intervention chirurgi
cale, la malade est revue en clinique exteme, se porte bien, a eu une grossesse
non compliquee et son enfant est porteur
de pigmentations mucocutanees.
Heredite
L’analyse des differentes families
porteuses du syndrome de Peutz-Jeghers
a demontre un mode de transmission
autogene dominant, avec atteinte egale
des deux sexes. Quant aux cas rapportes, 50% ont une histoire familiale
positive alors qu’un autre 50% sont
des cas presumement isoles, resultant
de mutations sporadiques. Aucune pre
dilection raciale n’est relevee dans les
differentes series.
Les manifestations mucocutanees et
intestinales seraient secondaires a la
presence d ’un seul gene a expression
phenotypique multiple, mais a haute
penetrance. E n effet, les cas m ontrant
une atteinte isolee sont inhabituels.
Quant a l’analyse des chromosomes,
ceux-ci sont quantitativement et qualitativement norm aux dans la majorite
des cas. M ais en 1969, Kieselstein et
collegues9 ont rapporte trois cas ayant
un chrom osom e “y” anormalement
long chez une famille juive iraquienne.
Les memes auteurs ont aussi rap.porte
Fassociation d’une maladie renale polykystique avec ce syndrome.

et sont mises en evidence tres tot dans
l’enfance. Elies sont habituellement
pathognomoniques de la maladie. En
effet, les lesions cutanees apparaissent
comme des macules brunes ou noires
alors que les lesions muqueuses ont
souvent une teinte plutot bleu-gris
dans la plupart des cas. La majorite des
taches ont environ 1 a 5 mm de diame
tre, sont rondes ou ovales ou quelquefois irregulieres et montrent peu de
tendance a la coalescence. Les lesions
sont invariablement aplaties, non prurigineuses et sans poil. A l’examen histologique de ces differentes taches, nous
pouvons y voir une augmentation des
grains de melanine presente au niveau
des melanocytes localises dans la
couche basale de l’epithelium.
Les lesions pigmentees sont rencontrees le plus souvent au niveau des
levres, particulierement au niveau de
la muqueuse de la levre inferieure
(Fig. 3). Le second point le plus fre
quent en importance est la muqueuse
buccale (Fig. 4), mais nous pouvons
aussi en retrouver au niveau de la face
au pourtour du nez et des yeux (Fig.
5), au niveau des doigts et des pieds et
au niveau de la region perianale.
D urant 1’evolution du syndrome de
Peutz-Jeghers, les lesions cutanees peuvent disparaitre legerement alors que
les lesions muqueuses demeurent inchangees. Bartholomew et collegues18
rapportaient la presence de la lentigi
nose peribuccale chez 174 malades sur
un total de 182.
Le mode de presentation clinique du

syndrome de Peutz-Jeghers est essentiellement lie a la presence des polypes
au niveau du tractus digestif.
Chez 85% des patients le syndrome
se manifeste souvent durant les deux
premieres decades de la vie par des
coliques abdominales recidivantes et
migratrices, secondaires a un processus
d ’intussusception. Chez 25% des pa
tients, une spoliation sanguine avec
anemie hypochrome secondaire, associee ou non a un syndrome d’occlusion
intestinale, peut etre la manifestation
i nitiale.11
A 1’examen de l’abdomen, en phase
aigue d’invagination, un boudin peut
etre palpe.
Plus rarement, le prolapsus d’un
polype anorectal peut devenir la pre
miere manifestation du syndrome et il
faudra se rappeler les localisations pulmonaire et urinaire de la pathologie,
ainsi que la survenue de kystes multi
ples au niveau des voies biliaires, avec
complexe de Meyenburg a l’histologie.
De fagon isolee, l’obesite, l’amenorrhee,
la scoliose et l’hippocratisme digital ont
ete rapportes.12

FIG. 2—Cas no 1. Conglomerat de
polypes au niveau de l’angle splenique.

FIG. 4— Aspect classique des pigmen
tations de la muqueuse buccale.

FIG. 3—Pigmentations
de la region peribuccale.

FIG. 5—Pigmentations cutanees periorbitaires.

Manifestations mucocutanees
et digestives
Les manifestations mucocutanees du
syndrome de Peutz-Jeghers sont presentes chez a peu pres tous les patients
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mucocutanees
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Aspect radiologique

FIG. 6—Polype hamartomateux pedicule.

Quant a l’aspect radiologique du syn
drome, les dernieres annees ont vu
s’ajouter quelques contributions en angioradiologie.
En 1972, Fenlon et Shackelford13
decrivaient l’hypovascularisation des
hamartomes avec manque de remplissage veineux precoce. Ces constatations
sont differentes de celles rencontrees
dans le leiomyome intestinal caracterise par une neovascularisation avec
une phase veineuse precoce et dans le
carcino'ide avec un profil arteriel etoile.
Les manifestations radiologiques frequentes sont celles reliees a l’invagination avec occlusion intestinale secondaire.14
Discussion

etait touche dans 50% de ces cas. Le
coeur, les ganglions, le foie, le pan
creas, le poumon et le peritoine sont les
foyers de metastase dans la serie de
Reid et, recemment, des atteintes des
os et du cerveau ont ete rapportees.18
Les polypes peuvent etre presents au
niveau de tout le systeme gastrointes
tinal, mais peuvent aussi se rencontrer
soit dans l’arbre urinaire, soit dans le
systeme bronchique. Le petit intestin
est implique chez environ 95 % des
patients, le colon et le rectum chez
environ 30% et l’estomac chez a peu
pres 25% des patients. On rencontre
quelquefois des localisations appendiculaires et, dans de tres rares occasions,
l’oesophage peut etre atteint.
A l’examen macroscopique, les poly
pes peuvent etre sessiles ou pedicules
et d’un diametre variant de 0.1 a 3 cm
et, a l’occasion, nous pouvons rencon
trer de petits polypes de 1 a 2 mm
formant un conglomerat. Quelques cas
ont aussi ete decrits oil les polypes recouvraient completement l’intestin; ceci
n’a pas encore ete decrit pour l’estomac et le colon. Les polypes plus
grands que 0.5 cm ont tendance a etre
pedicules et, au point de vue macro
scopique, ils ont une apparence tout-afait similaire aux polypes adenomateux
(Fig. 6). Les polypes du petit intesti.'
ont souvent comme manifestation Clini
que associee, la presence d’intussusception, alors que les polypes presents au
niveau du colon ont tres rarement ten
dance a provoquer des manifestations
occlusives associees a l’invagination. La
rectorragie peut etre le mode de pre
sentation des polypes coliques.
Les caracteres histologiques sont bien
decrits: les hamartomes ont un exces
d’epithelium normal qui recouvre des
bandes de muscles lisses. L’epithelium
contient les trois types de cellules normalement rencontres dans la muqueuse du
petit intestin, a savoir: les cellules
cylindriques absorbantes, les cellules
mucipares et les cellules de Paneth.
Les cellules ont un arrangement et un
rapport similaire a celui present dans
la muqueuse du petit intestin normal
(Fig. 7). Des entrelacements de muscles
lisses sont aussi une observation pathologique rencontree de faqon caracteristique au niveau de ces differents ha
martomes. Ces embranchements sont
presents au centre des tumeurs et parfois, de faqon moindre, a la peripherie.
Cette derniere malformation presente
au niveau du muscle lisse laisse supposer qu’une malformation de ce tissu
soit a l’origine de la pathologie. Quel
ques cas ont ete decrits signalant une
extension au niveau de la paroi intesti
nale, observation qui a fait dire a
plusieurs que cette lesion pouvait etre
une neoplasie a caractere envahissant.
Une analogie est faite, a ce titre, au

FIG. 7—Histologie d’un polype du
grele. (a) Axe conjonctif et glandes (he
matoxylin, phloxine et eosine, image reduite de 50% apres grossissement de
128X). (b) Cellules cylindriques et calciformes et micro-villosites (hematoxylin,
phloxine et eosine, image reduite de
50% apres grossissement de 320 X).

En 1969, Dozois et collegues15
avaient recense 321 cas, dont 29
avaient ete releves aux Etats-Unis, 18
en France, 13 en Italie et 11 en Angleterre. Six cas seulement avaient ete
rapportes au Canada et nous pensons,
sauf erreur, depuis la publication de
Shibata et Phillips12 en 1970, rapporter
les huitieme et neuvieme cas.
Quant aux publications plus recentes,
plusieurs cas isoles ont ete signales et
aucune autre serie n’est aussi importante que celle publiee par Utsonomiya
et collegues16 qui couvre 1’experience
japonaise de 1961 a 1974 avec 222 cas
publies. Cette etude represente tous les
cas releves au Japon a l ’echelle nationale;
Page moyen des patients etait de 23 ans
pour les hommes et de 26 ans pour les
femmes. La proportion des sexes est de
1 et, quant aux differentes manifesta
tions cliniques de la maladie, elles se
rapprochent de celles rapportees dans
le reste de la litterature, a savoir, 42.8%
de manifestations cliniques d’occlusion,
23.4% de phenomenes de douleurs
abdominales, 13.4% de rectorragies et
7.2% de prolapsus d’un polype rectal.
Les frequences des differentes localisa
tions des polypes dans cette serie sont
de 48.6% pour l’estomac, 64% au
niveau du grele, 53.2% au niveau du
colon et 32% au niveau du rectum.
De 1921 a 1969, 321 cas avaient ete
releves dans la litterature. Entre 1969
a 1978, nous pouvons dire que ce
nombre a au moins double, les series
de Dozois et d’Utsonomiya totalisant
a elles seules 543 malades.
Vingt-huit cas de neoplasie ont ete
rapportes par Utsonomiya et colle
gues,16 dont 11 avec metastases prouvees. Reid17 rapportait pour sa part en
1974. 14 cas de syndrome de PeutzJeghers avec metastases, mais faisait
bien ressortir que l’envahissement de
la sereuse etait un critere incertain de
malignite. Le carrefour gastroduodenal
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sinus de Rokytanski Aschoff dans la
vesicule et a la colite cystique profonde
rencontree au colon.
Quant au polype de Pestomac et du
cadre duodenal, il montre les memes
caracteres histologiques prealablement
decrits pour les hamartomes du petit
intestin. Le polype colique dans le syn
drome de Peutz-Jeghers montre aussi
des lesions de type proliferatif. Cependant, nous y rencontrons le plus souvent un seul type cellulaire au niveau
de Pepithelium de recouvrement du
polype et cet epithelium est tout-a-fait
non discernable de celui du polype
adenomateux classique.
Parmi les autres polyposes digestives
hereditaires (Tableau I), nous devons
mentionner la polypose colique familiale
dont le potentiel precancereux n’est
plus a demontrer, le syndrome de
Gardner19 caracterise par l’association
de polypose intestinale, tumeurs osseuses et anomalies des tissus mous et
dont le mode de transmission est identique au Peutz-Jeghers. La mise en
evidence des lesions extra-digestives
apparait ici essentielle au diagnostic;
elles se manifestent par des osteomes
au niveau du crane, par des epaississements corticaux au niveau des os longs
et par des kystes epidermoi'des et des
fibrolipomes au niveau des tissus mous.
La polypose juvenile generalisee19 se

manifeste durant la premiere decade de
vie par des diarrhees, rectorragies et
autoamputation de polypes. Ceux-ci
sont des hamartomes et, recemment,
une incidence elevee de neoplasie a ete
rapportee. Aucune manifestation extra
digestive n’est ici notee.
Le syndrome de Turcot,19 lui, est
caracterise par I’association de polypes
digestifs et des tumeurs du systeme
nerveux central. Son mode de trans
mission est different; il est autosomal
recessif. Le syndrome Cronkhite Cana
da19 associe une polypose gastro-intestinale avec alopecie, pigmentations
cutanees et onychodystrophie, mais n’a
pas d’incidence familiale relevee.19
De plus, de rares neoplasies ovariennes ont ete associees au syndrome
de Peutz-Jeghers et ce de fa§on non
equivoque par Scully.20
Il s’agit en effet de tumeurs ovariennes presentant une structure tubulaire avec tendance a la calcification
et dont l’origine histologique serait la
granulosa.
D’interessantes hypotheses ont ete
fournies quant a l’origine de ces neo
plasies ovariennes. Gillman21 explique
ce phenomene par une origine extragonadique des cellules de la granulosa,
soit de Pepithelium germinal primitif
de nature endodermique.
Dozois et collegues22 rapportent une

incidence nette de 14% des neoplasies
ovariennes chez les femmes porteuses
du syndrome et ce, chez 115 patientes.
Bailey23 rapportait en 1957 une inci
dence de 24% de neoplasie dans la
polypose intestinale de Peutz-Jeghers.
Ces chiffres initiaux cependant resultaient d’une mauvaise interpretation de
l’histopathologie de la lesion. Il appa
rait maintenant plus realiste de parler
de risque accru de neoplasie chez le
malade atteint du syndrome de PeutzJeghers et ce risque est evalue a environ
2% a 3 % .
Quant a la survie a 60 ans d’un
malade atteint du syndrome de PeutzJeghers, celle-ci est diminuee de fa?on
significative. En effet, dans l’etude
d’Utsonomiya et collegues,16 34.6%
des patients etaient decedes a cet age.
La spoliation sanguine et Pinvagination
intestinale etaient responsables de la
majorite de ces deces. Quant au groupe
de malades ages de moins de 30 ans,
la neoplasie devenait la premiere cause
de deces, et ce, chez 60% des patients
retenus pour controle ulterieur. La neo
plasie du colon etait responsable a elle
seule de 8 des 24 cas de deces attribuables au cancer. D’autre part, Dozois
et collegues15 en 1969, demontraient
qu’il n’y avait aucune correlation entre
la localisation des hamartomes et les
differentes neoplasies, a savoir que les

Tableau I— Les syndromes de polypose gastro-intestinale hereditaire (adapte d'Erbe RW.19)

Lesions
gastro-intestinales

Nature
pathologique
des polypes

Polypose colique adeno- Polypose limitee au
mateuse familiale
colon etau rectum

Adenomateuse

Aucune

Syndrome
Jeghers

Hamartomateuse

Taches de melanine sur Risque d’environ 2-3% Autosomale dominante
les levres, la muqueu- d’un cancer gastro-inse buccale et les doigts testinal, impliquant souvent la region duodenale

Syndrome

de

Peutz-

Syndrome de Gardner

Polypose generalisee,
mais les polypes de I’intestin grele sont cons
tants

Polypes du colon et du Adenomateuse
rectum (rarement de
i’intestin grele)

Lesions
extra-intestinales

Predisposition
au cancer

Transmission

Marquee (un adenocar- Autosomale dominante
cinome du colon se developpe chez la plupart
des patients non-traites)

Tumeurs osseuses et
des tissus mous, habi
tuellement
multiples
(les osteomes globuleux
de la mandibule avec
fibromes associes sont
caracteristiques);
on
rencontre aussi des
osteomes de la calotte
crdnienne recouverts de
fibromes des kystes epidermoi'des, des lipomes
et, specialement apres
une operation, des tu
meurs desmoi'des et une
fibromatosecicatricielle

Marquee, comme dans Autosomale dominante
la polypose colique ade
nomateuse
familiale,
mais avec un risque additionnel de carcinome
de la region du pancreas
etdu duodenum

Polypose juvenile gene Habituellement du colon
ralisee
et du rectum mais peut
atteindre I’intestin grdle
e tl’estomac

Hamartomateuse

Aucune

Probable, mais I’impor- Autosomale dominante
tance du risque demeure
incertaine

Syndrome de Turcot

Adenomateuse

Tumeurs cerebrales

Du cerveau (aucun can Autosomale recessive
cer du tractus gastro
intestinal signale)
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differents cas de cancer retrouves chez
les gens porteurs du syndrome de
Peutz-Jeghers correspondaient aux lo
calisations retrouvees dans la popula
tion en general; 326 cas avaient ete
releves pour une incidence de 2.4%.
Dodds et collegues24 en 1972 rapportent de leur cote que l’age moyen des
malades atteints de cancer et porteurs
du syndrome de Peutz-Jeghers est
significativement abaisse. En effet, les
malades porteurs d’un cancer du colon
et du rectum avaient une moyenne
d’age de 41 ans, ceux porteurs d’une
neoplasie gastrique 27 ans et ceux
ayant une neoplasie du duodenum de
28 ans; ce qui est significativement
plus has que pour ces differentes neoplasies dans la population en general
dont Page moyen se situe aux environs
de 55 ans. Ils concluaient que le potentiel precancereux dans la polypose
digestive de Peutz-Jeghers etait en re
lation avec un phenomene de duplica
tion cellulaire augmentee, et ce, en
raison de la polypose disseminee.
Le comportement a long terme du
syndrome de Peutz-Jeghers doit nous
dieter une attitude conservatrice face
a ses diverses manifestations.
La spoliation avec anemie secondaire
et Pocclusion intestinale demeurent
toujours des indications chirurgicales,
mais, meme dans ces cas, une polypectomie sera toujours preferee si elle
est possible. Meme dans une polypose
etendue du grele. il faut eviter les re
sections etendues, les reinterventions
etant toujours possibles. Une localisa
tion gastroduodenale et colique devra
toujours etre consideree avec attention,
considerant le risque de neoplasie
rapporte pour ces endroits, surtout
face a des polypes de plus de 2 cm. La
surveillance a long terme de la poly
pose par endoscopie haute et basse et
serie digestive, ainsi qu’un examen
gynecologique, nous apparaissent adequats pour suivre ces malades.
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SESAP II Question
Items 269-272
(A) Anaphylaxis
(B) Diarrhea, nausea and vomiting
(C) Pancytopenia
(D) N ephrotoxicity
(E) Hepatitis
269. Kanamycin
270. Isoniazid
271. Erythromycin
272. Penicillin
For each numbered word above, select the one lettered word or phrase that
is most closely associated with it. Each lettered word or phrase m ay be
selected once, more than once, or not at all.
F or the critique of Items 269-272 see page 273 of this issue.
(Reproduced by permission of the American College of Surgeons from
SESAP II Syllabus: Surgical Education and Self-assessment Program N o. 2.
F or enrolment in the Surgical Education and Self-assessment Program N o. 2
please apply to the American College of Surgeons, 55 East E rie St.,
Chicago, IL 60611.)
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Relieves spasm without
interfering with muscle
function
Usually patients can be relieved of muscle spasm and not
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Prompt onset of action
Clinical improvement has been observed as early as the first
day of therapy in some patients. The full therapeutic response
often can be expected during the first w eek of therapy.
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acute, painful musculoskeletal conditions.

Toute communication initiate doit etre
adressee aux coredacteurs, CP 8650,
Ottawa, Ont. K1G 0G8 sous la mention:
"Le journal canadien de chirurgie".

S hould be used only for short periods (up to two or three w eeks), because
adequate evidence of effectiveness for more prolonged use is not available, and
because muscle spasm associated with acute, painful musculoskeletal conditions
is generally of short duration and specific therapy for longer periods is seldom
warranted.
It has not been found effective in the treatment of spasticity associated with
cerebral or spinal cord disease, or in children with cerebral palsy.

Les textes originaux des articles et des
autres communications y compris un
nombre lim ite de rapports sur des cas
speciaux doivent etre rediges en double
exemplaire, en frangais ou en anglais, et
accompagnes d'une lettre demandant
leur publication dans le Journal. Veuillez
les dactylographier sur une seule face
d'une feuille non reglee avec double
interligne et grandes marges.

D O S A G E A N D A D M IN IS T R A T IO N
T h e usual dosage o f FLE XERIL* is 10 m g three times a day, with a range o f 2 0 to
4 0 m g a day in divided doses. D osage should not exceed 60 m g a day. Use o f
FLE X E R IL is not indicated o r recom m ended for periods longer than two o r three
weeks.
C O N T R A IN D IC A T IO N S
Hypersensitivity to the drug. Concom itant use o f monoamine oxidase inhibitors or
within 14 days after their discontinuation. Acute recovery phase o f myocardial infarction,
and patients with arrhythmias, heart block or conduction disturbances, or congestive
heart failure. Hyperthyroidism.

Les principales unites de mesure doivent
etre exprimees selon le Systeme inter
national d'unites si c'est possible.

W A R N IN G S
U s e for periods longer than two or three w eeks is not recommended (see
IN D IC A T IO N S ).

Les illustrations telles que des photo
graphies d’appareils cliniques, des radiographies, des photomicrographies, des
graphiques et des diagrammes doivent
etre fournies sous la forme d'epreuves
sur papier glace sans montage, les bordures intactes, d un format ne depassant
pas 20 X 25 cm. Chaque illustration doit
etre munie d'une legende dactylographiee sur une page separee du texte de
/'article. S'il s'agit de radiographie, en
voy e2 une copie et non / ’original. S'il
s'agit d’une photomicrographie, indiquez
le contraste et I ’echelle de I'agrandissement. Les lettres qui servent a identifier
les elements d'une illustration doivent
etre d'une dimension suffisante afin de
demeurer visibles lorsque les necessites
de /'impression imposent une reduction
de I ’image fournie.

FLE X E R IL is closely related to the tricyclic antidepressants, e.g., amitriptyline and
imipramine. In short-term studies for indications other than muscle spasm associated
with acute musculoskeletal conditions, and usually at doses somewhat greater than
those recom m ended for skeletal muscle spasm, som e o f the m ore serious central
nervous system reactions noted with the tricyclic antidepressants have occurred (see
W A R N IN G S below, and A D V E R S E R E A C T IO N S ).
F L E X E R IL may interact with M A O inhibitors. Hyperpyretic crises, severe convulsions,
and deaths have occurred in patients receiving tricyclic antidepressants and M A O
inhibitors.
Tricyclic antidepressants have been reported to produce arrhythmias, sinus tachycardia,
prolongation o f the conduction time leading to myocardial infarction and stroke.
FLE X E R IL’ may enhance the effects o f alcohol, barbiturates, and other C N S
depressants.
P R E C A U T IO N S
M ay impair mental and/or physical abilities required for performance o f hazardous
tasks, such as operating machinery or driving a m otor vehicle.
Because o f its atropine like action, FLEXERIL* should be used with caution in patients
with a history o f urinary retention, angle closure glaucoma, increased intraocular
pressure, and in patients taking anticholinergic medication.
Tricyclic antidepressants m ay block the antihypertensive action o f guanethidine and
similarly acting compounds.

Use in Pregnancy: T h e safe use in pregnant w om en has not been established. T h ere
fo re it should not be administered to w om en o f childbearing potential unless, in the
opinion o f the treating physician, the anticipated benefits outweigh the possible
hazards to the fetus. Use in Nursing Mothers: Because it is likely that F L E X E R IL * is
excreted in milk, it should not be given to nursing mothers. Use in Children: Safety and
effectiveness in children below the age o f 15 have not been established.

II ne faut pas qu'on puisse identifier un
patient grace a une illustration a moins
qu’il n'y ait expressement consenti par
ecrit; faute de permission les traits de
sa physionomie doivent etre obliteres.
Les illustrations en couleur ne seront
publiees qu'aux frais de I'auteur. Si
I illustration provient d'une autre source,
il convient d’obtenir tant de I'auteur que
de I'editeur de I'ouvrage dont elle est
tiree, I'autorisation de s en servir aux
fins de la publication.

A D V E R S E R E A C T IO N S

Most frequent: Drowsiness (4 0 % ), dry mouth (2 8 % ), dizziness (11% ). Less frequent:
Increased heart rate (and several cases o f tachycardia), weakness, dyspepsia,
paresthesia, unpleasant taste, blurred vision, and insomnia. Rare: Sweating, myalgia,
dyspnea, abdominal pain, constipation, coated tongue, tremors, dysarthria, euphoria,
nervousness, disorientation, confusion, headache, urinary retention, decreased bladder
tonus, and ataxia.
T h e listing which follows includes other adverse reactions which have been reported
with tricyclic compounds, but not with FLE X E R IL* when used in short-term studies
in muscle spasm o f peripheral origin. S om e o f these reactions (e.g., hallucinations)
w ere noted, however, when FLE X E R IL* was studied for other indications, usually in
higher dosage. Pharm acologic similarities am ong the tricyclic drugs require that each of
the reactions be considered when FLE X E R IL* is administered. Cardiovascular.
Hypotension, hypertension, palpitation, myocardial infarction, arrhythmias, heart block,
stroke. CNS and Neuromuscular: Confusional states, disturbed concentration,
delusions, hallucinations, excitement, anxiety, restlessness, nightmares, numbness and
tingling o f the extremities, peripheral neuropathy, incoordination, seizures, alteration in
E E G patterns, extrapyramidal symptoms, tinnitus, syndrome o f inappropriate A D H
(antidiuretic horm one) secretion. Anticholinergic: Disturbances o f accom m odation,
paralytic ileus, dilatation o f urinary tract. Allergic: Skin rash, urticaria, photosensitization,
ed em a o f face and tongue. Hematologic: B on e marrow depression including
agranulocytosis, leukopenia, eosinophilia, purpura, thrombocytopenia. Gastrointestinal:
Nausea, epigastric distress, vomiting, anorexia, stomatitis, diarrhea, parotid swelling,
black tongue. Rarely hepatitis (including altered liver function and jaundice). Endo
crine: Testicular swelling and gynecomastia in the male, breast enlargem ent and
galactorrhea in the fem ale, increased o r decreased libido, elevation and lowering o f
b lo o d sugar levels. Other: Fatigue, weight gain or loss, urinary frequency, mydriasis,
jaundice, alopecia. Withdrawal Symptoms: Abrupt cessation o f treatment after pro
lo n ged administration m ay produce nausea, headache, and malaise. Th ese are not
indicative of addiction.

II faut que les tableaux soient conformes
au format rectangulaire du Journal et
rediges sur des feuilles separees du
texte, un tableau par feuille.

Les references doivent etre citees dans
le texte au moyen d'un chiffre et groupees dans I ’ordre a la fin de / ’article
selon la maniere de faire adoptee par
ce Journal. Les references a des periodiques doivent etre conformes a celles
qu'adopte /'Index Medicus.
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Un resume qui ne doit pas depasser 125
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sur une feuille separee.
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ORIGINAL CONTRIBUTIONS

Primary Malignant Retroperitoneal Tumours:
Analysis of 30 Cases
B. Bose,

A n a n a ly s is is p re se n te d o f a ll ca s e s ,
30 in n u m be r, o f m a lig n a n t re tro 
p e rito n e a l tu m o u r o c c u rrin g in no rth e rn
A lb e r t a d u rin g an 11-year p e rio d . The
in c id e n c e w a s 0.28 c a s e s p e r 100 000
p o p u la tio n an d th e 30 tu m o u rs c o n s t i
tu te d 0.1% o f a ll m a lig n a n t le sio n s .
The a g e s o f th e p a tie n ts ra nge d from
3 1/z to 83 y e a rs bu t 50%
w e re in the s ix th , se v e n th and
e ig h th d e c a d e s . The s e x d is trib u tio n
w a s e q u a l. M a lig n a n t re tro p e rito n e a l
tu m o u rs have d iv e rs e h is to lo g ic
c h a r a c t e r is t ic s b e c a u s e of th e ir o rig in
fro m d iffe r e n t t is s u e s w ith in the
re tro p e rito n e a l sp a ce . L e io m y o sa rc o m a
w a s th e c o m m o n e s t ty p e an d next in
o rd e r o f fre q u e n c y w e re rh ab d o m yo 
s a rc o m a an d lip o s a rco m a . T um our s iz e
v a rie d fro m 8 to 30 cm in d ia m e te r
(m ean 14.6 cm ).
A b d o m in a l p a in o r d is c o m fo rt w a s th e
c o m m o n e s t sy m p to m and th e p re se n c e
o f a m a s s th e c o m m o n e st fin d in g .
The ra re a s s o c ia tio n o f h y p o g ly c e m ia
w a s p re s e n t in a s in g le c a s e . Eighty
p e rc e n t o f in tra v e n o u s p y e lo g ra m s and
ro e n tg e n o g ra m s o f th e g a s tro in te s tin a l
tr a c t w e re ab n o rm a l, a fig u re high er
than th a t g e n e ra lly re p o rte d in the
lite ra tu re . In s ix c a s e s an giograp h y
c le a r ly d e m a rc a te d th e g ro w th , e sta b 
lis h e d it s re tro p e rito n e a l n a tu re and
p ro v id e d th e n e c e s s a ry a n a to m ic a l
k n o w le d g e p rio r to s u rg ic a l e x p lo ra tio n .
T he a u th o rs b e lie v e th at an g io g rap h y
sh o u ld be c a rrie d o u t m ore fre q u e n tly .
The d ia g n o s is o f p rim a ry re tro p e rito 
n e a l tu m o u r h a s lo n g been c o n s id e re d
d iffic u lt . A p re o p e ra tiv e d ia g n o s is
w a s m ade in 19 (63% ) c a s e s but in
o n ly 6 w a s th e tu m o u r's p re se n c e
s u s p e c te d b e fo re in v e s tig a tio n s w e re
u n d e rta k e n . In th e re m a in in g 11 c a s e s

md , frcs[c], frcs, frcs ( edin ), facs

(37% ), th e d ia g n o s is w as m ad e a t o p e r 
a tio n o r a u to p sy . S u rg e ry is th e
tre a tm e n t o f c h o ice , bu t the tu m o u r w a s
re s e c ta b le in o n ly s ix (20% ) p a tie n ts ,
and in fo u r o f th e s e the n e o p la s m
re c u rre d . R e s u lts o f p a llia tiv e ra d io 
th e ra p y an d c h e m o th e ra p y w e re g e n e ra lly
d is a p p o in tin g . The 5-year s u rv iv a l ra te
o f 20% re fle c ts th e u su a lly p o o r
p ro g n o s is . A b e tte r p ro g n o s is c a n b e
e x p e c te d in the fu tu re from a d ju v a n t
ra d io th e ra p y and re c e n t p r o g r e s s m a d e
in c o m b in a tio n c h e m o th e ra p y u s in g
c y c lo p h o s p h a m id e , v in c ris tin e , d o x o ru 
b ic in an d d im e th y l-tria ze n o -im id a zo le
c a rb o x a m id e . A n e w staging s y s t e m fo r
s o ft t is s u e sa rc o m a fo rm u la te d b y th e
A m e r ic a n J o in t C o m m itte e on C a n c e r
S ta g in g is e x p e c te d to bring m o re
u n ifo rm ity to th is h e te ro g e n e o u s g ro u p
o f n e o p la s m s and a id in p re d ic tin g
t h e ir b e h a v io u r m o re a c c u ra te ly .

O n p re s e n te une a n a ly se d e s 30 c a s
d e tu m e u rs m a lig n e s re tro p e rito n e a le s
o b s e rv e s d a n s le no rd de I’ A lb e r t a
s u r un e p e rio d e de 11 ans. C e s c a s
r e p r e s e n t e d une in c id e n c e d e 0.28
p a r 100 000 h a b ita n ts et le s 30
tu m e u rs c o n s titu e n t 0.1% de
to u te s le s le s io n s m alig n e s.
L'a g e d e s p a tie n ts s 'e c h e lo n n a it

e n tre

c o m m u n s e t la p r e s e n c e d 'u n e m a s s e
c o n s t it u a it (’o b s e rv a tio n la p lu s c o u ra n te .
L ’h y p o g ly c e m ie e ta it u n e r a r e a s 
s o c ia tio n re tro u v e e d a n s u n s e u l c a s .
Q u a tre -v in g t p o u rc e n t d e s p y e lo g ra m m e s in tra v e in e u x e t d e s ra d io g ra p h ie s d e s v o ie s g a s t r o - in te s tin a le s
e ta ie n t a n o rm a u x, s o it u n e fre q u e n c e
s u p e rie u re a c e q u i e s t g e n e r a le m e n t
re tro u v e d a n s la lit t e r a t u r e . D a n s s ix
c a s , I’a n g io g ra p h ie a c la ir e m e n t re tra c e
le c o n to u r d e la tu m e u r, e lle a e t a b li
s o n o rig in e r e t ro p e rit o n e a le e t
fo u rn i la c o n n a is s a n c e a n a to m iq u e
n e c e s s a ir e a I’e x p lo r a tio n c h ir u r g ic a le .
L ’a u te u r c r o it q u e Ton d e v r a it r e c o u r ir
p lu s fre q u e m m e n t a I’a n g io g r a p h ie .
Le d ia g n o s tic de t u m e u r r e t r o p e r i
to n e a le p rim a ire a lo n g te m p s e te
c o n s id e r e c o m m e d if f ic ile . U n d ia g n o s t ic
p re o p e ra to ire a v a it e te p o s e d a n s
19 c a s (63% ) m a is on n e s o u p c o n n a it
la p re s e n c e d e la tu m e u r q u e d a n s
6 c a s av a n t d 'e n tr e p re n d re ( 'in v e s 
tig a tio n . D a n s le s 11 a u tr e s c a s
(37% ), le d ia g n o s tic a e te e t a b li lo r s
d e I’o p e ra tio n ou a I’a u to p s ie . L a
c h iru r g ie e s t le t ra ite m e n t d e c h o ix ,
m a is la tu m e u r n 'e ta it r e s e c a b le q u e
c h e z s ix p a tie n ts (20% ) e t, p o u r q u a tre
d ’e n tre eux, il y e u t r e c id iv e . L e s
r e s u lta ts de la ra d io th e ra p ie e t d e la
c h im io th e ra p ie p a llia t iv e s fu r e n t d e c e v a n ts . U n ta u x d e s u r v ie d e 5 a n s
d a n s s e u le m e n t 20% d e s c a s c o n s t it u e
le p r o n o s tic h a b itu e l. D a n s le ffutur,
on p e u t s ’a tte n d re a un m e ille u r
p r o n o s tic g ra c e a la r a d io t h e r a p ie
d 'a p p o in t e t a u x p r o g r e s r e c e n t s d e la
p o ly c h im io th e ra p ie a s s o c ia n t la c y c l o 
p h o s p h a m id e , la v in c r is t in e , la
d o x o ru b ic in e e t le d im e th y l- tria z e n o im id a z o le c a rb o x a m id e . U n n o u v e a u
s y s te m e de c la s s if ic a t io n d e s s a r c o m e s
d e s t is s u s m o u s, fo rm u le p a r I 'A m e r ic a n
J o in t C o m m itte e on C a n c e r S t a g in g ,
p e rm e t d 'e s p e r e r a p p o r te r p lu s
d ’u n ifo rm ite d a n s c e g ro u p e h e t e r o g e n e
d e n e o p la s ie s e t d ’a id e r a p r e d ir e le u r
e v o lu tio n d e fa g o n p lu s p r e c is e .

From the Dr. W.W. Cross Cancer
Institute, Edmonton, Alta, and Barrhead
General Hospital, Barrhead, Alta.
Reprint requests to: Dr. B. Bose,
Box 263, Barrhead, Alta. TOG 0E0

3 1/2 a n s e t 83 an s, m ais 50% d e s
p a tie n ts e ta ie n t d a n s leur s ix ie m e ,
s e p tie m e ou h u itie m e d e ca d e . II y
a v a it a u ta n t d ’h o m m e s que d e fe m m e s .
L e s tu m e u rs m a lig n e s re tro p e rito n e a le s
p r e s e n t e d d iv e rs e s c a r a c te r is tiq u e s
h is to lo g iq u e s du f a it q u 'e lle s o r ig in e n t
d e d iffe r e n t s t is s u s c o n te n u s d a n s
I'e s p a c e re tro p e rito n e a l. Le le io m y o s a rc o m e e s t le ty p e le p lu s c o u ra n t,
s u iv i p a r o rd re d e fre q u e n c e , du
rh a b d o m y o s a rco m e e t du lip o s a r c o m e .
La t a ille d e s tu m e u rs v a ria it e n tre
8 e t 30 cm de d ia m e tre (14.6 cm
en m o ye n n e ).
U n m a la is e ou une d o u le u r a b d o m in a le e ta ie n t le s sy m p to m e s le s p lu s
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Primary retroperitoneal tumours com
prise a variety of neoplasms arising
from the different soft tissues of the
potential retroperitoneal space, exclud
ing the retroperitoneal viscera. This
space, which extends from the dia
phragm to the pelvic floor and is
bounded laterally by the iliac crest and
tip of the 12th rib, has been described
as a cradle-shaped area embracing the
intra-abdominal contents, some of
which are partially fixed.1,2
The first description of a primary
retroperitoneal tumour (PRT) is gener
ally ascribed to Morgagni in the latter
part of the 18th century, but it was
Lobstein in 1829 who recognized these
tumours as a separate entity and gave
the first systematic account.3-6 During
the next 11 decades sporadic case re
ports and reviews appeared in the
literature.7 In 1946 Donnelly8 analysed
and reported on 95 consecutive cases
seen over a 20-year period at one group
of hospitals.
There was no accepted classification
of this mixed collection of tumours
until 1954 when Ackerman9 published
his classification based on tissue of
origin. Scrutiny of the literature since
that time confirms unanimous accept
ance of that classification.10 For prac
tical purposes, from a surgeon’s view
point, these tumours can be broadly
divided into two groups, lymphomatous
and nonlymphomatous tumours (sar
comas), because surgery plays no thera
peutic role in the former (except to
establish the stage) and is the treatment
of choice in the latter. Primary retro
peritoneal tumours represent a very
small percentage (0.08% to 0.3%) of
all neoplasms4,6,7,11 and this degree of
rarity limits individual experience. It is
therefore very unlikely that any surgeon
will encounter more than a few cases
during his lifetime.

This paper presents an analysis of 30
cases of malignant PRT seen at the
Dr. W.W. Cross Cancer Institute, Ed
monton during the 11-year period from
Jan. 1, 1966 to Dec. 31, 1976. As
registration of all cancer cases is com
pulsory in the province of Alberta,
these cases represent the total number
occurring in the northern half of the
province, reflecting an incidence of
0.28 cases per 100 000 population.
They constitute 0.1% of all cases of
cancer reported from that area during
the study period.
Patients

Thirty-four cases of PRT were avail
able for analysis, but four cases were
excluded from this report because of
inadequate data, improper coding or
absence of histologic confirmation.
Age and Sex
The age of the 30 patients ranged
from 3Vi to 83 years with 50% of the
cases occurring in the sixth, seventh
and eighth decades. There was an
almost equal distribution between the
two sexes (14 males and 16 females)
(Fig. 1).
Clinical Features
The diagnosis of PRT has long been
considered difficult and challenging
because there is no definite group of
symptoms or signs leading a clinician
to the diagnosis. This is exemplified by
the fact that a retroperitoneal origin
for the tumour was suspected in only
20% of patients in this series. Ab
dominal pain or discomfort, present in
60% of patients, was the commonest
symptom and next in order of fre
quency was weight loss, in 35%.
One out of five patients experienced

anorexia, nausea and back pain. Lower
extremity swelling, an important early
clue to pelvic tumour, was present in
17% and weakness in 13% of the
cases. Two patients had symptoms due
to hypoglycemia and one elderly
asymptomatic patient was found to
have a mass during a routine medical
examination. The duration of symp
toms was from 4 days to 4 years; in
50% of the patients it varied from 2
to 9 months with a mean of 3.66
months, and 20% had experienced
symptoms for a year.
The presence of a mass was the
commonest sign and of 25 patients
(83%) with a palpable mass, 5 were
aware of its presence, which prompted
them to seek medical advice (Figs. 2
and 3). Fifteen of 30 tumour masses
(50%) were located either in the left
upper or right lower quadrant of the
abdomen. Six masses (20%) originated
in the pelvis; three of these were con
fined to the pelvic cavity and could
be palpated only by vaginal or rectal
examination, whereas the other three
were large enough to be palpable in
the suprapubic region. Two tumours in
the right lower quadrant extended to
the flank and one large tumour oc
cupied both upper and lower quadrants
on the right side. The location and ex
tent of the 30 tumour masses is il
lustrated in Fig. 4. The size of the
tumour mass in its greatest dimension
varied from 8 to 30 cm with a mean
of 14.6 cm and in 50% the size ranged
between 12 and 16 cm.

FIG. 2— Hemangiopericytoma
in pelvis of 29-year-old man.

FIG . 1— Age and sex distribution of 30 patients with primary retroperitoneal
tumour (14 male, 16 female). Ages ranged from 3 Vi to 83 years and 50% of patients
were in sixth, seventh and eighth decades of life.
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FIG. 3— Neurogenic sarcoma in 61year-old man showing enlarged liver (L),
tumour mass and end of recent transverse
laparotomy scar.
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The wide variety of symptoms and
the relatively few signs so typical of
PRT are summarized in Table I and
their incidence in this series is com
pared with that quoted in some pub
lished reports.1'3-5-1214
Analysis of Investigations

Hematologic and Biochemical
The peripheral blood count and
hemoglobin estimation did not in any
way aid the diagnosis. A hemoglobin
value of less than 12 g/dl was present
in only six cases. In one patient the
tumour mass was mistaken for an en
larged spleen which led to a complete
hematologic screening. Routine mea
surement of the sedimentation rate was
not performed; the average rate in 10
patients was 26 mm/h. The blood bio-

chemistry profile was normal in the
majority of cases.
Radiologic (Table II)
The type of initial radiologic exam
ination was influenced by the location
of the palpable tumour mass. An epi
gastric or left upper quadrant mass
prompted an upper gastrointestinal
series, whereas a flank or pelvic mass
led to intravenous urography or roent
genography after a barium enema, or
both. Intravenous urography was most
commonly performed and next in order
of frequency were roentgenography
after a barium enema and upper gastro
intestinal series. A combination of two
or all three studies were performed in
9 of 26 patients. Displacement without
obstruction of the gastrointestinal tract
was the commonest finding (Figs. 5
and 6). In one child with angiosarcoma
there was partial obstruction of the
duodenum. In another elderly patient
the tumour had eroded into the stomach
and a fistula had formed. The ab
normalities noted on the urograms
were displacement of the ureter or
bladder, obstructive uropathy and, in
two cases, a nonfunctioning kidney

(Figs. 7 and 8). Six patients were sub
jected to angiography and all had ab
normal findings (Figs. 9 and 10). In
three patients a retroperitoneal tumour
was diagnosed before angiography was
undertaken, but in the other three the
diagnosis was a neoplasm of kidney,
adrenal or liver, respectively. Angio
graphy not only demonstrated the
blood supply but also delineated the
extent of the tumour. Lymphangio
graphy and venography of the inferior
vena cava were not performed in this
series, although others1 have found
the latter procedure beneficial. Only
one patient, a child, was investigated
by ultrasonography and the finding that
the tumour mass was distinct from the

T a b le I I — A n a ly s is o f R a d io lo g ic S tu d ie s

S tu d y
In tra v e n o u s
u ro g ra p h y
U p p e r g a s tr o in 
te s tin a l s e rie s
R o e n tg e n o g ra p h y
a f t e r b a riu m
enem a
A n g io g ra p h y

FIG. 4—Distribution of 30 primary
retroperitoneal tumours in various regions
of abdomen; two tumours in right lower
quadrant extended to flank and one
tumour occupied right upper and lower
quadrants.

T o ta l
no. of
p a tie n ts

P a tie n ts w it h
a b n o rm a l
fin d in g s , n o .
(a n d % )

26

21

(8 0 )

13

11

(8 5 )

19
6

14 ( 7 3 )
6 (1 0 0 )

FIG. 5— Upper gastrointestinal series
showing compression of stomach by mass
which was mistaken for pancreatic cyst.

T a b le 1— In c id e n c e o f S ig n s an d S ym p tom s w ith F ig u re s
fro m th e L ite r a tu r e fo r C o m p a riso n

S ig n /s y m p to m
M ass d is c o v e re d b y : p a tie n t
p h y s ic ia n
A b d o m in a l p a in (d is c o m fo rt)
W e ig h t loss
A n o re x ia
N a u s e a and v o m itin g
B ack p a in
L o w e r e x tr e m ity s w e llin g
C o n s tip a tio n
W eakn ess
D ysp ep sia
U r in a r y sym ptom s
D ia rrh e a
In c re a s in g g irth
H y p o g ly c e m ia
J a u n d ic e
M e n o rrh a g ia
A c u te abdom en
N o sym ptom s
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P re s e n t s e rie s
n o . (a n d % )

H ith e r to
re p o rte d , %

20 > (8 3 )

30 - 90

18
11
6
6
6
5
4
4
3
3
2
2
2
1
1
1
1

/

(6 0 )
(3 5 )
(2 0 )
(2 0 )
(2 0 )
(1 7 )
(1 3 )
(1 3 )
(1 0 )
(1 0 )
(6 )
(6 )
(6 )
(3 )
(3 )
(3 )
(3 )

50 - 70
2 .5 - 54
40
20 - 30
7 - 25
6 -7
19
7 -2 2
—

2 .5 - 3
10
—

—
—
—
—

FIG. 6— Roentgenogram after barium
enema showing displacement, stretching
and compression of sigmoid colon by large
fibrosarcoma arising in pelvis.
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liver helped to rule out a hepatic
tumour that had been suspected on
clinical grounds. The initial chest roent
genogram was abnormal in seven
(23%) patients. In six there was evi
dence of a pulmonary metastasis and
one had hilar adenopathy. Other non
specific findings due to the upward
pressure of a large mass included high
diaphragm, basilar pulmonary infiltrate
and atelectasis. Of 17 liver scans ob
tained, 5 were considered abnormal
and in 1 the finding was equivocal. In
general scanning was not helpful as a
diagnostic examination except for pro
viding preoperative knowledge of
hepatic involvement by a malignant
process and indirectly indicating a poor
prognosis. Renal scanning was not per
formed in any of the patients.
Diagnosis
Based on history and physical exam
ination, the diagnosis was suspected in
6 of the 30 patients, but the laboratory
and radiologic investigations established
the presence of a PRT in 19. In the
other 11 patients the diagnosis was
made at operation or autopsy.
Analysis of Treatment
Complete operative removal of the
tumour was achieved in six cases, giv
ing a resectability rate of 20%. How
ever, the tumour recurred in four
patients and it is uncertain whether the
recurrence originated from microscopic
fragments of tumour tissue left behind
or represented a new neoplasm. These
figures emphasize that most malignant
retroperitoneal tumours infiltrate the
surrounding tissue and are not amen
able to total removal although it may

appear to the naked eye that excision
has been complete. The four recur
rences were detected at 1, \'/i, 2 and
9 years after the original operation.
In 7 cases removal of the tumour
was known to have been incomplete
and in 16 cases biopsy only was done
in the presence of a nonresectable
growth. Of 29 patients subjected to ex
ploration, the tumour was found to be
unresectable in 16 (55%), only partial
removal was possible in 7 (24%) and
the growth was resectable in 6 (21%).
Ten patients received radiotherapy
but in none of them was the response
considered good. However, six patients
showed some degree of response as
judged by a reduction in tumour size
and temporary improvement in the
quality of life. Three patients responded
poorly and in one the treatment was
abandoned because of severe irradi
ation sickness and deterioration in the
patient’s general condition.
Thirteen patients received chemo
therapy. A single agent was used in
eight patients during the first 7 years
of the study. In the last 4 years five
patients received combination chemo
therapy. The combination of choice
currently in use is doxorubicin (Adriamycin®), dimethyl-triazeno-imidazole
carboxamide (DTIC), vincristine and
cyclophosphamide. Experience with
this regimen is limited but the results
have so far been encouraging.15 A
longer period of study involving sev
eral hundreds of patients is required
to obtain statistically significant results.

nerves. This histopathologic distribu
tion is different from that described in
other reports,‘■4'5’7 where lymphoma
constituted 25% to 33% of the total
and next in order of frequency was
liposarcoma, myosarcoma or fibro
sarcoma. This difference may be due
to the diagnosis of lymphoma having
been made in our cases before the
development of a palpable abdominal
mass, and thus escaping the label of
retroperitoneal tumour.

T a b le I I I — H is to p a th o lo g y o f 3 0 T u m o u r s

T u m o u r ty p e
L e io m y o s a r c o m a
R h a b d o m y o s a rc o m a
L ip o s a rc o m a
L ip o m y x o s a r c o m a
N e u r o g e n ic s a rc o m a
U n d i f f e r e n t i a t e d s a rc o m a
F ib r o s a r c o m a
N e u r o b la s t o m a
A n g io s a r c o m a
M esenchym om a
E m b r y o n a l c a r c in o m a
R e t ic u lu m c e ll s a rc o m a
H e m a n g io p e r ic y t o m a

N o . o f cases
8
4
4
3
2
2
1
1
1
1
1
1
1

Histopathology (Table III)
Histologically, tumours of muscle
origin were most frequent, followed by
neoplasms arising from fatty tissue and
FIG. 9— Arteriogram showing tumour
circulation. N ote tumour (arrows) displac
ing right kidney.

FIG. 7— Intravenous pyelogram showing
obstruction of right ureter with distortion
of bladder.
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FIG. 8—Retrograde pyelogram show
ing marked obstructive uropathy. (Re
produced by permission from Bose B,
Boake RC.10)
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FIG. 10— Arteriogram showing tumour
blood supply from right lumbar arteries
and iliolumbar arteries. (Reproduced by
permission from Bose B, Boake RC.10)
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Survival

The dismal prognosis is reflected in
the survival of only 6 patients for more
than 5 years (range 6 to 12 years).
Two patients are alive with disease at
1Vi and 3V2 years. Twenty-two (73%)
patients were dead within 5 years;
13 died within 1 year and 5 within
2 years.
Discussion

Primary retroperitoneal tumours are
rare, usually escape early detection and
have an unpredictable behaviour pat
tern. Four out of five of these tumours
are malignant and both the sexes are
affected equally. Generally about 50%
occur during the fifth, sixth and seventh
decades of life, 25% in the first decade
and the rest (25%) in the second to
fourth decades.10 Findings in the
present series correlate well with the
above figures.
Unlike cancer in other parts of the
body, these neoplasms are not iden
tified by any suggestive group of symp
toms and findings. They tend to infil
trate and grow in the direction of least
resistance and thus produce symptoms
referred to the intra-abdominal organs
they compress, displace or obstruct.
Pressure on or invasion of the muscles
or nerves of the posterior abdominal
wall causes back pain and nerve root
symptoms; interference with the venous
or lymphatic drainage produces lower
extremity edema. Abdominal pain or
discomfort is the most common symp
tom and a palpable mass the com
monest finding.
Symptoms due to hypoglycemia, pro
duced very rarely by some of the
large fibrosarcomas, are well docu
mented.16-10 Two patients in this series
had such symptoms but in only one
was laboratory confirmation obtained.
A classic episodic attack consisting of
weakness, sweating and fainting is
common, but not infrequently patients
are seen in different stages of coma or
with bizarre mental symptoms which
can be mistaken for psychiatric ill
ness.17 The mechanism producing this
hypoglycemia is interesting because a
low plasma insulin concentration is
present during the attack. This anomaly
of hypoglycemia and low plasma in
sulin concentration is explained by the
fact that an insulin-like substance,
chemically unrelated to insulin, is
secreted by the tumour. This substance,
which can be recovered from tumour
extract, acts like insulin to produce
hypoglycemia which in turn suppresses
the beta-cell activity of the pancreas,
lowering the plasma insulin concentra
tion. The degree of hypoglycemia is
directly proportional to the size of the
tumour and the values of blood glucose
VOLUME 22, NO. 3, MAY 1979
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and insulin revert to normal following
excision of the tumour. Should the
tumour recur the hypoglycemia again
becomes evident and in such cases
symptoms have been controlled by
raising the blood glucose concentration
using diazoxide or trichlormethiazide.
It is also important to remember that
in such patients treatment of the hypo
glycemia is imperative during operative
manipulation of the tumour analogous
to the treatment of hypertension during
operative removal of a pheochromocytoma.
The diagnosis of retroperitoneal
tumour has always been considered
difficult, but in this series it was made
in 6 patients after a routine history
and physical examination and in an
other 13 patients the presence of a
retroperitoneal mass was confirmed
following appropriate roentgenologic
studies. Thus in 19 (63%) patients the
diagnosis of a retroperitoneal tumour
was made before operation; the diag
nosis was made in 9 patients at opera
tion and in 1 at autopsy. It is interest
ing that in five cases the diagnosis of
kidney tumour was entertained before
investigation, and that in three of these
the correct diagnosis was reached after
routine roentgenologic studies. How
ever, in the two in whom the diag
nosis was made only at operation, an
giography had not been performed,
which in retrospect would have ruled
out kidney tumour. The various clinical
diagnoses made in 24 cases are listed
in Table IV.
Although 80% of intravenous pyelograms appeared abnormal, intravenous
pyelography is less valuable than
angiography which gives more informa
tion. The initial aortogram will allow
visualization of all the branches in the
retroperitoneal area and display the
stretching or displacement of the
arteries and the viscera that they
supply. In a large series of arterio
grams,20 renal arteries and kidneys

Table IV— Clinical Diagnosis in 24 Cases
Clinical diagnosis
Renal neoplasm
Pancreatic cyst
Carcinoma of stomach
Carcinoma of cecum
Fibroid uterus
Prostatism
Splenomegaly
Retroperitoneal lymphoma
Carcinoma of colon
Ovarian cyst
Neuroblastoma
Secondary testicular neoplasm
Peritonitis (emergency)
No diagnosis
Total

No. of cases
5
3
3
2
2
1
1
1
1
1
1
1
1
1
24

were displaced in 50% of cases and in
two thirds the blood supply to the
tumour was found to be derived from
the lumbar arteries (Figs. 9 and 10).
The role of these arteries in the diag
nosis of retroperitoneal tumour has
been emphasized by Lowman and
colleagues.21 Apart from showing
tumour circulation, angiography can
confirm organ invasion and helps the
surgeon to plan his approach by pro
viding prior knowledge of the tum our’s
anatomical extent and the source of its
vascular supply. Although arteriography
is an invasive technique, its usefulness
in the management of retroperitoneal
tumour far outweighs its danger, as
borne out by the positive findings in
6 cases in this series and in 52 of 56
cases in the study reported by Levin,
Watson and Baltaxe.20
The noninvasive technique of ultra
sonography is now of proven value in
the investigation of retroperitoneal
tumour. It is possible, especially with
grey-scale ultrasonography, to outline
a retroperitoneal mass and determine
its consistency and relationship to the
surrounding organs.22’23 In this series
ultrasonography was used in one case
to differentiate a large retroperitoneal
angiosarcoma from a hepatic tumour
in a 6-year-old child. The increasing
role of ultrasonography in the diag
nosis of abdominal masses has been
recently emphasized by Gramiak and
Borg.24 However, I believe it is still not
as helpful as arteriography in planning
a surgical attack on a retroperitoneal
mass.
In spite of early diagnosis, the prog
nosis in general remains poor, as in
dicated by the overall 5-year survival
rate of only 5% .10 With advances in
radiotherapeutic technique achieved
during the last decade, the indications
and benefit of radiotherapy in the
treatment of soft tissue sarcomas are
well recognized.25-27 The previously
held view that radiotherapy has limited
application and benefit is no longer
accepted. Local recurrence remains a
problem; the frequency of local recur
rence was 66% in this series and has
been reported as high as 80% in soft
tissue sarcomas in general.20 Sometimes
it may be impossible to remove a large
tumour and instead only a “debulking
procedure” may be possible followed
by radiotherapy. Occasionally it may
be necessary simply to biopsy the
tumour and resort to combined treat
ment with irradiation and chemo
therapy; later one may attempt
an adequate resection at a so-called
“second-look” operation. This was
done in one patient (Fig. 2) but
unfortunately the tumour could not be
removed at the second exploration. It
is therefore important for the surgeon
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to realize that the majority of these
tumours infiltrate early and that com
plete surgical excision can be achieved
in only 20% to 30% of cases. The
tumour or its bed should therefore be
outlined with radiopaque markers to
permit accurate application of irradia
tion. Chemotherapy has advanced ra
pidly and encouraging results, in terms
of partial or complete remission with
increased median duration of response,
have been obtained with a combination
of Adriamycin®, DTIC, vincristine and
cyclophosphamide.15,28
There is no set prognostic indicator
for this heterogeneous group of retro
peritoneal sarcomas and therefore it is
difficult to draw any firm conclusions
about their prognosis. The histopatho
logic grade is an important indicator of
prognosis and of local recurrence. In
addition, tissue type, the size and loca
tion of the tumour, and the presence
of metastases affect the outcome.29,30 All
these prognostic variables have recently
been merged into a staging system
(TNM system with “G” added for
grade of tumour)31 that should bring
more uniformity to this group of
tumours. The staging system can now
be used not only to predict survival
but also for case evaluation to assist in
deciding on the best treatment and to
determine the results of the different
types of therapy.
This retrospective study and some
recent reports5,32"34 indicate that less
than satisfactory advance has been
made during the last 20 years in the
management of malignant retroperito
neal tumours. The rapidly advancing
field of computer-guided radiotherapy
and the introduction of new chemo
therapeutic agents are expected to play
a larger role in providing the necessary
adjuvant therapy to obtain a better
cure rate, as has been achieved in other
malignant diseases. Although surgical
excision still remains the first treat
ment, it is important to ensure that no
tumour tissue has been left behind.
Because of what is known of the natural
history of this disease, especially in
terms of local recurrence, it is the duty
and responsibility of the surgeon to
involve the radiotherapist and chemotherapist in the total management of
this group of malignant tumours.
I thank Dr. Anita Bose for her help

in the preparation of this article, Miss
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Clinical and Angiographic Determinants of Early Mortality
Related to Aortocoronary Bypass Surgery
D ominique Crochet,

L ucien C ampeau , md , frcp [c ], J acques L esperance , md ,
Alain H eitz, md, C laude G rondin, md , frcs [c] and M artial G. Bourassa,

md ,

Clinical and angiographic features
were identified that influenced early
mortality in 807 patients who underwent
aortocoronary bypass grafting alone
among the first 1000 consecutive
patients subjected to aortocoronary
bypass operations at the Montreal Heart
Institute. The early mortality was 4.7%
and was related to the patient’s age,
the duration of the illness from its first
clinical manifestation, certain types of
clinical presentation, electrocardiographic
findings, the number of obstructed
arteries and the ejection fraction. The
influence of the number of obstructed
arteries appeared to be independent of
other factors, including the number of
grafts and the degree of correction.
Early mortality was not influenced by
risk factors such as lipid abnormalities,
hypertension or diabetes, by the history
of previous myocardial infarction or the
number of grafts.
L'etude porte sur I'influence des parametres cliniques et angiographiques sur
la mortality precoce (du premier mois)
associee au pontage aortocoronarien
isole. Huit-cent-sept patients, parmi les
premiers 1000 operes, ont ete etudies.
La mortality precoce a ete de 4.7% et
elle s'est averee reliee a I'age, la duree
de la maladie, certaines presentations
cliniques, I'electrocardiogramme de
repos, le nombre d’arteres obstruees et
la fraction d’ejection. Le nombre
d’arteres obstruees a semble jouer un
role independamment des autres
facteurs, y compris le degre de
correction et le nombre de greffes. La
mortality precoce n'a pas ete influencee
par les facteurs de risque, tel que les
anomalies des lipides, le diabete, I'hypertension, I’histoire d’infarctus et le
nombre de greffes.

The early mortality during the initial
phase of aortocoronary bypass surgery
has been reported as varying between
4% and 12%.18 A substantially higher
mortality has been observed in patients
From the Montreal Heart Institute and
the University of Montreal, Montreal, PQ
Supported in part by research funds
from the J.L. Levesque Foundation
Reprint requests to: Dr. Lucien Campeau,
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with acute myocardial infarction with
or without shock, heart failure or pre
infarction angina. Poor left ventricular
function was soon recognized as an im
portant determinant of early mortal
ity.9'11 Involvement of three coronary
arteries and stenosis of the left main
trunk also has been noted to be asso
ciated with a higher early mortality.12'17
The patient’s age, the severity of angina
and the presence of electrocardiographic
abnormalities have also been con
sidered as significant operative risk
factors.12,15
This study was carried out to in
vestigate the potential influence of pre
operative conditions on early mortality
following isolated aortocoronary bypass
surgery.
Patients and M ethods

The study was based on 807 of
the first 1000 consecutive cases of
aortocoronary bypass surgery per
formed in our institution from Sept.
24, 1969 to June 30, 1974. Excluded
were 62 patients with associated
rheumatic valve disease or other car
diac anomalies, 88 patients who had

md

associated internal mammary artery im
plantation, 35 who had left ventricular
wall resection and 8 patients who were
operated on for acute myocardial in
farction or cardiogenic shock, of whom
5 did not survive surgery. There were
685 men (84.9%) and 122 women
(15.1%). Their ages ranged from 22 to
70 years (mean 50.1 — 7.7 years). The
mean duration of illness was 52 ± 49
months. The clinical features, electro
cardiographic findings and the angio
graphic data are set forth in Table I.
Stable angina was graded according
to the Canadian Cardiovascular Society
classification of effort angina.18 The
classification of unstable angina was
assigned when either of the following
two conditions was present within 3
months of surgery, whether or not
there had been previous stable angina:
(a) a crescendo pattern or rapid pro
gression in severity; (b) unprovoked
pain lasting more than 15 minutes.
Also included in this category were six
cases of Prinzmetal’s angina. The
diagnosis of recent heart failure was
based on objective clinical evidence of
water retention and on roentgenologic
signs such as pulmonary venous hyper-

T a b le 1— B a s e lin e C h a ra c te ris tic s in 807 P a tie n ts
Who U nderw ent Is o late d A ortocoronary Bypass G ra ftin g

No. o f p a tie n ts

C haracteristic

P e rc e n t

Asym ptom atic

33

4.1

Stable ang in a *
l/ I V
ll-IV /l V

30
570

70.6

U nstab le angina

151

18.7

23

2.9

H istory of in farction

412

51.1

Electrocardiogram
Abnorm al
Abnorm al S T -T segment
Old in farction p attern
Conduction anom alies

594

/3.D

360
269
113

44.6
33.3
14.0

250
287

31.0
35.6

156
651

19.3
80.7

H ea rt fa ilu re

i.t

No. of a rte rie s w ith obstruction > 5 0 %
2
3
Ejection fractio n

< 0 .4 5
£ 0 .4 5

‘ Canadian C ardiovascular Society g ra d in g .
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tension and edema of the lungs in spite right coronary artery was dominant or
of optimal therapy. The duration of the
when the coronary circulation had a
clinical illness was considered to be the
balanced pattern. Left ventriculograms
interval between the first clinical mani were obtained in the right anterior
festation and the operation. The his oblique view at 60 frames per second
tory of previous myocardial infarction and were analysed by visual inspection
was accepted from the patient without
of silhouettes traced on the projection
further documentation. The resting
screen in end-diastole and in endelectrocardiogram
was
considered
systole, and also qualitatively during
normal when the following conditions
projection of the cineangiogram in
were absent: (a) abnormal rhythm, ex motion. The “ejection fraction” was
cept for sinus tachycardia and sinus
derived from a table that related a
bradycardia; (b) QRS axis greater than contraction score to the calculated
+ 9 0 ° and less than —15°; (c) atrio ejection fraction as measured by the
ventricular conduction delay, complete
method of Kennedy, Trenholme and
bundle branch block and hemiblocks;
Kasser20 (Fig. 1). This contraction
(d) abnormal ST-T segments or T score was the sum of the wall motion
waves, or both; (e) evidence of old
quality of the six left ventricular seg
myocardial infarction; and (f) ventri ments and was graded as follows:
cular hypertrophic patterns. The equiv akinesis 0, severe hypokinesis 1, slight
ocal tracings were considered as normal
to moderate hypokinesis 2 and normal
and constituted 15%. All abnormalities
motion 3. The distal arterial run-off
of the ST-T segments and T waves was evaluated angiographically as pre
were included under this heading, in viously described.21
cluding the nonspecific alterations
Surgical techniques have varied dur
which represented 30.3%.
ing the period under consideration and
Cinearteriograms were obtained in at have been described in detail previous
least four projections on 35-mm film.19 ly.22 Bypass was accomplished using
Obstructions reducing the lumen by saphenous vein in 95.5% of patients.
more than 50% were considered
Saphenous vein was used in combina
significant. The main coronary arteries
tion with the internal mammary artery
were included in determining the num or radial artery in 3%. The internal
ber of involved arteries, but their
mammary artery alone was used in
branches such as the diagonal branches
1.5%. The anterior descending artery
of the left anterior descending artery,
was grafted in 77.3% of patients, the
the marginal branches of the circum right coronary artery in 56.7%, the
flex artery, and the marginal and pos circumflex artery or its branches in
terolateral branches of the right cor 22.5% and the diagonal branches of
onary artery were excluded. Stenosis
the left anterior descending artery in
of the left main coronary artery was
15.4% of the patients. A single graft
considered as involvement of three
was introduced in 29% of patients,
arteries when the left artery was
two grafts in 43.4%, three grafts in
dominant and of two arteries when the
22.2% and four or more grafts in
5.5%, an average of two grafts per
patient.

In 86.5% of patients the correction
was considered optimal; this was de
fined as the insertion of a graft in all
main coronary arteries having an ob
struction of at least 70%. Graft
patency was established in 92.4% (61
of 66 grafts) of 34 patients who died
during the first postoperative month
without having had angiographic evalu
ation. Angiographic studies were per
formed during the first month after
surgery in 402 patients and graft pa
tency was found in 86.6% (624 of 721
grafts).23,24
Results

Early mortality was defined as death
occurring at operation or during the
first 30 postoperative days. The results
were analysed with a CYPER 74 com
puter (Control Data Corp., Minne
apolis, MN) using the SPSS package25
for statistical analyses.
The early mortality for the patients
in our series was 4.7% (38 of 807).
There were 16 intraoperative deaths,
attributed to myocardial infarction in
4, ventricular arrhythmia in 4, technical
difficulties in 2 and to an unknown
cause in 6. The 22 postoperative deaths
were attributed to acute myocardial in
farction in 13, cardiogenic shock in 5,
intrathoracic hemorrhage and cardiac
tamponade in 2, ventricular arrhythmia
in 1 and a cerebrovascular accident
in 1 other patient.
Clinical Features and Early
Mortality (Table II)
Early mortality increased propor
tionately with age: it was 1.4% (1 of
69) for patients younger than 40 years
of age, 2.4% (7 of 292) for patients

Table II— Correlations between Clinical Variables and Early Mortality

Clinical variable

Mortality,
No. of patients

No. of deaths

%

P value

Age
<50 yr
^50 yr

o l --------- 1--------- 1______I______ l
0.20 0.30 0.40 Q50

i
0.60

i______ |
070 0.80

Ejection fraction

F I G . 1— Correlation between left ven
tricu la r ( L V ) contraction index, derived
fro m qualitative analysis o f segmental
w all m otio n (see text) and calculated ejec
tion fra ctio n in 150 patients with ischemic
heart disease, r = 0.926, y = 3.041 x
-2 .6 0 2 .
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361
446

8
30

2.2
[
6.7,

<0.02

Duration of illness
<36 mo
^36 mo

386
421

10
28

2 6'
[
6.7,

<0.02

Clinical presentations
“ Asymptomatic” *
Stable angina ll-IV/IV
Unstable angina
Heart failure

63
570
151
23

0
26
7
5

Electrocardiogram
Normal
Abnormal
ST-T segment normal
ST-T segment abnormal

214
593
447
360

2
36
12
26

0
4.6
4.6
21.7

09 |
>
6.1 J
2.7 1
7.2]

<0.05f

<0.01f

<0.005
<0.005

’ Patients with asymptomatic postmyocardial infarction or slight angina operated upon in the
hope of prolonging life.
fA s compared to stable angina.
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Patients whose resting preoperative
electrocardiogram was normal had a
0.9% early mortality compared with
6.1% for patients with an abnormal
tracing. Patients with abnormal ST-T
segments or T waves had a 7.2% early
mortality compared with 2.7% for pa
tients without such abnormalities.
There was no significant difference in
the early mortality of patients who
presented other abnormalities, such as
old myocardial infarction patterns or
disturbances of rhythm or conduction.

between 40 and 49, 6.3% (23 of 367)
for patients between 50 and 69 and
8.9% (7 of 79) for patients aged 60
and older (P < 0.05). The demarcation
appeared to be at age 50. Early mor
tality was 2.2% in patients younger
than 50 years as compared with 6.7%
in patients older than 50. Patients
whose first clinical manifestation ap
peared within 36 months before surgery
had a 2.6% early mortality as com
pared with 6.7% for patients whose ill
ness was of longer duration (P < 0.02).
There was no death among 63 “asymp
tomatic” patients (postmyocardial in
farction or effort angina grade I/IV),
whose operation was performed on a
prophylactic basis with the hope of
prolonging life. The patients with stable
angina (effort angina grade II-IV/IV)
and the patients with unstable angina
had a similar early mortality, 4.7%
and 4.6% respectively. The early mor
tality was 21.7% in 23 patients with
congestive heart failure, significantly
higher than in those with stable angina
(P < 0.01).

Angiographic Findings and
Early Mortality (Table III)

An early mortality of 9.8% observed
in patients with triple coronary artery
disease was significantly (P < 0.001)
higher than the 2.4% and 1.5%
mortality found in patients with in
volvement of only two arteries or a
single vessel. Patients with an ejection
fraction below 0.45 had an early mor
tality of 8.3% compared with 3.8%
for patients with higher ejection frac

Discussion

Table I II— Correlations between Angiographic Variables and Early M ortality

Angiographic
variable

M ortality,
%

P value

No. of patients

No. of deaths

No. of arteries obstructed > 5 0 %
1
2
3

270
250
287

4
6
28

1.5 ]
2.4 )
9.8 J

<0.001

Ejection fraction
<0.45
>0.45

156
651

13
25

®o\
3.8 /

<0.05

Distal run-off (grafted arteries)
Good in all
Poor in all

440
54

21
6

,?■? \
11.1 /

NS

NS = not significant.

Table IV— Correlations between Early M o rtality in Subsets Based on the Number
of Obstructed A rteries and O ther Determ inants of Early M ortality
No. of arteries obstructed > 5 0 % ,
no. of patients/total no. (and % )

Age

P value

3

2

1

Variable
2/139
2/131

(1.4)
(1.5)

2/116
4/133

(1.7)
(3.0)

5/105
23/183

(4.8)
(12.6)

NS
<0.01

Duration of illness
< 36 mo
^36 mo

2/169
2/99

(1.2)
(2.0)

1/104
5/143

(1.0)
(3.5)

7/105
20/181

(6.7)
(11.0)

<0.01
<0.003

Electrocardiogram,
ST-T segment
Normal
Abnormal

1/162
3/108

(0.6)
(2.8)

1/145
5/105

(0.7)
(4.8)

10/140
18/147

(7.1)
(12.2)

<0.001
<0.01

Ejection fraction
<0.45
>0.45

1/51
3/219

(2.0)
(1.4)

2/42
4/208

(4.8)
(1.9)

10/63
18/224

(15.9)
(8.0)

< 0.0 0 5
< 0.0 01

<50 yr
^50 yr
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tions (P < 0.05). There was no dif
ference in early mortality between pa
tients with ejection fractions below
0.35 (8.8% [8 of 91]) and those with
ejection fractions of 0.35 to 0.44 (7.7%
[5 of 65]). It differed slightly in pa
tients with ejection fractions between
0.45 and 0.54 (5.2% [13 of 248]) and
those with ejection fractions equal to
or greater than 0.55 (3% [12 of 403]).
In patients whose grafted arteries all
had a poor arterial run-off capacity the
early mortality was 11.1% compared
with 4.8% for patients whose grafted
arteries were considered to have a good
distal segment at angiography, but the
difference is not statistically significant.
As shown in Table IV, the early mor
tality paralleled the number of affected
coronary arteries irrespective of the
duration of the clinical illness, the ST-T
segment findings on the resting electro
cardiogram or the ejection fraction.
However, the number of affected ves
sels did not influence early mortality
in patients younger than 50 years, al
though it was still an important deter
minant of early mortality in patients
aged 50 and older.
In our series of cases significant de
terminants of early mortality were the
patient’s age, the duration of illness,
electrocardiographic findings, the num
ber of obstructed arteries and the status
of left ventricular contraction. The
higher mortality observed in patients
with heart failure was related to the
poor ejection fraction. The higher mor
tality in patients with disease affecting
three coronary arteries does not appear
to be related to the larger number of
grafts or to incomplete correction. In
fact, early mortality was not influenced
by the number of grafts, as shown in
Table V. This discrepancy between
mortality related to the number of
diseased arteries and to the number of
grafts is owing to the fact that not all
affected arteries are grafted. As also
shown in Table V, the early mortality
was related to the degree of correction
achieved. The early mortality was 3.8%
in patients with optimal correction, that
is, when all major coronary arteries
with a stenosis of at least 70% have
been bypassed, whereas it was 9.7%
in patients with incomplete correc
tion. However, among patients with
optimal correction early mortality
was only 1.5% when a single coronary
artery was involved whereas it was
5.3% when two or three coronary
arteries were diseased (P < 0.01). The
most important determinants of early
mortality appear to be the number of
obstructed arteries, the status of left
ventricular contraction and the electro
cardiographic findings. It is of interest
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that the number of obstructed arteries
appears to influence early mortality
irrespective of the duration of illness,
the electrocardiographic findings and
the ejection fraction, as shown in Table
IV.
Undoubtedly early mortality was also
related to inadequate surgical tech
niques during the early phase of aorto
coronary bypass surgery. Most groups
have reported a significant improve
ment over the years in the early m or
tality following isolated aortocoronary
bypass surgery and mortality rates
varying from 0 to 3% are now fre
quently quoted.2628 In our institution
this rate has decreased progressively
from 5.8% in 1970 to 2% in 1976.
It is not certain that the preoperative
conditions that were found to increase
the risk of operation earlier in this
series still have an im portant influence
in patients operated upon now, when
the mortality is much lower.
It should also be mentioned that the
natural history of ischemic heart dis
ease has been found to be determined
by most of the same conditions that
appear to influence early postoperative
mortality, such as age, duration of the
illness, electrocardiographic abnormal
ities, the number of obstructed arteries
and the degree of left ventricular func
tion.27-34 Also conditions associated with
a good prognosis without surgery con
fer the lowest operative risk.
We thank F. Lustman, PhD, D. Tesson
and J.P. Beausejour from the computer
science division, Montreal Heart Institute
and University of Montreal for their as
sistance, and Drs. Pierre Grondin, Gilles
Lepage, Yves Castonguay, Claude Meere
and Jean-Paul Martineau for allowing us
to study their cases.
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Intussusception after Intestinal Bypass for Morbid Obesity:
Use of Ultrasonography in the Diagnosis
G arry O. H ansen,

Intussusception following jejunoileal
bypass for morbid obesity is an
uncommon condition, but one that is
being recognized with increasing
frequency. It may occur after the use
of either end-to-side or end-to-end
technique. Inadequate fixation or
excessive turn-in of the blind proximal
end of the excluded segment may
predispose to intussusception. The
intussusception usually occurs from
5 to 20 months after the bypass operation
and symptoms may fail to lead to
the diagnosis for many months.
Characteristically there are intermittent
bouts of crampy abdominal pain which
later become more constant and radiate
through to the back. Initially there
are no abdominal signs. Later a mobile
periumbilical mass may be palpable.
Ultrasonography can confirm the
diagnosis when the changes in the bowel
wall (i.e., edema) have developed
sufficiently to produce the characteristic
echograms.
At operation the intussusception
is reduced manually when possible.
Excision of part or ail of the affected
segment may be necessary.
Jejunopexy of the proximal end of
the nonfunctioning bowel to the
anterior abdominal wall appears
to prevent recurrence of the
intussusception.
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L'intussusception consecutive a une
anastomose jejuno-ileale pour obesite
pathologique est une complication rare
mais que Ton rencontre de plus
en plus frequemment. Elle peut
survenir apres I'emploi d'une technique
termino-laterale aussi bien que d’une
technique termino-terminale. Une fixation
inadequate ou une courbure excessive
de I'extremite proximale borgne du
segment exclus peut predisposer a son
developpement. L’intussusception
survient habituellement de 5 a 20 mois
apres I’operation et il faut souvent
plusieurs mois avant que les symptdmes
ne menent au diagnostic. De maniere
caracteristique, on assiste a I’apparition
d'episodes de crampes abdominales
douloureuses qui deviennent ensuite
plus constantes et irradient jusque
dans le dos. Plus tard, une masse
peri-ombilicale mobile peut devenir
palpable.
L’ultrasonographie peut confirmer le
diagnostic quand les changements de
la parof intestinale (i.e., I’oedeme) se
sont assez developpes pour produire
un echogramme caracteristique.
A I'operation, l'intussusception est
reduite manuellement quand cela est
possible. L’excision d'une partie ou de
tout le segment affecte peut etre
necessaire. Une jejunopexie de I’extremite proximale de I'intestin non
fonctionnel a la paroi abdominale
anterieure, semble prevenir la recidive
de l'intussusception.

Intussusception of the bypassed jejunal
segment is an uncommon late compli
cation of jejunoileal bypass for morbid
obesity. Clinical diagnosis can be diffi
cult. Standard laboratory tests and
radiologic examinations help only to
exclude other conditions.
We present three cases in which ab
dominal ultrasonography aided in the
diagnosis and describe a method of pre
venting recurrence of the intussuscep
tion.
Case Reports

Case 1.—A 41-year-old woman whose
weight was 120 kg had undergone an endto-side jejunoileal bypass for morbid obes
/
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ity in November 1974. The proximal end
of the bypassed segment had been closed
in two layers and anchored to the me
sentery near the jejunoileal anastomosis.
Weight loss (50 kg) had been satisfacto
ry and she had remained well for approxi
mately 17 months, when she began to
suffer intermittent upper abdominal pain.
Her symptoms lasted nearly 3 months and
increased in severity during the final weeks
before she was admitted to the Health
Sciences Centre, Winnipeg, in June 1976.
The pain radiated through to the back,
was not related to eating and was relieved
somewhat by walking and changing posi
tion. She experienced nausea but no vomit
ing, and her bowel movements were un
changed.
Physical examination discovered a vague,
slightly tender mass in the left upper
abdominal quadrant. A plain roentgeno
gram of the abdomen was not abnormal,
and after administration of barium, films
of the small bowel showed the usual post
bypass pattern. The serum amylase con
centration, results of liver function tests
and the appearance of a biopsy specimen
from the liver were normal.
A normal liver, pancreas and kidneys
were demonstrated by ultrasonography
(Fig. 1).
The only abnormality evident was an
oblong mass in the right upper quadrant
of the abdomen extending across the mid
line into the left flank. The echodense
centre was surrounded by an echolucent
band 1 to 2 cm in width. This pattern had
not been previously encountered and was
thought to represent bowel surrounded by
fat or edema.
At laparotomy we found an intussuscep
tion of the proximal end of the bypassed
segment. We could not reduce the intussus
ception manually because of edema and
adherence of the affected bowel. The 100cm portion of bowel, which had tele
scoped, was resected after the intussuscipiens had been incised to delineate the
mesentery (Fig. 2). The new jejunal stump
began at once to invaginate and was there
fore anchored by silk sutures to the peri
toneal surface of the left anterior abdo
minal wall.
The postoperative course was smooth
and there has been no recurrence of symp
toms to date.
Case 2.—A 31-year-old woman had had
an end-to-side bypass performed elsewhere
in March 1976 for obesity. She had been
well for 12 months and her weight had
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dropped 41 kg from 143 kg. Two months
before admission in April 1977 she began
to suffer intermittent crampy pain in the
right upper abdominal quadrant and right
flank. Latterly the pain had become dull
and almost continuous with occasional
superimposed bouts of colic. The pain
occurred after meals and radiated across
the abdomen and into the back. On the
day of admission the patient experienced
nausea and vomiting.
Physical examination of the abdomen
disclosed tenderness to deep palpation in
the right lower quadrant and a vague, mo
bile mass in the right periumbilical area.
Plain films of the abdomen and roentgeno
grams of the colon obtained after barium
enema and of the small bowel after a

barium meal appeared normal, as did a
cholecystogram and intravenous cholangiogram. Serum amylase concentration, results
of liver function tests and the histology
of the liver as shown by biopsy were
normal.
All major intra-abdominal organs ap
peared to be normal as shown by ultra
sonography. However, an oblong mass
(Fig. 3) was seen below the liver extending
to the level of the umbilicus and across
the midline into the left flank. The mass
appeared similar to that found in case 1
(Fig. 1).
Intussuception of the bypassed jejunal
segment was diagnosed and laparotomy
was performed. The intussusception
(Fig. 4) was found and reduced manu
ally, but gross edema necessitated re
section of the proximal 20 cm of intussuscepted bowel. The new stump was
sutured with silk to the left anterior ab
dominal wall.
The postoperative course was smooth
and the patient has remained well.

Case 3.—A 31-year-old man (weight 157
kg) had undergone end-to-end intestinal
bypass in August 1975. The proximal end
of the excluded segment had been closed
around a jejunostomy tube and anchored
to the abdominal wall. The jejunostomy
tube had been removed 5 days postoperatively.
The patient had been well for 19 months
(weight loss 82 kg) but had then experi
enced a period of upper abdominal pain
lasting 48 hours. The pain had recurred
1 month later and lasted 6 days. He had
become nauseated, had vomited several
times and had lost 5 kg during this period.
In August 1977, 6 months after the first
attack, the pain again recurred and be
came almost constant. It was located in
the mid-abdomen, was not related to eat
ing but was eased by walking or changing
position.
On examination a mobile, slightly tender
mass was felt to the left of and below the
umbilicus. The mass was easily visible with
the patient standing. Plain abdominal ro-

Fig. lb
FIG. 1— Case 1. (a) Longitudinal scan
just obtained to right of midline. Oblong
complex mass (black arrows) extends
from above umbilicus (U) down into
pelvis, (b) Transverse scan, 8 cm below
umbilicus, shows that mass (black arrows)
crosses midline (M) and extends into left
flank.

Fig. 3b
FIG. 2— Case 1. At operation. Intussuscipiens has been incised to reveal intussusceptum prior to excision.
228

FIG. 3— Case 2. (a) Longitudinal scan, 5 cm to right of midline. Despite technically
poor study, oblong mass (arrows) can be seen lying caudal to inferior surface of liver,
(b) Transverse scan, 1 cm above umbilicus, shows mass (black arrows) lying anteriorly
in mid-abdomen (m) and extending into left flank.
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entgenograms, films of the small bowel
after barium enema, serum amylase con
centration and results of liver function tests
were all normal.

Abdominal ultrasonography demonstrat
ed a mass (Fig. 5) distinct from all major
organs, similar in composition to that seen
in the other two cases. However, it was
shorter and lay wholly to the left of the
midline. Based on the history and the ex
perience with the previous cases, intussus
ception of the bypassed jejunal segment
was diagnosed.
At laparotomy an intussusception (Fig.
6) was found and easily reduced. Resection
was unnecessary, but fixation of the blind
end of the jejunum to the left anterior ab
dominal wall was performed.

FIG. 4— Case 2. Intussusception of defunctionalized jejunum at operation.

The postoperative course was uneventful
and the patient has had no recurrence of
his symptoms.
Discussion

We have found ultrasonography to
be useful in making the diagnosis. The
mass identified corresponds exactly to
the area of maximal tenderness and has
a characteristic appearance. It tends to
be oblong in one plane and to have a
central area of increased echodensity
and a peripheral area of relative echolucency. The central density almost cer
tainly represents mucus and air in the
bowel lumen, whereas the surrounding
lucency is due to the gross edema of
the bowel wall as seen in Fig. 4.
Resection of the affected jejunum
may be necessary5'7 as in our case 1.
To prevent intussusception, fixation of
the jejunal stump to the mesentery is
advocated. However, in one of our pa
tients (case 1) and in 7 of 16 other
reported cases2,3 the complication oc
curred despite seeemingly adequate fixa
tion. Even the use of the stump as a
temporary jejunostomy (case 3) may
not prevent intussusception. Moreover,
excessive inversion of the blind proxi
mal end may be a predisposing cause.
A more secure form of anchorage would
therefore seem to be indicated, espe
cially when an intussusception has oc
curred despite a seemingly adequate
fixation at the initial operation. A ttach
ment of the proximal end of the ex
cluded jejunum to the peritoneal aspect
of the left anterior abdominal wall has
proved an effective method of fixation
in our hands.

FIG. 6—Case 3. View at operation with
intussusception partially reduced.

Intussusception of the excluded jeju
nal segment following intestinal bypass
for morbid obesity is uncommon.1'7 The
frequency in reported series varies from
0 % ' to 2 % .2,4 It may occur following
the end-to-side or end-to-end operation.
To date 16 cases have been reported
in the literature.2'3 Authors have em
phasized the difficulty encountered in
diagnosis. The involved segment does
not participate in food transport and
therefore the usual clinical and radiologic features of intussusception are
absent. In addition, these patients are
often still quite obese, making palpation
of an intra-abdominal mass difficult.
The most characteristic symptom is
intermittent abdominal pain which be
comes more severe and more frequent
as time passes. It tends to radiate to
the back, especially to the left side,
possibly because of traction on the
jejunal mesentery.
Nausea and vomiting are not always
present, but when they are, they occur
usually in the later stages. Abdominal
signs are absent or minimal in most
cases until later, when a mobile, slightly
tender, periumbilical or left-sided abdo
minal mass may be seen or palpated.
Gross rectal bleeding has been reported
in one case.2
The time from bypass to the onset
of symptoms has varied from several
months to 32 months.2,3 In our cases
the intervals were 17, 12 and 18 months
respectively. The times between onset
of symptoms and diagnosis and correc
tion were 3, 2 and 6 months respec
tively. This emphasizes the difficulty of
diagnosing intussusception by clinical,
laboratory and radiologic means.
One ingenious aid to diagnosis has
been the intraoperative marking of the
closed proximal stump and its mesente
ric attachment with silver clips.3 These
markers are found to be widely sepa
rated on the roentgenograms when in
tussusception occurs.
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Fig. 5b
FIG. 5—Case 3. (a) Longitudinal scan,
6 cm to left of midline, demonstrates
complex mass (arrows) lying on either
side of umbilicus (U) separate from,
though ultrasonically similar to, normal
left kidney, (b) Transverse scan at level
of umbilicus demonstrates mass (black
arrows) extending towards, but not up to,
midline (M).
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an urgent problem
postoperative anaerobic
in gynecological
infections

in abdominal
infections

.clindamycin is an important antibiotic in the
therapy of such [gynecological] infections.”

This study suggests ‘‘ ...clindamycin is an excellent
and relatively safe antibiotic for treatment of
[abdominal] infection caused by anaerobes when
combined with surgery (when indicated) or other
antibiotics active against aerobic gram-negative
bacilli, if present.”

Swenson. R.M.,et al. (1974). Obstet. & Gynecol., 44:699.

Levison,M .E.,etal.(M ar, 1974).
Antimicrob. Agents & Chemother., p. 276-280.
■i

an accepted solution

4
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Indications: Dalacin C Phosphate (clindam ycin phosphate in je c tio n N.F.) D alacin C Phosphate S terile S o lu tio n is in dicated fo r th e trea t
m ent o f in fe c tio n s where the oral route is not indicated or feasible.
C lind am ycin phosphate is in dicated in the treatm ent o f serious in fe c tio n s due to sensitive anaerobic bacteria, such as B acteroides
species, peptostre pto coccus, anaerobic streptococci, C lo s trid iu m species and m icro-aero philic stre p to co cci.
C lind am ycin phosphate is also in dicated in serious in fe c tio n s due to sensitive G ram -positive organism s s ta p h y lo co cci (in c lu d in g p e n ic il
linase-producing staphylococci), s trep tococci and pne um o cocci when the p a tie n t is in tolerant of, or th e organism re sista n t to, o the
appropriate antib iotics.
Contraindications: The use of Dalacin C Phosphate is contra in d ica te d in p a tie n ts previo usly found to be hype rsen sitive to th is co m p o u n d
the parent com pound, clindam ycin, or clindam ycin p alm ita te. A lth ough c ro s s -s e n s itis a tio n w ith Linc o c in (lincom ycin) has not beer
dem onstrated, it is recom m ended that Dalacin C P hosphate not be used in p a tie n ts w ho have dem onstrated lin co m ycin sensitivity. U nti
further clinical experience is obtained, Dalacin C Phosphate is not indicated in the new born (infants below 30 days of age), or in pregnant wom en

infections
in pulmonary
anaerobic infections

Warnings: Some cases o f severe and persistent diarrhoea have been reported du rin g or after therapy w ith D alacin C Phosphate. Thi£
diarrhoea has been occasionally associated with blood and m ucus in the s to o ls and has at tim es resulted in acute c o litis . W hen endoscopy
has been perform ed, som e of these cases have shown pseudom em brane form ation .
If s ig n ific a n t diarrhoea o ccurs during therapy, this drug s h ou ld be d is c o n tin u e d or, if necessary, contin ued o nly w ith clo se obse rva tio n
S ig n ific a n t diarrhoea occurring up to several weeks post-therapy should be m anaged as if antib iotic-associated .
If c o litis is suspected, end oscopy is recommended. M ild cases show ing m in im a l m ucosal changes may respond to sim p le drug dis
contin uance. M oderate to severe cases, including those sho w in g ulceration or pseudom em brane form ation, s h ou ld be m anaged w ith flu id
electrolyte, and protein supp lem entation as indicated. C o rtic o id retention enem as and system ic c o rtic o id s may be of help in p ersisten
cases. A n tic h o lin e rg ic s and a n tip e ris ta ltic agents may w orsen the con d itio n . O th e r causes of c o litis should be considered.
Precautions: Dalacin C Phosphate, like any drug, should be prescribed w ith c a u tio n in ato p ic individuals.
The use of a n tib io tic s occasionally results in over-growth o f non susceptible org a n is m s - particularly yeasts. S hould s u p e rin fe c tio n s occur
appropriate measures should be taken as dictated by the c lin ic a l situatio n.
S ince abn orm alities of liver fu n c tio n te s ts have been noted occasionally in an im a ls and man, perio dic liver fu n c tio n te sts sh ou ld be per
form ed durin g prolonged therapy. Blood coun ts should a lso be m onitored du rin g extended therapy.
As w ith all a n tib io tic s , perform culture and sensitivity s tu d ie s in c o n ju n c tio n w ith drug therapy.
C lind am ycin phosphate may be used in*anuretic p a tie n ts and patie nts w ith im paire d liver function. The serum half-life o f c lin d a m y c ir
phosphate in patients w ith m arkedly reduced renal fu n c tio n is greater than th a t o f the h alf-life o f the com poun d in norm al p a tie n ts. The
dose of clindam ycin phosphate should, therefore, be app rop riately decreased. H a em odialysis and peritone al d ia ly s is are no t effective
m eans o f removing the com pound from the blood. Periodic serum levels of c lin d a m y c in should be determ ined in p a tie n ts w ith severe rena
insufficiency.
Adverse Reactions: Local.
(a) Intram uscular Inje ctio n s: Of 404 p atie nts treated w ith c lindam ycin phosphate in tram uscula rly (w ith a s o lu tio n co n ta in in g 150 m g /m l)
six (1.5%) dem onstrated local reactions as follow s: Two com pla ined o f pain at th e in je c tio n site, tw o dem onstrated in duration at the in je c
tio n s ite and tw o developed s te rile abscesses.
(b) Intravenous Infusion: Of 192 patie nts treated w ith c lindam ycin phosphate by intravenous in fusion, 14 (7.3%) dem onstrated loca
reactions. Eleven patie nts developed superficial th ro m b o p h le b itis and one p a tie n t developed both supe rfic ia l and deep th ro m b o p h le b itis
The m ajority o f these cases developed in conjunction w ith th e use o f in d w e llin g IV catheters and it is d iffic u lt to know how m uch the druc
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Urticaria.............................................................................................. 1
S hortness o f B re a th .................................................................................
P ru ritis................................................................................................ 1
S u p e rin fe c tio n *.........................................................................................
Fever, Leucocytosis...........................................................................1

Nausea, with or without vom iting................................................... 1

Cardiac arrest* .................................................................................

Diarrhoea (See also under “ W arnings” )

Bad o r b itte r ta s te in m o u th ....................................................................J

*S up e rin fe ctio n is a com p lic a tio n o f a n tib io tic therapy in general and is not n e ce ssarily a true side effe c t o f clin d a m ycin phosphate.
* * Due to underlying m yocarditis in this patient.
Clinical and Laboratory Findings: P atients treated du rin g c lin ic a l tria ls of c lin d a m y c in phosphate were fo llo w e d w ith c lin ic a l laboratory
tests, in cluding com ple te haematology, urinalysis and liver and kidney fu n c tio n te s ts . Some o f these te s ts were abnorm al in itia lly anc
returned to normal during therapy w ith clindam ycin phosphate, w h ile others w ere norm al in itia lly and becam e abnorm al d u rin g therapy
Overall evaluation o f clin ic a l laboratory values in these p a tie n ts does not in d ica te th a t c lindam ycin phosphate therapy has a to x ic e ffe c t or
the haem atopoietic, hepatic or renal system s. Transient e levations o f serum tran sam inases have occurred in som e patients, bu t o th e r live
fu n c tio n te s ts (alkaline phosphatase, serum bilirubin) have not show n any te n d e n c y to increase and there have been no c lin ic a l s ig n s o
drug-induced hepatic toxicity.
Symptoms and Treatment of Oversoage: No cases o f overdosage have been reported. No s p e c ific a n tid o te is know n. Doses as high a:
1200 mg every six hours (4800 m g/d ay) by in fusion for five days have been given w ith o u t adverse effect.
DOSAGE AND ADMINISTRATION
Adults
In tram uscular Injectio n: 600 m g /d a y in tw o equal doses.
M oderately severe in fe c tio n s : 600 to 1200 m g/day in tw o or three equal doses.

;.. clindamycin has been reported to be the most Severe in fe c tio n s : 1200 to 2400 m g /d a y in two, three or fo u r equal doses. In tra m u s c u la r in je c tio n s of m ore than 600 mg in to a s in g le sit*
active antimicrobial agent tested in vitro against are not recom mended.
Intravenous A d m in is tra tio n : Dalacin C Phosphate m ust be d iluted prior to IV a d m in is tra tio n to a d ilu tio n o f 300 mg in 50 ml o f d ilu e n
anaerobic bacteria; [in the pulmonary tract]
(6 m g /m l) or more, and infused in not less than 10 m inutes. A d m in istra tio n of m ore than 1200 mg in a s in gle one -ho ur in fu sio n is no t recom
boficentrations of 3.1 jig/ml or less inhibited 96% m ended. Dalacin C Phosphate should not be in jected in traveno usly u n d ilu ted as a bolus.
M oderately severe in fe c tio n s : 900 to 1800 m g/day by c o n tin u o u s drip or in tw o or thre e equal doses, each in fu s e d over 20 m inutes o r lo nge
pf strains tested..."
Severe in fe c tio n s : 1800 to 2700 m g /d a y by continuous d rip or in three or fo u r equal doses, each infused over 20 m inutes or longer. In life
threatening in fectio ns, doses o f 2700 to 4800 m g/day by c o n tin u o u s drip o r in thre e or fo u r equal doses each in fuse d over 20 m in u te s o
longer may be given.

Fass, R.J., et al. (1973). Annals Intern. Med., 78:853.

Children: (Over one m onth o f age)
In tram uscular Injectio n: 10 to 15 m g /k g /d a y in two, three or fo u r equal doses.
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M oderately severe in fe c tio n s : 15 to 20 m g /k g /d a y in thre e or fo u r equal doses.
S e v e re in fe c tio n s : 20 to 30 m g /k g /d a y in three or fo u r equal doses.
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Thermal Injury to the Bowel as a Complication
of Laparoscopic Sterilization
R .F. M audsley ,

Thermal injury to the small bowel
occurred four times in a series of
7466 consecutive laparoscopies and
tubal cauterization performed for
sterilization. The four patients presented
with signs and symptoms of delayed
bowel perforation 4 to 11 days after
the procedure. The perforations were
small and involved the antimesenteric
border of the terminal ileum. Histologic
study of the excised specimen in one
case showed full thickness coagulative
necrosis of the bowel wall. Potential
causes for bowel burn associated
with tubal cauterization are discussed.
Steps to minimize the occurrence of
this complication include proper use
of the laparoscope and cautery
equipment, good anesthesia and gas
distension of the abdomen, correct
positioning of the patient and clear
visualization of the operative field.

Dans une serie de 7466 laparoscopies
consecutives avec cauterisation des
trompes pour fin de sterilisation, une
brulure du petit intestin est survenue
dans quatre cas. Les quatre patientes
ont presente les signes et les
symptomes d’une perforation tardive de
I'intestin, 4 a 11 jours apres I’intervention. Les perforations etaient petites
et se situaient sur le bord oppose au
mesentere de I'ileon terminal. Dans
un de ces cas, I'etude histologique
des prelevements excises a revele une
necrose coagulative de toute I’epaisseur
de la paroi intestinale. On discute des
causes possibles de brulures de
I'intestin associees a la cauterisation
des trompes. La procedure pouvant
reduire la frequence de cette compli
cation incluent I'emploi approprie du
laparoscope et de I’equipement de
cauterisation, une bonne anesthesie et
la distension gazeuse de I'abdomen, la
position correcte de la patiente et une
visualisation claire du champ operatoire.

From the departments of obstetrics
and gynecology* and laboratory
medicine,f Hamilton Civic Hospitals
and the faculty of health sciences,
McMaster University, Hamilton, Ont.
Reprint requests to: Dr. R.F. Maudsley,
Henderson General Hospital, McMaster
clinic, Concession St., Hamilton, Ont.
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The use of the laparoscope for diag
nosis and as a surgical tool appears to
be well established.1,2 Its most common
use, however, is for tubal cauterization
to effect sterilization in women. The
procedure can be performed under
local or general anesthesia. Although
laparoscopic sterilization is relatively
safe, effective and well tolerated by
patients, complications do occur. Ther
mal injury to the bowel is an omni
present danger and has been the focus
of attention recently.1-5 Tubal banding
techniques now are beginning to be
used to avoid the possibility of electric
shock and thermal injury. However,
tubal diathermy is still the most widely
practised method of laparoscopic sterili
zation. Furthermore, diathermy may be
necessary during an attempted banding
procedure. This review of the expe
rience at the Henderson General Hos
pital, Hamilton, will include reports of
four cases of electrosurgical burn in
jury to the small bowel.
Patients and Method

Charts of all patients who underwent
laparoscopic sterilization between Feb.
1, 1970 and Dec. 31, 1971 were
reviewed. Intestinal burns were found
to have occurred in 3 of these 1430
patients. Between Jan. 1, 1972 and Dec.
31, 1977 a further 6036 laparoscopic
sterilizations were performed. Among
these a fourth instance of a bowel burn
occurred and only in this last case was
a detailed histologic examination of
the excised intestinal tissue performed.
The operative technique employed
carbon dioxide insufflation through a
Verres needle, a Wolf laparoscope
(Richard Wolf, Knittlingen, West Germ
any) or ACMI laparoscope (American
Cystoscope Makers Inc., Pelham, NY)
and coagulation performed by Palmer
forceps through a second abdominal
incision. The tubes were cauterized by
means of the coagulation current of
a Bovie electrosurgical generator (Liebel-Flarsheim Co., Cincinnati, OH). Since
late 1973 insulated instruments have
been used and the former metal patientcontact plate has been replaced with a
flexible type of disposable contact pad.
Since 1975 solid state electrosurgical
generators have been used as well as
the Bovie apparatus.
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At this hospital the technique of
laparoscopic sterilization used is tubal
cauterization without subsequent divi
sion of the fallopian tube. All laparo
scopies are done with the patient under
general anesthesia, with or without in
tubation.
Case Reports
Case 1.—A 36-year-old woman, gra
vida 4, para 4, underwent tubal cauteriza
tion in May 1970. At laparoscopy a large
number of distended loops of small bowel
were seen. By manipulating the uterus,
it was possible, however, to obtain a
clear view and to perform the steriliza
tion. The patient was discharged from
hospital on the following day. Four days
later she presented complaining of severe,
crampy, abdominal pain; she had noticed
mild abdominal discomfort since the
operation. Her temperature was 36.2°C.
the pulse rate was 120 beats/min and the
blood pressure was 144/80 mm Hg.
While the patient was in hospital under
observation her abdominal pain increased
in intensity; it was located mainly in the
right lower quadrant but radiated to the
midline and upper abdomen. Examina
tion revealed marked abdominal tender
ness, rebound tenderness and reduction of
bowel sounds. At laparotomy a large
quantity of fibrinopurulent exudate was
present in the peritoneal cavity. Approxi
mately 100 cm from the ileocecal valve
a roughened area was noted on the ileum
and a small 0.2-cm perforation along the
antimesenteric border. The perforation
was oversewn. The patient made a good
recovery and was discharged 9 days after
the operation.
Case 2.—A 34-year-old woman, gra
vida 4, para 3, underwent laparoscopic
tubal cauterization in June 1971. No dif
ficulty was encountered during the pro
cedure and the patient was discharged on
the following day. Three days later she
presented in the emergency room com
plaining of acute abdominal pain. She
reported that on the day following sur
gery she had had two bowel movements,
at one of which the stools were black
and tarry. Approximately 4 hours prior
to admission the patient experienced
central abdominal pain of sudden onset
that rapidly spread over the entire ab
domen. This was associated with nausea.
She complained also of a sensation of
pressure in the rectum. The vital signs
and temperature were normal. There was
abdominal rigidity with marked tender
ness and rebound tenderness. The bowel
sounds were infrequent. At laparotomy a
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small amount of purulent fluid was found
in the pelvis, culture of which produced
a moderate growth of Bacteroides sp. A
transverse perforation about 60 cm
proximal to the ileocecal valve was noted
in the ileum occupying about one third
of the circumference of the bowel. The
site of the perforation was debrided and
the wound closed. The patient was dis
charged 11 days after the operation.
Case 3.—A 32-year-old woman, gra
vida 3, para 3, underwent laparoscopic
tubal cauterization in November 1971.
There was no difficulty in performing
the procedure and the patient was dis
charged on the following day. Eleven
days after the procedure she started sud
denly to have severe pain in the right
lower abdominal quadrant, accompanied
by nausea. The temperature was 38.4°C,
the blood pressure 120/70 mm Hg and
the pulse rate 80 beats/min. Rebound
tenderness was elicited in the lower ab
domen. Bowel sounds were hyperactive.
At laparotomy an area of coagulation
was observed in the wall of the ileum at
its antimesenteric border, about 20 cm
from the ileocecal valve. In the centre of
this area was a perforation of pinpoint
size; this was oversewn in two layers.
Culture of a swab from the peritoneal
cavity produced a heavy growth of
Escherichia coli. After a short febrile
postoperative course the patient was dis
charged on the 12th day after operation.
Case 4.—A 40-year-old woman, gra
vida 4, para 4, underwent laparoscopic
tubal cauterization in October 1974.
There was excellent visualization during
the procedure, which was performed
without difficulty. The patient was dis
charged on the following day. On the
11th postoperative day she was admitted
because of nausea and severe pain of

sudden onset in the mid-abdomen that
soon became generalized. The tempera
ture was 37.5°C, the blood pressure
115/70 mm Hg and the pulse rate 90
beats/min. The abdomen displayed board
like rigidity and bowel sounds were ab
sent. At laparotomy a yellowish purulent
exudate was found in the pelvis. Along
the antimesenteric border of the ileum,
30 cm proximal to the ileocecal junction,
a small perforation 0.4 cm in diameter
was evident. The margin of the perfora
tion was debrided and closure effected
in two layers. The patient had a smooth
recovery and was discharged 9 days
after the operation.
Histologic examination of the tissue
removed during debridement revealed in
flammatory exudate on the surface with
the formation of granulation tissue. In
some areas the entire muscle coat had
undergone necrosis and fibrosis had
begun (Fig. 1). In other areas the outer
circular muscle coat appeared more
necrotic than the inner longitudinal
muscle layer. The inflammatory reaction
was confined to the serosa and the
necrotic muscle layers of the bowel. In
the submucosa fibroblasts and inflam
matory cells were noted. Some of the
small blood vessels in the submucosa
showed fibrinoid necrosis, while in others
hyalinization of the walls was the more
prominent feature (Fig. 1). The mucosa
showed various changes; in areas of ex
tensive involvement it was flattened and
showed features of early regeneration. In
adjacent areas edema of the lamina
propria was present.
D iscussion

The occurrence of four electrosurgical burn injuries to the bowel in 7466
consecutive laparoscopic sterilizations
gives a frequency of approximately
0.05% . Thompson and Wheeless3 re
ported 10 instances of bowel burns in
3600 laparoscopic sterilizations. In a
review of the literature Loffer and
Pent1 collected 44 cases of such burns;
a frequency of about 0.15%. Thirtynine of these 44 cases occurred in the
small bowel and only 5 in the colon. In
our four cases the burn occurred in the
terminal 100 cm of the ileum. As
we found, the majority of these injuries

go unrecognized at the time of lapa
roscopy and involve the antimesenteric
border of the small bowel.1
We encountered no difficulty in per
forming the sterilization procedure in
our four patients and all were dis
charged from hospital the day after
wards. Only in the first case was there
some difficulty in visualizing the pelvic
organs due to bowel distension. All four
patients presented with signs and symp
toms of bowel perforation 4 to 11 days
from the time of sterilization. The pain
was sudden in onset and located cen
trally or in the lower quadrants of the
abdomen. In all an immediate laparo
tom y was performed which confirmed
the presence of small-bowel perforation
and peritonitis. Previous reports in the
literature note a time interval between
the bowel injury and diagnosis of 18
hours to 14 days.1 In the m ajority of
cases the interval is 3 to 7 days.
Electrical thermal injuries are basic
ally of two types. They may be either
very superficial, causing only minimal
surface damage, or more extensive in
volving most or all layers of the bowel
wall. When recognized at laparoscopy,
superficial and small burns can be
treated expectantly without resorting to
surgery.3’"1 Perforation or more exten
sive lesions require immediate laparo
tomy and either oversewing o r resection
of the damaged areas.3,4 In two of our
cases the perforation was small and re
quired only oversewing. The other two
required debridement and two-layer
closure. No bowel resection was deemed
necessary in any of these four cases.
The histologic changes in tissue re
moved from one of our patients were
those of coagulative necrosis and were
similar to the changes described by
Thom pson and Wheeless.3
Therm al injury to the bowel may
occur in one of several ways (Fig. 2):
(1) inadvertent touching or grasping of
the bowel during the application of
current (or immediately after the cur
rent has been arrested but the cautery
tip remains hot); (2) a portion of bowel,
unnoticed, may come into contact with
the laparoscope trocar sleeve; if the
sleeve is touched by the hot cautery tip,
or if there is arcing from the cautery
to the sleeve, a bowel burn may result;
(3) sparking from the coagulation for
ceps to the bowel; (4) current passing
along the fallopian tube and jumping
from the fimbriated end to the bowel.
It is unlikely that the cauterized tubal
tissue retains sufficient heat to cause
dam age to adjacent viscera.
Accidental bowel burns are probably
due, at least in part, to the use of ex
cessive voltage for tubal cauterization.
The lowest peak voltage at the lowest
practical power level is recom m ended.6

FIG. 1— Low-power view of smallbowel wall showing necrosis o f muscular
layer with inflammation and fibrosis.
Mucosa was represented by single layer
of regenerating low columnar cells (large
arrow). Blood vessels in submucosa
showed hyalinization of walls (small ar
row) (hematoxylin and eosin, reduced by
37% from X50).

FIG. 2— Several possible ways in
which bowel bums may occur during
laparoscopy and tubal cauterization (see
text).
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Because the method used in this series
(cauterization without the removal of a
segment of tube) requires extensive f i 
guration (with charring and possible
sparking) to ensure tubal destruction,
higher peak voltage is required. Thus,
theoretically, this technique may in
crease the risk of inadvertent bowel
burns by sparking. However, it is to be
noted that no laparotomy has been
necessary in these 7466 cases to repair
a lacerated mesosalpinx.
Prevention of bowel burns requires

an adequate knowledge and proper use
of the laparoscope and cautery equip
ment, good anesthesia, adequate gas
distension of the abdomen, proper pa
tient positioning and clear visualization
of the operative field.7
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Spontaneous Aortoduodenal Fistula: Successful Treatment
by Extra-anatomic Vascular Bypass
R.T. L ewis ,

mb, frcs [c], facs* and

A 77-year-old woman was admitted
to hospital with massive upper
gastrointestinal bleeding of obscure
etiology and a palpable abdominal aortic
aneurysm. A spontaneous aortoduodenal
fistula, discovered at operation, was
treated successfully by resection
of the aneurysm, aortic closure, lateral
duodenal repair and axillobilateral
femoral grafting. The three clues to
the correct diagnosis were: a palpable,
pulsatile abdominal mass, recurrent
abrupt cardiovascular collapse and
significant upper gastrointestinal
bleeding with no obvious source. The
conventional method of treatment —
aortic resection, duodenal repair,
and intra-abdominal aortic grafting —
is followed by secondary infection
and aortic anastomotic bleeding, and
by death in nearly 50% of the patients.
The method of treatment used by
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the authors in this patient may be
safer and deserves further
consideration.
Une femme de 77 ans est hospitalisee
pour une hemorragie massive des voies
digestives superieures dont I’etiologie
est douteuse et pour un anevrisme
palpable de I'aorte abdominale. Une
fistule aortoduodenale spontanee
decouverte a I'operation, a ete traitee
avec succes par resection de I’anevrisme, fermeture de I'aorte, reparation
laterale du duodenum et greffe
femorale axillobilaterale. Les trois
indices qui ont mene a bon diagnostic
sont: une masse abdominale pulsatile
palpable, un collapsus cardiovasculaire
soudain et recidivant et un saignement
significatif des voies digestives
superieures, de source non evidente.
Le mode de traitement conventionnel —
resection aortique, reparation duodenale
e t greffe aortique intra-abdominale —
entraine des infections secondaires
e t des saignements anastomotiques au
niveau de I'aorte, et le deces dans pres
de 50% des cas. Le mode de traitement
utilise par les auteurs pour cette
patiente est probablement plus sur et
merite d'etre etudie davantage.

Spontaneous aortoduodenal fistula is a
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rare sequel to abdominal aortic aneu
rysm. The complication is almost
always fatal; even with treatment by
aortic resection and grafting almost
50% of patients die. We report a case
in which this problem was managed
successfully by aneurysmal resection,
duodenal repair and extra-anatomic
vascular bypass.
Case Report

A 77-year-old white woman was ad
mitted to the Queen Elizabeth Hospital
of Montreal Centre in September 1977
with a 2-day history of repeated hematemesis, hematochezia, melena and fainting.
On physical examination her pulse rate
was 90 beats/min, blood pressure 110/60
mm Hg lying and 90/50 mm Hg sitting.
A 10-cm pulsatile abdominal mass was
present consistent with an aortic aneu
rysm. Laboratory findings were a hemo
globin value of 8.8 mg/dl, hematocrit
26% and leukocyte count 10.9 x 108/ 1.
She was transfused with 2 units of
packed cells overnight and had no further
bleeding. Her blood pressure rose to
130/70 mm Hg. A gastroenterologist was
consulted who found only a few punctate
bleeding points) at the gastroesophageal
junction on endoscopic examination, but
noted that while the duodenum was
normal in its second stage, the possibility
of an aneurysmal leak into the duodenum
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could not be eliminated. He suggested
that endoscopy be repeated and aorto
graphy performed if she bled again. Two
days later her blood pressure fell to 100/
60 mm Hg and she had two melenic
stools. She was transfused again with 2
units of packed cells to a hematocrit of
31%. Her temperature was 38.5°C and
the findings on chest roentgenography
suggested aspiration pneumonia in the
base of the left lung. Four days after
admission she experienced abdominal
pain, her blood pressure fell to 80/50 mm
Hg and her hematocrit to 27%, and she
subsequently vomited bright red blood.
She was transferred to the intensive care
unit, where her condition stabilized rapid
ly. Two days later she collapsed again.
Her blood pressure could not be obtained,
bright red blood drained from the naso
gastric tube and she passed two small
melenic stools. She was transfused and
prepared for surgery.
At operation a 2-cm gastroesophageal
mucosal tear was identified and oversewn.
We identified an aortoduodenal fistula
between the 10-cm abdominal aortic
aneurysm and the third stage of the duo
denum. The aneurysm was resected, the
proximal infrarenal aorta and iliac ar
tery were oversewn with polypropylene
and the aortic suture line was buttressed
with a wad of omentum. Lateral repair
of the duodenum was effected in two
layers. The abdomen was then closed
and a 10-mm Dacron graft placed from
the left axillary artery to both femoral
arteries.
Postoperatively a wound abscess devel
oped which was drained. She also had
moderate jaundice. The peak bilirubin
value was 14.5 mg/dl (248 y.mol/1) total,
8.4 mg/dl (144 p.mol/1) direct, alkaline
phosphatase was 12.4 King-Armstrong
units and serum glutamic pyruvic tran
saminase was 30 IU/1. The jaundice re
solved spontaneously. She received cephradine and ventilatory assistance for
her Klebsiella pneumonitis. Following re
covery from this a low-grade fever
(37.5°C to 38.5°C) continued to the third
postoperative week. The source of the
fever was ultimately traced to an infec
tion caused by the intravenous catheter
and responded well to antibiotics and
removal of the catheter. The patient was
discharged from hospital 1 month after
operation and has remained well for
18 months.

Diagnosis

Treatment
Surgery is essential for the survival
of the patient; as recently as 1947
Cleland6 stated
that
spontaneous
aortoduodenal fistula is fatal. Even
with surgery few cases with survival
have been recorded. Reckless, McCoil
and Taylor2 could find only 15 patients
treated surgically out of 128 cases of
spontaneous aortoenteric fistulas in the
literature up to 1972. Five of these
survived, and they added three more.
Of 56 cases reported since 1957, 20
were treated surgically and 10 sur
vived beyond 3 months.3 Since then
eight further operative attempts, four
successful, have been reported.
Three methods of definitive treat
ment of the fistula have been record
ed.3
Transduodenal repair.— N o patient
has survived this approach.
Separate lateral repair o f the duo
denum and aorta.— A few survivors
of this form of treatm ent have been
reported but this technique is clearly
unsuitable for the fusiform aortic
aneurysm that is now the most com 
mon cause of the fistula.
Resection and grafting o f the lower
abdominal aorta with lateral duo
denal repair.— This is regarded as
the treatment of choice. Eight of
13 cases treated in this way in the
collected series of Evans and W ebster3
survived 3 months or more. H ow 
ever, rebleeding from the upper
end of the
prosthesis secondary
to infection or recurrent fistulization
is common even up to 5 months after
operation. Three of the five deaths
following resection and grafting in
Evans and W ebster’s report occurred
in this way, and both patients reported
by Elliott, Smith and Szilagyi7 suffered
this fate.
A fourth option.— The method of
treatm ent we used presents a fourth
option — resection of the abdominal
aortic aneurysm, lateral duodenal re
pair and axillobilateral femoral bypass.
This is the technique recommended in
the treatment of prosthetic false aneu
rysms with aortoduodenal fistulas,7 but
it has not been reported as definitive
treatm ent of spontaneous aortoduode
nal fistula. Olcott and associates8 re
cently reported a case treated initially
with a left axillofemoral graft that
was replaced by an aortobilateral fem 
oral graft several months later. Vas
cular surgeons prefer an aortic graft
for two reasons.
First they assume, often incorrectly,8
that the risk of contam ination of the
prosthesis following resection of the
aortic aneurysm and fistula is small
enough to m ake an intra-abdominal
graft safe; and they may go to inor-

Aortoenteric fistulas of any etiology
are uncommon; most now develop af
ter prosthetic replacement of the ab
dominal aorta. Spontaneous aortoduo
denal fistula, first described by Sir
Astley Cooper in 1837,1 is rare and,
as in our case, is usually a complica
tion of abdominal aortic aneurysm.
Since the condition is rare, the diagno
sis is often missed, and the optimal
treatment is uncertain. The case pre
sented here emphasizes the pitfalls in
diagnosis and raises questions with
respect to ideal treatment.

We considered the correct diagnosis
preoperatively, but did not pursue it
until, at operation, we could find no
other cause of bleeding. In retrospect,
our patient showed features that occur
sufficiently frequently to constitute a
diagnostic triad: (a) a pulsatile abdo
minal mass, (b) recurrent cardiovas
cular collapse and (c) significant upper
gastrointestinal bleeding in the absence
of an obvious source.
Pulsatile abdominal mass. — A pul
satile abdominal mass was palpable in
only 66 (56%) of 118 cases reviewed
by Reckless, McCoil and Taylor,2 but
only 72 (61% ) of the cases reviewed
were due to atherosclerotic aortic
aneurysm. Since the smaller mycotic
aneurysms and saccular aneurysms due
to syphilis or tuberculosis, seen more
often in the past, are less likely to
be palpable and since atherosclerotic
aortic aneurysm is now the principal
cause of spontaneous aortoduodenal
fistula,3 a higher proportion of aneuryms should be palpable in the future.
Recurrent cardiovascular collapse. —
The typical pattern of bleeding asso
ciated with aortoduodenal fistula in
cludes a “herald bleed”, a “period of
grace” and recurrent bouts of cardio
vascular collapse. In 115 of the 118
cases reviewed by Reckless, McCoil
and Taylor2 the interval between initial
bleed and demise or operation was
longer than 6 hours in three quarters
of the patients, longer than 24 hours
in over half of the patients, and longer
than 1 week in one third of the pa
tients. This interval was 8 days in
our patient. Bleeding is intermittent
because the fistula is sealed tem porari
ly by laminated thrombus or by in
testinal spasm and increased intralu
minal pressure. Abrupt, profound col
lapse is characteristic of bleeding from
a large artery. As explained by Moore,4
a break in the unicameral hemodyna
mic system of large arteries lowers
peripheral resistance so much that no
effective blood pressure can be main
tained •— hypotension is dispropor
tionate to the degree of hypovolemia.
Absence of an obvious source of
bleeding.— The source of massive bleed
ing from aortoduodenal fistula is
often obscure. Occasionally endoscopic
examination may reveal the diagnosis,5
but the fistula generally enters the
duodenum in its third stage, beyond
the usual level of such examination.
Grey-scale ultrasonography may dem
onstrate an abdominal aortic aneurysm,
and prompt further investigation by
aortography if it is not palpable. But
even aortography may not show the
fistula;2 indeed, the diagnosis may be
missed at operation.
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dinate lengths to construct an intra
abdominal graft. Thus even when the
contaminated stomach has been opened
prior to discovery of the aortoduodenal
fistula, Hardy, Buxton and Millar3 have
suggested that the stomach “should
be closed, the duodenum oversewn,
the abdomen irrigated, gloves, gowns
and instruments changed, and the an
eurysm resected,” and replaced by an
intra-abdominal graft. The frequency
of recurrent bleeding and fistulization
belies the assumption that this ap
proach is safe.
Second, axillofemoral grafts have
generally been regarded as less satis
factory than intra-abdominal grafts.
DeBakey and associates10 have shown
that the long-term survival following
resection and intra-abdominal grafting
of abdominal aortic aneurysms is only
slightly shorter than that of a normal
population of the same age and sex,
unless hypertension or ischemic heart
disease is present before operation. On
the other hand, axillo-unilateral fem
oral bypass carries a 5-year patency
rate of less than 40%. In 1966 Sauvage
and Wood'1 suggested that axillobilateral femoral bypass grafts, by virtue
of the increased flow rate through
them, might remain patent longer than
axillo-unilateral femoral bypass grafts.
This has not been supported by Moore,
Hall and Blaisdell.12 Johnson and asso
ciates13 have recently reported that the
patency rate (76%) and the survival
rate (67%) at 5 years of axiliobilateral
femoral grafts are similar to those of
aortobilateral femoral/iliac grafts.
Their 5-year patency rate for axillounilateral femoral grafts was only
37%. Sheiner14 also obtained higher
patency rates with axiliobilateral fem
oral grafts than with axillo-unilateral
femoral grafts.
We suggest, then, that the serious
risk of delayed bleeding from the
proximal end of the prosthesis in the
patient with spontaneous aortoduo
denal fistula treated by resection^ and
intra-abdominal grafting, together with
the improved patency and survival now
obtainable by axiliobilateral femoral
grafting support the further use of
axiliobilateral femoral bypass grafts in
the management of this condition.

without an obvious source. The method
of treatment employed is a reasonable
alternative to conventional methods
and may be preferable to them.
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Antiemetic Stemetil shown to have
beneficial effect on LOS tone
Aspiration of acid into the lungs remains a
common cause of death associated with gen
eral anaesthesia. The lower oesophageal
s p h in c te r (LO S ) is said to be a m a jo r
mechanism which maintains competence of the
gastro-oesophageal junction, and several drugs
commonly used during anaesthesia may influ
ence LOS tone, thereby increasing or decreas
ing the tendency to regurgitation.
Reporting in the July 1978 issue of the British
Journal of Anaesthesia, researchers demon
strated that Stemetil (prochlorperazine) an an
tiem etic used com m only before and after
surgery, significantly increases LOS tone with
out affecting oesophageal pressure. The resul
tant increase in Barrier Pressure (BP) de

creases the tendency to regurgitation. The in
vestigators measured an average increase of
BP from 2.31 kPa to 3.36 kPa (P<0.005) in 8
volunteers following the I.V. administration of
12.5 mg Stemetil.’
This information further enhances Stem etil’s
reputation as a pharmacologically complete an
tiemetic. In addition to its effect on LOS tone,
Stemetil’s multi-level antiemetic action promptly
stems nausea and vom iting of cen tra l or
peripheral origin. Its anxiolytic action2 inhibits
cortical impulses associated with “ psychological
vomiting”. Its C.N.S. action directly blocks the
chem oreceptor trigger zone,3 4 raising the
threshold for impulses arriving at the medullary
vomiting center.

Stemetil in
Radiation Sickness
The results of a trial involving 45 patients who
developed nausea and vomiting following radia
tion therapy showed that Stemetil was effective
in all of the patients within 1-2 days, with good to
excellent results.
Stemetil was administered in a dosage of 10 mg
b.i.d. after the onset of nausea and vomiting,
and was continued for 5-10 days after symp
toms ceased. The only side effect was drowsi
ness, which might not have been drug related.5

References: Brock-Utne, J. G. et al.: The action of commonly used
antiemetics on the lower oesophageal sphincter. British Journal of
Anaesthesia, no. 50, 295-298, July 1978. 2. Peterfy, G. and Pinter, J.:
Current Therap. Res., 14, (9), 590-598, September 1972. 3. Goodman,
L. and Gilmour, A.: The Pharmacological Basis of Therapeutics, 5th Ed.,
161, 1975. 4. Todays Drugs: British Medical Journal, 1, 481, February
21, 1970. 5. Dutta, A. K.: Study of Prochlorperazine (Stemetil) in radia
tion sickness, Antiseptic Vol. 73, no. 1, pp 16-18, 1976.
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Pure Squamous Cell Carcinoma of the Stomach
A ndre R ioux ,

The authors report a case of pure
squamous carcinoma of the stomach
in a 70-year-old woman who, when
she died of intercurrent disease, was
free of local or distant tumour.
They emphasize the rarity of the
tumour as disclosed by a brief review
of the literature. The histogenesis
of the neoplasm is also discussed.
Les auteurs presentent un cas de
carcinome epidermoi'de pur de I'estomac chez une patiente de 70 ans
qui est decedee sans evidence de
neoplasie residuelle ou a distance. Une
breve revue de la litterature a ete
faite qui souligne la rarete de la
lesion. Les theories histogenetiques
sont aussi discutees.

The frequency of pure squamous cell
carcinoma of the stomach is extremely
low. Its occurrence warrants a report
and brief review of the literature.
Case R eport

A 70-year-oid woman consulted her
physician in October 1975 because of
acute upper abdominal pain of short dura
tion succeeded by epigastric malaise ag
gravated by ingestion of solid food. The
patient had lost 5.4 kg and had experienced
increasing fatigability. There had been no
rectal bleeding, jaundice or constipation.
At another hospital roentgenograms ob
tained after a barium meal suggested
a lesion in the stomach. On physical
examination an epigastric mass was pal
pable and a systolic murmur was audible
from the aorta.
The patient’s father had died at 73
years of age of cancer of the prostate.
Two of her eight siblings had died of
cancer, one of the bowel and one at an
unknown site.
Results of blood chemistry investigation,
proctoscopy up to 19 cm and chest
roentgenograms were normal. A gastro
scopy was performed and at 43 cm from
the incisor teeth a fungating sessile
tumour was discovered on the lesser cur
vature. The tumour measured approxi
mately 4 cm in diameter, had an ir
regular surface and bled easily. Endo-

m d , frcs [c ]* and

scopic biopsy recovered tumour fragments
which on histopathologic examination
were seen to be sheets of neoplastic
squamous epithelium invading and re
placing normal gastric glands and stroma.
The tumour cells showed moderate pleomorphism and occasional mitotic figures.
No evidence of glandular formation or
secretory activity could be found with
use of routine or special stains (Fig. 1).
The liver scan was normal. The patient
underwent a Billroth II subtotal gastrec
tomy and splenectomy. The surgical spe
cimen consisted of part of the stomach,
18 cm in length over the greater curvature.
A large fungating and ulcerated tumour
mass occupied most of the lesser cur
vature and extended to the anterior and
posterior walls (Fig. 2). The intraluminal
mass was irregular, moderately firm and
had a friable, ulcerated surface. On trans
verse section it appeared well delineated
and invaded the whole thickness of the
gastric wall to the serosa. The lines of
resection were 3 cm beyond gross tumour.
Fourteen perigastric lymph nodes were
identified; all appeared to be free of
metastases.
Histologically the tumour was com
posed entirely of sheets and masses of
moderately pleomorphic squamous cells
with a whorled architecture and keratin
pearl formation (Fig. 1). There was also
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keratinization of individual cells and in
tercellular bridges (Fig. 3). The tumour
cells had an ample eosinophilic, slightly
granular cytoplasm and well-defined cell
membranes. No evidence of glandular dif
ferentiation could be discovered in any

FIG. 2— Surgical specimen showing
fungating ulcerated tumour. Tumour
was located near antrum some distance
from cardia.
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FIG. 1— Photomicrograph of biopsy
specimen showing keratinizing squamous
carcinoma, which was composed of sheets
and masses o f epithelial cells, and de
monstrating whorled pattern with pearl
formation (hematoxylin and eosin, re
duced by 50% from X 160).
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FIG. 3— High-power view of surgical
specimen showing intercellular bridges
(hematoxylin and cosin, reduced by 50%
from X 1000).
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sections examined. Special stains failed to
identify mucopolysaccharide material. The
gastric mucosa adjacent to and remote
from the tumour did not show adenocar
cinoma or squamous metaplasia. All lymph
nodes were clear of metastases.
On the morning following operation the
patient was aphasic with a right hemi
plegia, presumably due to left carotid
artery thrombosis, later confirmed by
cerebral scan. Over the ensuing weeks
she recovered partially from her hemi
plegia and was able to speak with some
difficulty. While awaiting transfer to a
chronic-care hospital, she had a cardiac
arrest and died, 3 months after surgery.
Autopsy revealed bilateral massive pul
monary embolism and a subocclusion by
atheroma of the intracranial portion of
the left internal carotid artery. The
stomach showed no evidence of recurrent
tumour and no metastases were found.
Review of the Literature
Since the review of the literature
by Strauss, Heschel and Fortm ann1 in
1969, three new cases of pure squamous
cell carcinoma of the stomach have
been reported by Milstoc,2 Cornet and
colleagues3 and Melato, Antonutto and
Bianchi.4 The frequency varies between
0.41 % 5 and 0.7% .6
Of the 49 reported cases of pure
squamous cell carcinoma of the sto
mach the patient’s sex was recorded in
46: there were 9 women and 37 men.
Age distribution was equal for both
sexes in the fifth to eighth decades.
More than 50% of the tumours arise
in the pyloric region; the body of the
stomach is the second commonest site
accounting for 25% . The prognosis is
thought to be somewhat better than for
adenocarcinoma but this may reflect
the exophytic type of tum our which
is often encountered in squamous cell
carcinoma. Although interesting, it is
probably coincidental that in two of the
last four reported cases the patient died
of pulmonary embolism.
Discussion

gastric mucosa. However, if a single
such focus had existed, upon malignant
transformation it would probably have
been completely obliterated. Therefore
this theory is plausible but cannot be
supported by the findings.
2. Squamous metaplasia of gland
ular mucosa has also to be considered
as a logical explanation. Observations
in human and experimental material
support this histogenetic mechanism.
The occurrence of squamous cell car
cinoma at other sites where normally
squamous epithelium is not found is
well documented.8 This theory is also
attractive but cannot be proved or dis
proved in the present case.
3. Another theoretical explanation is
the existence of a totipotential cell
(primitive precursor or reserve cell)
capable of differentiating into a squa
mous rather than a glandular cell and
occasionally into embryonal tropho
blastic cells as evidenced by the oc
currence of primary choriocarcinoma
in the stomach.9
4. Yet another explanation is squa
mous metaplasia or differentiation in an
adenocarcinoma, hence the generally
accepted term of adenoacanthoma.10 The
presence of this tumour in the stomach
and in other locations has been well
documented.1113 In the present case
there was no evidence of a glandular
component or secretory activity in the
many sections of the tumour examined.
We therefore discard this theory al
though it cannot be excluded entirely.
5. Squamous cell carcinoma at the
gastric cardia is well known and most
cases, if not all, represent an extension
or metastasis from a primary tumour
of the esophagus.14 The case we report
does not fall in this category because
of its location- and its distance from
the cardia. Furtherm ore at autopsy the
esophagus was examined and found to
be free of any lesion.
6. Finally, although admittedly this
explanation is highly hypothetical,
squamous cell carcinoma could originate
from endothelial cells of the blood
vessels.15
In conclusion, any of the first three
theories listed might have application
to the present case for the reasons
mentioned. However, the reasoning re
mains purely speculative since there is
no available technique to unravel the
exact histogenesis of the lesion.

As already mentioned pure squamous
cell carcinoma of the stomach, ex
clusive of that found at the esopha
gogastric junction, is rare and has been
reported only sporadically. The occur
rence of such a tum our in this viscus,
which normally does not bear squa
mous epithelium, provides interesting
speculations on its histogenesis. Six
theoretic pathogenic mechanisms will
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Injuries to the Fifth Carpometacarpal Region
I G. D ommisse , mb , ch b and G.J. L loyd, mb , ch b, frcs, frcs[c]

(
4

Because of the recent renewed
interest in fractures in the region
of the fifth carpometacarpal joint the
authors have reviewed their experience
with 17 such fractures and have
classified them into those caused by
direct or indirect injury. The type
of fracture or fracture-dislocation was
found to be related to the mechanism
of injury. The management of the
various types of fracture is described
and is dictated by the essential
functions of this region of the hand.
Etant donne le renouveau d’interet
porte recemment aux fractures de la
region de la cinquieme articulation
carpometacarpienne, les auteurs ont
revu leur experience de 17
fractures de ce type et les ont
classifies en deux groupes selon
qu’elles furent causees par une blessure
directe ou indirecte. La fracture ou
la fracture avec dislocation s’est
montree reliee au mecanisme de la
blessure. Le traitement des divers
types de fracture est decrit et dicte a
partir des fonctions essentielles
de cette region de la main.

In the past, fractures in the carpometa
carpal region were usually considered
to be of minor consequence. Recently,
however, those occurring in the region
of the fifth carpometacarpal joint have
aroused interest. A fracture compara
ble to, and a mirror image of, Ben
nett’s fracture of the first metacarpal
has been described.1 We therefore
reviewed the patients and records relat
ing to 17 fractures involving this re
gion and as a result have recognized
a number of fracture patterns. We
find that the type of fracture or frac
ture-dislocation is dependent on the
mechanism of injury.

side of the hand. Ligamentous support
is provided by the transverse dorsal
and palmar intermetacarpal ligaments
which extend from the radial half of
the base of the fifth metacarpal to the
base of the adjacent fourth metacarpal.
Additional stability is provided by the
pisometacarpal ligament (Fig. 1). Sub
luxation of this carpometacarpal joint,
when the musculi flexor carpi ulnaris,
extensor carpi ulnaris and opponens
digiti minimi act as deforming forces,

disrupts the arch formed by the heads
of the second to fifth metacarpals and
the deep transverse metacarpal liga
ments of the palm.
Mechanism of Injury

Injury to the carpometacarpal region
of the hand may be either direct or
indirect.
Direct Injury

In our series 10 patients sustained

Deep transverse
metacarpal lig .

t*

4

Transverse palmar
intermetacarpal lig
Pisometacarpal lig .

FIG. 1— Normal anatomy of palmar aspect of fifth metacarpal.

-f

Anatomical Considerations

The fifth carpometacarpal joint is
a saddle joint allowing extension and
flexion, either of which is accompa
nied by rotation towards the radial

i

From the division of orthopedic
surgery, department of surgery, Toronto
Western Hospital, University of
Toronto, Toronto, Ont.
Reprint requests to: Dr. G.J. Lloyd,
Division of orthopedic surgery, Toronto
Western Hospital, 399 Bathurst St.,
Toronto, Ont. M5T 2S8
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FIG. 2— Posteroanterior crushing injury shows comminuted fracture of fifth
metacarpal with minimal displacement and no proximal migration of shaft.
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direct injury which resulted from
either a posteroanterior crushing force
(6 patients) or a blow to the ulnar
border of the hand (4 patients). Injury
from a posteroanterior crushing force
produces a comminuted fracture with
little displacement of the fragments.
The articular surface is affected but
there is no proximal migration of the
metacarpal shaft (Fig. 2). A direct
blow to the ulnar border of the hand
can occur owing to a poorly executed
karate blow. This may cause an angulated fracture which is unstable but
spares the articular surface (Fig. 3).

Indirect Injury
Seven patients sustained an indirect
injury which may be one of two types.
The first is a lever type of strain in
which the fifth metacarpal is forced
into dorsiflexion, as by a fall on the
ulnar border of the hand. The second
type follows a blow over the head
of the fifth metacarpal. A vertical
force is transmitted along the shaft
to the base of the metacarpal.
These indirect injuries resulted in a
bipartite (Fig. 4) fracture-dislocation
in four patients and a tripartite (Fig. 5)
fracture-dislocation in three. The ra
dial portion of the base of the fifth
metacarpal is held in position by the
intermetacarpal ligaments while the
ulnar portion and the attached shaft
are drawn proximally by muscle ac
tion, particularly of the flexor carpi
uinaris, acting on the pisometacarpal
ligament.
Analysis of these injuries suggests
that the bipartite fracture is the result
of a hyperextension lever strain, where
as the tripartite fracture results from
a force transmitted through the shaft
to the base of the metacarpal.

FIG. 3— Direct blow to
ulnar border of hand
resulting in angulated
fracture. Joint surface
remains intact.

FIG. 4— Indirect lever
strain causing bipartite
fracture-dislocation with
proximal migration of
shaft.

Principles of Management

The fracture caused by a posteroan
terior crushing force does not disturb
the alignment between the metacarpal
heads and therefore it is stable. Treat
ment consists of keeping the hand
elevated and insisting on early activity.
An excellent functional result can be
anticipated. A fracture resulting from
a direct blow to the ulnar border of
trie hand, which leads to angulation
and instability but spares the joint
surface, should be reduced by manipu
lation and percutaneous pin fixation
between the shafts of the fourth and
fifth metacarpals. Once immobilization
is assured, early activity is encouraged.
The pins should be removed after the
fracture has united, usually after 4
weeks.
The fracture caused by an indirect
blow and resulting in a bipartite or tri-

FIG. 5— Vertical force
along shaft of fifth
metacarpal, resulting
in tripartite fracturedislocation and proximal
migration of shaft.
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To control upper
gastrointestinal bleeding
due to stress ulcer,
hemorrhagic gastritis, stress
gastritis, bleeding gastric
erosions, duodenal and
gastric ulcers...

a Sm ithKIine com pany

New

Tagamet
(cimetidine) injection

Th e 'Tagam et'ef feet
The precise mechanism by which 'Tagamet controls upper g.i. bleeding i®p-’junderstood, although several theories exist, of which these seem the most likely.

Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is
known to digest protein in an acidic environment) and possibly promoting clot formation.

May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism
to control bleeding.

May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2receptors, thereby encouraging
healing of the mucosal injury.

6 5 patients in whom other nonsurgical measures had failed, or
for whom surgical intervention
was considered impossible or
unduly hazardous, were
evaluated; the results are
reported in the adjacent table.1

Heavy
Moderate
Subacute/recurrent

C o m p le te
Su ccess

P a rtia l
Su ccess

C o m p le te
& P a rtia l
Su ccess

F a ilu r e

65%
52%
45%

15%
22%
25%

80%
74%
70%

20%
26%
30%

1. Data on file, SK&F Medical Department

The H2Receptor Antagonist-A major clinical
advance for uncontrolled g.L bleeding
SMITH KLINE &-FRENCH CANADA LTD.
Montreal, Quebec H4M 2L6

Tagamet®

DUODENAL ULCER, NON-MALIGNANT
GASTRIC ULCER. AND G ASTRO
ESOPHAGEAL REFLUX DISEASE

(cimetidine SK&F)
Tablets
Injection

Prescribing Inform ation
(Product Monograph available to practitioners on request)

ACTION
Cimetidine competitively inhibits the action of histamine
at the histamine H2 receptor, and thus represents a new
class of pharmacological agents, the histamine
H2 -receptor antagonists.
Cimetidine is not an anticholinergic agent. Studies have
shown that cimetidine inhibits both daytime and nocturnal
b asal gastric acid secretion. Cimetidine also inhibits
gastric acid secretion stimulated by food, histamine,
pentagastrin, caffeine and insulin. Its ability to inhibit
gastric acid secretion via this unique mechanism of action
permits a new approach to the treatment of acid-related
gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral administration.
The plasma half-life is approximately two hours. The
principal route of excretion is the urine.
The degree and duration of inhibition of basal and
stimulated gastric acid secretion are dose-related; the
data suggest that 8 0% or higher inhibition throughout a
2 4 hour period can be achieved by a dosage regimen of
3 0 0 mg four times daily given with meals and at bedtime.
Cim etidine 3 0 0 mg reduced total pepsin output as a result
of the decrease in volume of gastric juice. The drug had no
effect on the rate of gastric emptying or lower esophageal
sphincter (LES) pressure.

INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions
where the inhibition of gastric acid secretion is likely to be
beneficial, such as:
□
□
□
□
□

Duodenal ulcer
Non-malignant gastric ulcer
Gastroesophageal reflux disease
Management of upper gastrointestinal hemorrhage
Pathological hypersecretion associated with ZollingerEllison Syndrome, systemic mastocytosis and multiple
endocrine adenomas.

CONTRAINDICATIONS
There a re no known contraindications to the use of
'Tagam et' (cimetidine).

PRECAUTIONS
Use in P regnan cy : Nursing Mothers:
There has been no experience, to date, with use of
'Tagam et' (cimetidine) in pregnant patients. Reproduction
studies performed in rats, mice and rabbits have revealed
no evidence of impaired fertility or harm to the fetus due to
'Tagam et'. Studies have demonstrated that 'Tagamet'
crosses the p lacental barrier. It is also secreted in the milk
of animals. 'Tagam et' should be used in pregnant or
lactating patients or women of child-bearing potential only
when, in the judgement of the physician, the anticipated
benefits outweigh the potential risks.
Use in Children
C linical experience in children is limited. Therefore,
’Tagam et' (cimetidine) therapy cannot be recommended
for children unless, in the judgement of the physician,
anticipated benefits outweigh the potential risks. In very
limited experience, 20-40 mg kg per day has been
administered in divided doses by mouth or intravenously.
Use in Im paired Renal Function
Because 'Tagam et' (cimetidine) is excreted by the kidney,
a reduced dosage should normally be administered to
patients with impaired renal function. (See DOSAGE AND
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter
action between ’Tagamet' and commonly used drugs. No
significant interactions have been observed in man.
Mild and transient diarrhea, muscular pain, dizziness and
rash have been reported in a small number of patients
during treatment with ’Tagamet' (cimetidine). There have
been reports that a few patients have developed mild
nonprogressive gynecomastia during prolonged treatment.
No evidence of induced endocrine dysfunction was found,
and the condition remained unchanged with continuing
'Tagam et' treatment. Some increases in plasma creatinine
and serum transaminase have been reported.

OVERDOSAGE
In c ase s reported to date, involving oral ingestion of up to
1 0 gram s of 'Tagam et' (cimetidine), no untoward effects
have been noted, and recovery has been uneventful.
Treatm ent
The usual measures to remove unabsorbed material from
the gastrointestinal tract, clinical monitoring and
supportive therapy should be employed. Studies in animals
ind icate that assisted respiration may be of value and that
any tachycardia may be controlled by administration of a
B-blocker.

D O SA G E AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has
not been evaluated in clinical studies—see PRECAUTIONS)
In c lin ical studies ’Tagamet' (cimetidine) has been used in
divided doses of up to 2 4 0 0 mg/day.
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MANAGEMENT O F UPPER
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding of
sufficient magnitude as to require blood transfusions,
Tagam et' should be adm inistered parenterally,
preferably by intravenous injection or intermittent
infusion or, if necessary, by constant intravenous infusion
until 4 8 hours after active bleeding has stopped. At this
time an oral dosage regimen may be instituted and should
be continued for at least 7 -10 days.
Recommended dosage for oral administration:
3 0 0 mg every 6 hours.
Recommended d osage for intram uscular injection
adm inistration:
3 0 0 mg every 6 hours. Inject the entire contents of a 2 ml
ampul.
Recommended dosage for intravenous injection
adm inistration:
3 0 0 mg every 6 hours. Dilute ’Tagamet' in Sodium
Chloride Injection (0.9% ) (or other compatible i.v.
solution) to a total volume of 2 0 ml and inject over 1-2
minutes.
Recommended dosage for intermittent intravenous
infusion adm inistration:
3 0 0 mg every 6 hours. Dilute 'Tagamet' 3 0 0 mg in 1 0 0 ml
of Dextrose Injection (5%) (or other compatible i.v.
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage.
When this is necessary, the increases should be made by
more frequent administration of a 3 0 0 mg dose, but total
daily dosage should not exceed 2 4 0 0 mg.
Recommended d osage for constant intravenous
infusion adm inistration:
2 mg/kg/hour. Dilute ’Tagamet' for injection in a
compatible i.v. solution, such as Sodium Chloride Injection
(0.9% ) or Dextrose Injection (5% or 10% ). In some patients
it may be necessary to increase dosage. Dosage should
usually not exceed 4 mg/kg/hour.

DOSAGE ADJUSTMENT FOR PATIENTS WITH
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been
treated with ’Tagamet'. However, such usage has been
very limited. On the basis of this experience the
recommended dosage is 3 0 0 mg every 12 hours orally or
by intravenous or intramuscular injection. Should the
patient's condition require, the frequency of dosing may be
increased to every 8 hours or even further with caution. In
severe renal failure accumulation may occur and the
lowest frequency of dosing compatible with an adequate
patient response should be used. Hemodialysis removes
circulating cimetidine, therefore, the timing of dosage
should be adjusted to the dialysis schedule.

PATHOLOGICAL HYPERSECRETORY
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
Recommended a dult oral dosage:
3 0 0 mg four times a day with meals and at bedtime. In
some patients it may b e necessary to administer 3 0 0 mg
doses more frequently to control symptoms. Dosage should
be adjusted to individual patient needs, but usually should
not exceed 2 4 0 0 mg per day. If intravenous administration
is required, the d osage schedule should be the same as
that recommended for control of upper gastrointestinal
bleeding.

SPECIAL CASES

ADVERSE REACTIONS

partite fracture-dislocation, poses two
problems with respect to management.
The first is the maintenance of length,
in order to preserve the correct align
ment between the heads of the fourth
and fifth metacarpals, and the second
is the restoration of the damaged arti
cular surface. In our experience bi
partite fractures can be reduced by
manipulation and percutaneous pin fix
ation of the fifth to the fourth meta
carpal using two parallel Kirschner
wires. Manipulation of the tripartite
fracture proved less successful in our
series and open reduction proved to be
the most effective method of restoring
the articular surface and maintaining
the length of the metacarpal.

The recommended adult oral dosage for duodenal ulcer,
non malignant gastric ulcer and gastroesophageal reflux
disease is 300 m g four times a day, with m eals and at
bedtime.
While healing with 'Tagamet' often occurs during the first
week or two, treatm ent should be continued for a t least
four weeks unless healing has been demonstrated by
endoscopic examination.
Some patients may require concomitant antacids until
symptoms disappear.

In patients in whom control of gastric acid secretion is
desirable, the recommended oral dosage of 'Tagamet' is
3 0 0 mg four times a day, with meals and at bedtime. If
intravenous administration is required, the dosage
schedule should be the same as that recommended for
control of upper gastrointestinal bleeding.

STABILITY O F INJECTABLE FORM
’Tagamet' injection, when added to or diluted with most
intravenous solutions, such as Sodium Chloride injection
(0.9% ) or Dextrose injection (5% or 10% ), is stable for 4 8
hours at normal room temperature ’Tagamet' Injection
should not be refrigerated.

AVAILABILITY
Tablets:
Pale green circular biconvex film coated tablets, each
containing cimetidine 3 0 0 mg (monogrammed SKF T13).
Bottles of 10 0 tablets.
Injection:
Each 2 ml dose contains cimetidine HC1 equivalent to 3 0 0
mg of cimetidine, in Sterile Water for Injection. Preserved
with phenol, 0 .5 % . Ampuls of 2 ml, packaged in 10's.
g
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Results of Treatment
All patients were treated in accord
ance with the principles outlined above
and were followed up for at least 1
year. Those who had suffered a posteroanterior crushing force had no
functional disability but close scrutiny
showed a reduction in the range of
movement at the fifth carpometacarpal
joint as would be expected from an
intra-articular fracture. The four pa
tients who had received a direct blow
to the ulnar border of the hand had no
functional disability or anatomical alter
ation after 1 year. None of the seven
patients with bipartite or tripartite
fracture-dislocation resulting from an
indirect injury had a hand that was
anatomically normal 1 year after the
accident and five complained of weak
ness of grip. This is not surprising since
the major involvement of the carpo
metacarpal joint associated with this
type of injury leads to some loss of
rotation towards the radial side of
the hand. This movement at the saddle
joint is an integral component of grasp
ing movement.

Discussion
Injuries to the fifth carpometacarpal
region are rare. It is important to dif
ferentiate between the stable and un
stable injuries, and also to recognize
the importance of the arch formed by
the heads of the second to fifth meta
carpals and the deep transverse meta
carpal ligament. The integrity o f this
arch and the mobility, particularly in
rotation, of the fifth carpometacarpal
joint are essential for normal hand func
tion. The method of management de
scribed in this paper, depending as it
does on the type of injury inflicted,
serves to preserve these features.
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Agenesis or Atrophy of the Testis and Vas Deferens
S. M ercer,

In this study the author examines the
relationship between agenesis or
atrophy of the testis and of the vas
deferens. From a prospective study of
237 cases of unilateral and bilateral
undescended testis, 12 cases of
agenesis of a testis w ere seen; 9 of
the 12 cases were associated with
agenesis of the vas deferens and in 3
of these unilateral renal agenesis
was also present, not necessarily
ipsilaterally. Three other cases of
testicular agenesis and four cases of
extreme testicular atrophy were seen.
In all seven, the vas deferens was
present in part or in its entirety and
roentgenography disclosed a normal
upper urinary tract. Agenesis of
the vas deferens was seen only in
patients with monorchism. No patient
was anorchid. It is concluded that
an important link exists between
agenesis of the vas deferens and
agenesis of the testis.

md , frcs[c]*

un lien important entre I'agenesie du
vas deferens et I'agenesie du testicule.

The frequency of associated renal
anomalies in cases of undescended
testis has not been clearly documented,
neither has the prevalence of congen
ital renal anomalies in the general
population. To establish if radiologic
investigation of the upper urinary tract
was justified in cases of undescended
testis, a prospective study was begun
in 1966. It was found that serious
renal anomalies are rare but renal
agenesis is the most common of these.
An important link between agenesis of
the vas deferens and agenesis of the
testis was established. Renal agenesis
occurred in association with agenesis
of the vas deferens but was not neces
sarily ipsilateral to it.
Patient Data

G roup 1

The nine patients in this group
(3.8% of the entire series) had ipsi
lateral agenesis of the vas deferens
and testis. The agenesis was left sided
in six and right sided in three. In three
cases IVP demonstrated unilateral
renal agenesis which was ipsilateral in
two and contralateral in one. In previ
ous reports renal agenesis has been
linked to agenesis of the vas deferens
rather than to agenesis of the testis
and has been ipsilateral.1-4
G roup 2

In this group there were three pa
tients with agenesis of the testis alone
(1.23% of the total series). Tissue at
the lower end of the vas deferens was
examined microscopically in each and
testicular tissue was not found. No
upper tract anomalies were seen on
the intravenous pyelogram.

Reprint requests to: Dr. S. Mercer,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont. K1H 8LI

Two hundred and thirty-seven con
secutive cases of undescended testis
were studied prospectively at the Chil
dren’s Hospital of Eastern Ontario,
Ottawa. The study began in 1966 and
ended in 1977. Of the 237 cases of
undescended testis, 26 cases were bi
lateral, 105 were right sided and 106
left sided. Intravenous pyelography
(IVP) was carried out in 213 (90%).
Parental consent for IVP was refused
in 24 (10%). The author operated on
all the patients. The retroperitoneal
area and peritoneal cavity were ex
plored through the initial inguinal in
cision, without a separate laparotomy.
No patient had urinary symptoms.
Associated upper urinary tract anom
alies, classified as of major and minor
anatomical importance, will be report
ed elsewhere. Of 13 major anomalies,
8 were unilateral renal agenesis as
demonstrated by IVP using the usual
criteria of absence of bilateral excre
tion of dye and contralateral renal
hypertrophy. Cystoscopy, scanning and
arteriography were not performed.
Renal agenesis was not necessarily
related to the side of agenesis of the
testis or vas deferens. This is contrary
to previous reports.1-4 Extreme atrophy
or true agenesis of the testis was seen
in 16 cases; 9 were left sided, 5 right
sided and 2 bilateral. All 16 patients
underwent IVP. In none was there any
history of trauma or torsion. These
cases were divided into three groups.
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Dans cette etude, I’auteur examine le
rapport entre I’agenesie ou I'atrophie du
testicule et cede du vas deferens.
Dans une etude prospective de 237 cas
de cryptorchidie u n ila te ra l ou bilaterale,
12 cas d’agenesie d’un testicule ont
ete observes; 9 des 12 cas etaient
associes a une agenesie du vas deferens
et dans 3 de ces cas, une agenesie
renale u n ila te ra l, mais pas necessairement ipsilaterale, etait aussi presente.
Trois autres cas d’agenesie testiculaire
et quatre cas d'atrophie testiculaire
extreme ont ete notes; dans ces sept
cas, le vas deferens etait present,
partiellement ou au complet, e t la
radiographie a revele des voies urinaires
superieures normales. L'agenesie du
vas deferens a ete observee chez un
patient monorchide. Aucun patient
n’etait anorchide. On conclut qu'il existe

From the department of surgery,
Children’s Hospital of Eastern Ontario
and University of Ottawa, Ottawa, Ont.
Presented at the 10th annual meeting
of the Canadian Association of
Paediatric Surgeons, Vancouver, BC,
Jan. 25, 1978
*Chief, department of surgery, Children’s
Hospital of Eastern Ontario, Ottawa
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G roup 3

Four patients (1.68%) with extreme
testicular atrophy constituted this
group. Testicular tissue was seen only
on examination of the biopsy speci
men. In all patients the vas deferens
was present in part or in whole. The
atrophy in this group was thought to
be the result of an intrauterine vascular
accident secondary to torsion or some
other cause. As in group 2, IVP dem
onstrated a normal upper urinary
tract.
Discussion

If groups 1 and 2 are considered
together it can be noted that renal
agenesis, which was seen in 3 of the
12 cases of testicular agenesis, occurred
only when both the vas deferens and
testis were absent.
In a personal series of approximate
ly 3000 herniorrhaphies, without cystic
fibrosis, unilateral agenesis of the vas
deferens alone was seen only twice
(0.60%). In both patients the findings
on IVP were unremarkable. In two
other small series of unilateral agenesis
of the vas deferens, without testicular
agenesis or cystic fibrosis, ipsilateral
renal agenesis was found in 50% and
100% of the cases respectively.1,3 The
important factor in renal agenesis ap245

pears to be agenesis of the vas deferens
as a Wolffian duct derivative. This
is in agreement with conventional em
bryology (Fig. 1). However, the occur
rence of contralateral renal agenesis
in association with agenesis of vas
deferens or testis as in this series is
more difficult to explain embryologically. The frequency of unilateral renal
agenesis in the general population was
compared with that in the three groups
(Table I5,6). Unilateral renal agenesis
is more common in cases of undes
cended testis at the 0.01% level of
significance and is not necessarily ipsilateral. Neither agenesis nor atrophy
of the testis alone (without agenesis
of the vas deferens) were associated
with renal agenesis. However, although
this association cannot be statistically
rejected, no firm conclusion can be
drawn.
Agenesis of the vas deferens was
seen only in cases of agenesis of the
testis in the present series. However,
in 3 of the 12 cases of testicular
agenesis the vas deferens was normally
present. The frequency of unilateral
agenesis of testis in this series of 237
cases of undescended testis was 5.06% .
The reported frequency of monorchism
in cases of undescended testis varies
from 3.7% to 13.3% ,7-9 depending in
part on the size of the series and
presumably on the intensity of the
search for the testis.
Problems still exist with respect to
the diagnosis of monorchism. Even
with adequate surgical exploration,
angiography, arteriography and scan
ning techniques, we cannot be abso
lutely sure that monorchism is present.
Therefore, testicular hypoplasia or in
trauterine atrophy cannot always be
excluded. The exact incidence of mo
norchism in the general population is
uncertain but is reported as being
0.02% to 0.1 % .4'5
To establish if a link exists between
agenesis of the vas deferens and
agenesis of the testis, a statistical eva
luation was made taking into consider
ation the following factors: (a) the

Table 1— Incidence of U nilateral Renal Agenesis

Group

No. with
renal agenesis

General population — undes
cended testis, vas deferens
present(n = 197)

8

0.4

0.01% . Z = 16.46

1 — agenesis of testis, vas de
ferens absent (n = 9)

3

33.3

Less than 0.01%

2 — agenesis of testis, vas de
ferens present(n = 3)

0

3 — atrophy of testis (n = 4)

0

0

!

0

j

1
i

No conclusion to be drawn,
Link w ith renal agenesis
cannot be rejected (sig. =
0.5% )

*The frequency of unilateral renal agenesis in the general population is reported as ranging from
0.01% to 0.19% ,5 e depending on the size of the series and the mode by which the figure was
derived. A fig u re of 0.1% was taken as a basis for the comparison.

incidence of agenesis of vas deferens
in the general population (0.5% to
0.1% ) and in our series of 237 cases
of undescended testis (3.8%) and (b)
the incidence of agenesis of the testis
in the general population (0.02% to
0 . 1%) and in our series (5.06%).
The hypothesis that agenesis of the
vas deferens and agenesis of the testis
are independent of each other is im
probable to a significance level of less
than 0.5% . This link has been under
rated in the past. Since all methods of
exploration and investigation of a pos
sible intra-abdominal testis are inac
curate, this significant link is of great
importance in considering indications
for more major surgical exploration
to avoid future testicular cancer.

It is concluded from this study that
renal agenesis is more common in the
presence of undescended testis than in
the general population. Unilateral renal
agenesis has previously only been as
sociated with ipsilateral agenesis of
the vas deferens and testis. In this
series it was associated with contra
lateral agenesis of vas deferens and
testis in one case. Following from this
the finding of contralateral renal
agenesis suggests that either the con
ventional embryology may be incorrect
and the vas deferens and ureteric bud
may develop separately from the uro
genital sinus, or that loss of the vas
deferens may occur after development
of the ureteric bud and after their
separation by the 60-mm stage.
Contralateral derangements of renal,
testicular and Wolffian duct develop
ment may occur more commonly than
is presently believed, without external
physical evidence.
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In the past,penicillins were not considered as products of first choice in the treatment of anaerobic infections, such as
bacteroides, and consequently, other potentially more toxic therapeutic agents were used.
Now, PYOPEN* (carbenicillin), one of the newer broad-spectrum semisynthetic penicillins, offers advantages previously
unavailable in this type of therapy.
Recent studies1* 3have shown that PYOPEN is effective in 94.1 % of cases of pelvic infections due to anaerobic and/or
mixed gram-negative aerobic infections. PYOPEN is not only effective, it is also free from dose-related toxicities, and
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Effect of Cardiopulmonary Bypass and Hypothermia
on Pancreatic Endocrine Function
and Peripheral Utilization of Glucose
R oderick W. L andym ore , m d ,* D avid A. M u rph y , m d , fr c s [c ]*
and W il l ia m J. L o n g ley , ph Df

,
*
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Extracorporeal circulation has been
reported to produce abnormalities
of glucose metabolism. Pancreatic
endocrine function and peripheral
glucose utilisation w ere studied in 11
nondiabetic patients who underwent
myocardial revascularization.
Nonpulsatile flow with hemodilution
and moderate hypothermia to 28°C
w ere used in each case. Following the
onset of cardiopulmonary bypass,
serum glucose values rose rapidly to
a mean of 972 mg/dl (54.0 m m ol/l) and
were associated with high circulating
concentrations of insulin in the range
of 216 jxU/ml (1549.8 p m ol/l). High
circulating concentrations for both
insulin and glucose were maintained
throughout the bypass period. These
returned to normal postoperatively
when the patient was in the recovery
room. The results of this study
indicate that both the pancreatic
endocrine response and the peripheral
utilization of glucose are impaired
during cardiopulmonary bypass with
hemodilution and moderate hypothermia
to 28°C.
On a constate que la circulation
extracorporelle produisait des anomalies
du metabolisme du glucose. La
fonction pancreatique endocrine et
(’utilisation peripherique du glucose
ont ete etudiees chez 11 patients non
diabetiques qui subirent une
revascularisation du myocarde. Une
circulation non pulsatile avec
hemodilution et une hypothermie
moderee a 28°C ont ete utilisees dans
chaque cas. Apres le debut de la
derivation cardiopulmonaire, les
mesures du glucose serique
augmenterent rapidement jusqu’a une
moyenne de 972 mg/dl (54.0 m m ol/l) et

From the departments of surgery*
and pathology ,f Victoria Genera!
Hospital, and the Maritime Heart Center
Halifax, NS
Supported by the Nova Scotia Heart
Foundation
Reprint requests to: Dr. D.A. Murphy,
Maritime Heart Center, Pavillion,
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furent associees a des concentrations
elevees d'insuline circulante evaluees
a 216 jj,.U/ml (1549.8 p m o l/l). Ces
concentrations elevees d'insuline et
de glucose dans la circulation se
sont maintenues pendant toute la
periode de derivation. Elies revinrent
a la normale apres I'operation, alors
que le patient etait dans la salle
de reveil. Les resultats de cette etude
indiquent une alteration de la reponse
endocrine du pancreas et de I'utilisation
peripherique du glucose pendant la
derivation cardiopulmonaire avec
hemodilution et hypothermie moderee
a 28°C.

The patients were admitted to hos
pital 3 days before operation. The pro
pranolol dosage was gradually reduced
following admission to ensure that
the medication was discontinued 24
hours before operation. A screening
biochemical profile was obtained in
each case; it included a complete blood
count, glucose, load testing, measure
ment of serum electrolytes, blood urea
nitrogen and creatinine values, and
urinalysis.
The preoperative medication regi
men consisted of pentobarbital sodium
(Nembutal®, Abbott) 100 mg hs, and
morphine, 10 to 15 mg intramuscular
Cardiopulmonary
bypass
produces ly, at 06:45 hours on the day of sur
many profound metabolic disturbances. gery. Induction of anesthesia was car
Pancreatic endocrine function has been ried out with thiopental sodium and
studied by a number of authors.1-6 pancuronium bromide, 0.1 mg/kg
However, the endocrine response still body weight. Anesthesia was main
has not been accurately defined. While tained with a combination of oxygen,
some authors3-5 have demonstrated nitrous oxide and halothane.
A Bentley - Temptrol oxygenator
impaired insulin release during bypass,
(Bentley
Laboratories, Irvine, CA) was
others1,2,6 have failed to duplicate these
findings. The varied results must be used in each case and was primed with
owing in part to differences in cardio 1500 ml of plasmolyte solution and 1
pulmonary bypass technique in com unit of blood. Volume was replaced
bination with varying degrees of hypo with plasmolyte solution while the pa
tient was on the pump. Moderate hypo
thermia.
thermia to 28 °C was utilized in each
The purpose of this paper is to case.
determine the pancreatic endocrine
In the induction room following
response during myocardial revascula
preparation
for surgery, blood was
rization procedures using moderate
drawn from the radial artery for a
hypothermia (28°C).
complete blood count and measure
ment of serum electrolyte, glucose and
Patients and Method
insulin values and hematocrit. Similar
Eleven patients (10 men and 1 samples were drawn at 30 minutes and
woman) who underwent elective myo 1 hour following the onset of bypass
cardial revascularization were studied. and again 2 Vi and 5 hours after the
Their ages ranged from 36 to 64 years termination of bypass.
(mean 50.9 years). Patients who re
Insulin was assayed utilizing a radio
quired or had associated cardiac pro immunoassay technique (Amersham
cedures were eliminated from the stu Corporation, Oakville, Ont.) and glu
dy. No patient had had a serious cose was measured by the glucoseillness previously other than coronary oxidase Trinder indicator method
insufficiency. In each case the patient (Boehringer - Mannheim Laboratories,
was taking propranolol (Inderal®, St. Laurent, PQ).
Ay erst) in doses ranging from 40 mg
to 120 mg (mean 50 mg) q6h. The
Results
majority of patients were also taking
isosorbide dinitrate (Isordil®, Wyeth)
Thirty-three grafts were placed, an
and nitroglycerin in addition to In average of three per patient. The
deral® but no other medications.
time required for induction and pre-
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paration for bypass ranged from 90
to 160 minutes (mean 117 minutes).
The duration of bypass ranged from 95
to 198 minutes (mean 140 minutes)
and of hypothermia (to 28°C) from 50
to 150 minutes (mean 101 minutes).
The time required for closure ranged
from 50 to 105 minutes (mean 83
minutes).
Glucose load testing 24 hours before
operation demonstrated normal glucose
tolerance in all patients. The results
obtained on the operative day are
shown in Fig. 1. Five samples were
taken on the day of operation. The
first sample (TO was taken following
the completion of the induction phase.
One sample (TBA) was drawn V2 hour
and another (TBB) 1 hour following
the onset of bypass. Two further sam
ples were drawn in the recovery room,
2 1 /2 hours and 5 hours after the ter
mination of bypass and were labelled
TRA and TRB respectively. All values
for both insulin and glucose during
cardiopulmonary bypass and in the re
covery room were significantly elevat
ed (P = 0.005) as compared with rest
ing values. There was, however, no
statistical difference between the two
bypass measurements for insulin and
glucose.
Discussion

metabolism during cardiopulmonary
bypass have not been clearly eluci
dated. Deep hypothermia appears to
impair insulin release.4 Flowever, the
observation of glucose metabolism dur
ing moderate hypothermia has pro
duced conflicting results. Lin and
associates8 reported that moderate hy
pothermia had little effect on insulin
release, whereas Hill, Sonksen and
Braimbridge5 demonstrated severely
impaired insulin release with moderate
hypothermia to 32°C. Growth hor
mone is the most important insulin an
tagonist and is not elevated during
cardiopulmonary bypass.2 When glu
cose tolerance is normal preoperatively, core temperature appears to be
the most important factor in determin
ing the pancreatic endocrine response
during extracorporeal circulation.
The movement of glucose into the
cell is dependent upon the circulating
concentrations of insulin, membrane
transport and the kinetics of glucose
phosphorylation.
In the presence of adequate circu
lating concentrations of insulin, glucose
phosphorylation is the main rate-limit
ing step concerned with glucose up
take.9 It has been clearly demonstrated
that insulin is required for normal
membrane transport of glucose, al
though slow diffusion will take place
in the absence of insulin. Insulin binds
to the cell wall altering membrane
structure, thus facilitating the rapid
movement of glucose into the cell.10'12
The kinetics of this movement suggest
an enzyme-catalyzed, energy requiring,
carrier system.13 Hypothermia alters
greatly the rate at which glucose moves
into the cell. Narahara and Ozand14
and Wohltmann and Narahara15 have
shown that hypothermia does not in
hibit insulin binding but does impair

the effect of insulin-enhanced permea
bility, reducing permeability to zero at
19°C. Hypothermia will also affect the
kinetics of the enzyme-mediated carrier
system and the glucokinase glucose
phosphorylation step by rendering the
enzyme systems ineffective even with
moderate hypothermia (28°C). The re
sults of this study clearly indicate that
the pancreas is capable of an imme
diate response to elevated glucose con
centrations during cardiopulmonary by
pass with moderate hypothermia to
28°C. However, the magnitude of the
insulin release is inappropriate to the
concentration of circulating glucose.
Following the onset of bypass, serum
glucose values rose to a mean of 972
rng/dl (54.0 mrnol/1). This large glu
cose load was associated with a mean
serum insulin value of 216 uU/ml
(1549.8 pmol/1). Cerasi and Luft16 and
Elrick and associates17 found that
intravenous glucose loading is as
sociated with an insulin release of
lesser magnitude than that following
oral glucose administration. However,
even taking into account the decreased
insulin release associated with intra
venous glucose loading, the insulin
release during cardiopulmonary bypass
with moderate hypothermia is consi
derably impaired. Appropriate serum
insulin concentrations in association
with a circulating glucose concentra
tion of 900 mg/dl (50.0 mmol/1) would
be in the range of 500 pLJ/ml (3587.5
pmol/1). The impaired insulin release
is undoubtedly the effect of moderate
hypothermia. Furthermore, the serum
glucose concentration remained ele
vated during bypass as indicated by
the second bypass sample (mean glu
cose concentration 937 mg/dl [52.01
mmol/1]). A persistently elevated se
rum glucose concentration in spite of
a high circulating insulin concentration
indicates poor peripheral utilization.
Most of a glucose load is metabolized
by skeletal muscle in the extremities.
Cardiopulmonary bypass with moder
ate hypothermia induces intense peri
pheral vasoconstriction which reduces
the perfusion of the extremities causing
a reduction in the availability of glu
cose to the cell. In our study the
peripheral vascular resistance increased
from mean prebypass values of 1431
dynes/s-cnv5 to 1740 dynes/s^cnv5
during bypass (P = 0.05) indicating
increased peripheral vasoconstriction
and decreased peripheral perfusion
during extracorporeal circulation. Fur
thermore, hypothermia will significant
ly impair glucose movement into the
cell by affecting the mechanisms of
glucose transport and metabolism al
ready elaborated. The combined effect
of decreased peripheral perfusion and
impaired transport mechanisms will

The uptake of glucose and secretion
of insulin studied during cardiopul
monary bypass show varying responses
to both pancreatic endocrine function
and glucose utilization. Moffitt and as
sociates1,2 demonstrated a marked in
crease in serum glucose values with
the onset of bypass together with a
delayed insulin response. Other inves
tigators3'5 showed that endocrine res
ponse is markedly impaired during by
pass, while Valentin and Rasmussen6
demonstrated an appropriate insulin
response associated with impaired
peripheral glucose uptake.
Normal glucose utilization is depen
dent upon appropriate islet cell res
ponse to elevated serum glucose con
centrations associated with normal glu
cose uptake by the skeletal muscle and
the extremities. The pancreatic endo
crine response during cardiopulmonary
bypass is dependent upon normal
preoperative islet cell function, pan
creatic blood flow, core temperature
and the presence or absence of insulin
antagonists.
Islet cell function is readily assessed
by glucose tolerance or glucose
load testing prior to operation. Mandelbaum and Morgan7 have demonstrated
FIG. 1— Blood glucose and iramunothat pancreatic blood flow remains reactive
insulin values during myocardial
normal or may actually increase during revascularization
in nondia
prolonged extracorporeal circulation. betic patients. Plotsprocedures
are mean values and
The effects of hypothermia on glucose ± standard error of mean is also shown.
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result in reduced peripheral glucose
utilization. These mechanisms return
to normal following the termination
of bypass and associated rewarming as
evidenced in the recovery room by
gradually decreasing serum glucose
concentrations.
In summary, it is apparent that the
pancreas is capable of an immediate
insulin release in response to high cir
culating glucose concentrations follow
ing the onset of extracorporeal circu
lation with moderate hypothermia to
2 8 °C . However, the magnitude of this
response is inappropriate indicating
impairment of pancreatic endocrine
function with moderate hypothermia.
In addition, peripheral glucose utiliza
tion is impaired as a result of the
combined effects of decreased peri
pheral perfusion and impaired glucose
transport mechanisms during cardio
pulmonary bypass.
We would like to thank Drs. C.E.
Kinley and J.A. Parrott (division of car
diovascular surgery) and the staff of the
department of anesthesia, Victoria Gen
eral Hospital, for their cooperation dur
ing this study. We also thank Mrs. P.
Langille for preparing the manuscript.
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Formation of Abdominal Cyst Secondary to
Ventriculoperitoneal Shunting
C .E.U . E k o n g ,

The formation of an abdominal cyst is
an uncommon complication of ventri
culoperitoneal shunts. Three cases are
presented in this paper and 21
previously reported cases are reviewed.
The authors believe that decreased
absorptive power of the peritoneum
as a result of adhesions from previous
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multiple abdominal procedures or
infection (particularly by Staphylococcus
epid erm id is}, or both, is of etiologic
significance. The patients presented
with abdominal swelling and tenderness
due to a malfunctioning shunt. Early
diagnosis is possible by roentgenography
of the abdomen and radioisotope
scanning of the shunt. Paracentesis
with conversion of the shunt to a
ventriculoatrial or ventriculocisternal
type is the treatment of choice.
La formation d’un kyste abdominal est
une complication rare des pontages
ventriculoperitoneaux. Cette presen
tation etudie trois cas et passe en
revue 21 cas rapportes anterieurement.
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Les auteurs croient qu'une diminution
de la capacite d'absorption du peritoine
resultant d'adherences consecutives a
des interventions abdominales multiples
ou a une infection (particulierement
le Staphylococcus epiderm idis), ou aux
deux, est significative du point de vue
etiologique. Les patients presentent
une enflure et une sensibilite abdo
minales dues a un dysfonctionnement
de la derivation. Le diagnostic precoce
est possible grace a la radiographie
de I’abdomen et a la scintigraphie radioisotopique de la derivation. La
paracentese et la conversion a une
anastomose ventriculo-auriculaire ou a
une ventriculo-cisternotomie constituent
le traitement de choix.
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Various complications of ventriculo
peritoneal (VP) cerebrospinal fluid
(CSF) shunting have been reported.
These have ranged from mere block
age of the tubing' to volvulus ,2 infec
tion' and perforation of the umbilicus ,3
vagina 4 and intestine .5 Since 1954, 21
cases of CSF encystation in the ab
dominal cavity complicating
CSF
shunting have been reported .612 We
encountered three cases at the Univer
sity Hospital, Saskatoon, between 1967
and 1977. The aim of this paper is to
draw attention to this uncommon com
plication of CSF shunting; we also
attempt to document the diagnostic
criteria of this complication, both from
our three cases and from those pre
viously reported.

Case Reports
Case /.—An 11-year-old girl was
admitted to the University Hospital, Sas
katoon, on Aug. 5, 1974 for repair of a
skin defect behind the left ear resulting
from erosion by VP shunt tubing (Holter
system).
She was the fifth of six children born
to a 43-year-old dentist and a 35-year-old
mother. The pregnancy had been ter
minated at 35 weeks by cesarean section
because of ruptured membrane, hemor
rhage and a prolapsed umbilical cord. The
birth weight was 2.25 kg. At 2 weeks
of age the child’s head was noted to be
larger than usual and hydrocephalus was
confirmed by a transfontanelle ventri
culogram. A ventriculocaval shunt was
inserted without delay. Postoperatively
she had a low-grade fever secondary to
wound infection. Culture of CSF and
blood yielded no growth of organisms.
Leukocyte count was normal. She was
treated successfully with chloramphenicol
and oxacillin and was discharged. The
shunt worked well until the child was
V/2 years old, when the caval end be
came blocked, requiring revision. When
the child was 10 years old the caval tube
again became blocked and the shunt was
converted to a VP type. She recovered
rapidly and continued to do well until she
was readmitted on Aug. 5, 1974.

free within the cyst. The cyst was opened
and the tube replaced in the left para
colic gutter. The skin defect behind the
right ear was repaired at the same time.
The system functioned for 2 weeks,
when the lower end again blocked and
resulted in CSF leakage and exposure of
the cannula behind the right ear. The
entire Holter shunt system was removed
from the right side and replaced with a
left ventriculoatrial (VA) shunt. The
child has done well since then.
Case 2.—This 11-year-old girl was
admitted to the University Hospital, Sas
katoon, on Aug. 31, 1975 with a history
of increasing abdominal pain for 1 week
and frontal headache and drowsiness for
2 days. There was a question as to
whether she might have peritonitis from
acute appendicitis.
She had first been seen 3 years pre
viously with headaches, forgetfulness and
deterioration in academic ability. Investi
gations at that time (which included
ventriculography and pneumoencephalo
graphy) revealed markedly increased in
tracranial pressure and hydrocephalus
due to aqueduct stenosis. Ventriculo
peritoneal shunting was carried out using
a Mishler-Pudenz device for the ventri
cular end and Raimondi tubing for the
abdomen. On the fifth postoperative day
the patient became febrile (temperature
39.4°C) and was treated symptomatically
with acetylsalicylic acid and ampicillin.
She was well for 2 Vi years and then the
shunt became blocked twice in 1 week,
and required two further laparotomies
and revisions. She did well for a further
31/2 months before being admitted on
Aug. 31, 1975.
On examination she was drowsy and
irritable. The flushing device was tense
and difficult to empty. The abdomen was
distended and tender in the upper half.

A 10-cm soft tissue mass was palpable in
the epigastrium. There was no sign of
peritonitis. Roentgenography of the ab
domen (Fig. 1) showed an extensive paraunbilical soft tissue mass extending to the
pelvic region which was presumed to be
a CSF cyst. Percutaneous aspiration of
the mass yielded 150 ml of clear yellow
CSF and relieved the patient’s headaches.
The peritoneal tube was pulled out of the
abdomen without further laparotomy and
the shunt converted to a VA system. The
peritoneal mass gradually disappeared over
the following week.
Following this procedure, the shunt was
changed first to external drainage be
cause of septicemia caused by Staphylo
coccus epidermidis, then to a Torkildsen’s
ventriculocisternal shunt which became
blocked; finally a VP shunt was re
established. This functioned well for 2V4
years, then the peritoneal end had to be
revised because it became blocked. The
shunt has functioned well since.
Case 3.—A 2-year-old girl was ad
mitted on July 26, 1975 with pyrexia and
acidotic breathing. Investigation revealed
that she had multiple pulmonary emboli
and septicemia caused by S. epidermidis.
She had pulmonary hypertension and
right-sided cardiac failure.
The patient had had a repair of a
myelomeningocele on the day of birth. A
VP shunt had been inserted at 1 week to
control CSF leakage at the site of the
myelomeningocele repair. Because the
wound appeared inflamed she had re
ceived penicillin and kanamycin. Two
weeks later oral thrush developed and
was treated with nystatin. Her shunt had
functioned well for 6 months but in the
interim she had had a repair of an um
bilical hernia. Following this operation her
shunt became blocked and laparotomy and
revision were required. Three days later a
further malfunction necessitated conver
sion to a VA system. Thereafter she did
well until admitted on July 26, 1975.
Three consecutive blood cultures grew
S. epidermidis, so on Aug. 8, 1975 the
VA shunt was removed. Antibiotic ther
apy and external drainage were instituted.
Two days later a VP shunt was re-estab
lished as it was obvious that the child
was shunt-dependent. On Aug. 20, the
ventricular end of the shunt became
blocked with debris and was revised. The
child improved slightly for a few days,
then became irritable, febrile and had
abdominal swelling and tenderness. Ro
entgenograms of the abdomen showed a
soft tissue mass at the tip of the abdo
minal shunt tubing. This was thought to
be a CSF cyst. At laparotomy on Aug.
27, the shunt tubing was delivered from
a thin-walled cyst and placed in the lesser
sac. The cyst contained about 350 ml of
clear yellow CSF. The cyst wall was
1 mm thick and on histologic examina
tion was found to consist of fibrous tissue.
Postoperatively she improved, but on
Sept. 5, 1975, while the abdominal sutures
were being removed, she had a massive
wound dehiscence followed by respiratory

Physical examination showed that the
child was small for her age. No neurologic
abnormality was noted. Clinically the
shunt did not appear to be blocked. The
shunt tubing was exposed to the surface
for about 1 cm behind the right ear. On
abdominal examination a fluctuant epi
gastric mass, which was not tender, was
apparent. This was thought to be a CSF
cyst. An
abdominal roentgenogram
showed a soft tissue mass which had
displaced the stomach posteriorly and
inferolaterally. At operation a cyst lying
between the liver and the stomach and
extending down to the umbilicus was
found. It contained 300 to 400 ml of
clear fluid. The distal 3 cm of peritoneal
tubing was enclosed by the fibrous wall
of the cyst and the tip of the tubing lay

FIG. 1— Case 2. Anteroposterior ab
dominal roentgenogram showing soft
tissue mass with displacement of bowel.
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arrest from which she could not be
resuscitated.
Discussion

Cerebrospinal fluid cyst is a rela
tively uncommon complication of VP
shunting but an important one which,
with awareness, should be more fre
quently diagnosed. Our cases represent
3 (2.5%) of 120 consecutive patients
with VP shunting done in the Univer
sity Hospital, Saskatoon, between 1967
and 1977. Gutierrez and Raimondi10
reported 11 such cases in 1585 peri
toneal shunts. Fischer and Shillito9 and
Parry, Schuhmacher and Llewellyn6
each reported three cases. Jackson
and Snodgrass7 reported one case out
of 62 patients and in a series reported
by Harsh8 1 of 12 patients who had
fallopian tube peritoneal shunts had a
large cyst about the fimbria.
Previous abdominal surgery was a
feature in all our patients and all had
had some wound infection previously.
In our third case shunt infection by
S. epidermidis was confirmed. Adhe
sions from previous infection or
surgery seem to interfere with the ab
sorptive power of the peritoneum. If
localized, CSF cysts form and if
generalized, CSF ascites develops.1'13'14
In the case reported by Ames1 in
which CSF ascites developed as a com
plication, there was “an acute febrile
illness characterized by vomiting, diar
rhea, abdominal pain, and leukopenia”
3 weeks before the abdomen became
distended. Gutierrez and Raimondi10
reported previous shunt infection in 8
of their 11 cases of peritoneal cyst,
and previous shunt revisions in 9.
Fischer and Shillito9 reported some in
fection in two of their three patients
— septicemia in one and ventriculitis
in the other. All three patients had
had previous abdominal procedures.
Harsh’s8 patient had had two previous
abdominal operations. The cases of
Parry, Schuhmacher and Llewellyn6
each had one shunt revision; shunt in
fection was confirmed in one and the
other two were being given high doses
of antibiotics. In most cases in which
an infective organism was identified in
previous shunt infection or in the cyst,
the organism responsible was Staphylo
coccus sp. Organisms were cultured
from the cyst in 5 of the 11 cases of
Gutierrez and Raimondi;10 S. epider
midis was present in 4 cases and
Escherichia coli in 1. The shunt in
fection in two of the cases reported by
Fischer and Shillito9 was caused by
Staphylococcus aureus, coagulase ne
gative. The identity of the organism
probably has no more significance than
the fact that these are the commonest
causes of shunt infection. Whether
VOLUME 22, NO. 3, MAY 1979
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Staphylococcus sp. have a specific,
potent effect, reducing the absorptive
power of the peritoneum, is unclear.
The diagnosis should be made easily
in most cases. The common physical
findings in our three cases were: ab
dominal distension and evidence of
malfunctioning of the shunt. Abdo
minal tenderness was also present in
two of the three patients. Our first
case showed no evidence of raised in
tracranial pressure and no abdominal
tenderness, presumably because the
CSF cyst was continuously being de
compressed through a skin defect
around the shunt tubing. Gutierrez
and Raimondi10 reported abdominal
distension and malfunctioning of the
shunt in all their cases. Abdominal
tenderness and abnormal bowel sounds
were present in nine. Fischer and
Shillito’s9 three patients all had ab
dominal distension and tenderness as
well as evidence of raised intracranial
pressure. The three patients reported
by Parry, Schuhmacher and Llewellyn,6
however, demonstrated no evidence of
shunt blockage initially, either by
symptoms and signs of increased intra
cranial pressure or by the bubble
palpation method of Ames.1

Nevertheless, it is prudent to avoid
shunting CSF into the peritoneal cavity,
if possible, after a CSF cyst has
formed. Another procedure which
could also be done in selected cases is
ventriculocisternal shunting.
The authors are grateful to Mrs. M.
Faulkner for secretarial assistance.
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Gelfoam
used by a generation of physicians
in hepatic surgery, haemorrhoidectomy,
cholecystectomy and decubitus ulcer

still the only absorbable haemostat that meets all these criteria:
absorbed completely in four to six weeks
safe as a permanent packing in any tissue; won’t interfere with bone
regeneration, cause cyst formation or excessive scar tissue
effective dry or moistened with thrombin solution, isotonic
sodium chloride or antibiotic
non-irritating, naturally-occurring, neutral pH; may be cut,
molded, or sutured in place when necessary
stimulates natural clotting and healing of disrupted tissue
769
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Upjohn
THE UPJOHN COMPANY OF CANADA/DON MILLS, ONTARIO

available in a variety of sizes, shapes
and forms for most areas of
surgery where haemostasis is desired
p a c k in g fo r g y n a e c o lo g ic
and re c ta l su rg e ry

p a c k in g c a v itie s - o b lite r a tin g
d e a d sp a ce

S te rile Pack, size 2 cm
4 0 x 2 cm
ja r o f on e s p o n g e

S te rile Pack, size 6 cm
40 x 6 cm
box o f s ix sp o n g e s

S te rile S po ng e, size 200
80 x 250 x 10 m m
b o x o f s ix s p o n g e s

fo r ge n e ra l s u rg e ry

fo r ge n e ra l su rg e ry

s p e c ia lly p re p a re d fo r d ry
a p p lic a tio n a n d e m e rg e n cy
h a e m o s ta s is

fo r n a sal p a c k in g
P P
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S te rile S p o ng e, size 100
80 x 125 x 100 m m
bo x o f s ix s p o n g e s

S te rile S po ng e, size 50
80 x 62.5 x 10 mm
box o f fo u r sp o n g e s

S te rile C o m p re sse d S p o n g e
size 100
1 2 .5 x 8 cm
b o x o f s ix sp o n g e s

fo r general a n d n e u ro lo g ic a l
su rg e ry

fo r g e n e ra l an d n e u ro lo g ica l
su rg e ry

p ro m o te h e a lin g in c h ro n ic
le g u lc e r

S te rile S po ng e, size 1 2 -3 m m
20 x 60 x 3 m m
bo x o f fo u r s p o n g e s

S te rile S ponge, size 12-7 m m
20 x 60 x 7 m m
b o x o f fo u r sp o n g e s
ja r o f fo u r sp o n g e s

S te rile P ow de r
ja r c o n ta in in g 1 g

n o n -h a e m o s ta tic
fo r o c u la r s u rg e ry

Precautions

Gelfoam and Gelfilm are simple to use, and with conscientious observance of certain precau
tions satisfactory results may generally be expected where their use is indicated.
1. Gelfoam should be used discriminately in arterial bleeding because of the intra-arterial pres
sure. It is advisable to suture and reinforce where possible.
2. Although Gelfoam generally serves its purpose well in the presence of haemorrhagic blood
dyscrasias, it should hot be relied upon as the sole method of haemostasis in such conditions.

O p h th a lm ic S te rile G e lfilm
25 x 50 m m
bo x o f 6

CE 7734.4

3. Gelfoam should not be used to stop menstrual bleeding. In postpartum and menorrhagic
bleeding it serves only as a temporary vaginal tampon.
4. Gelfoam must be in snug contact with the bleeding surface in order to be effective.
5. Use Gelfoam as sparingly as possible in order to minimise the amount of implanted foreign
material.
6. Do not overfill cavities with Gelfoam.
7. Do not use Gelfoam in grossly contaminated wounds which are so deep that drainage is
interfered with. However, it may be used for temporary haemostasis in more superficial
contaminated wounds, provided it is removed after it has served its haemostatic purpose.
8. Avoid prolonged exposure to Gelfoam to contaminated air.
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Ischemic Colitis Associated with Hypertension
Roger D etry,

md , G hislain D evroede, md , frcs [c], P rometeo M adarnas md frcp IcI
H enry H addad, md , frcp [c] and E tzel G ysling, md

A 48-year-old man with accelerated
hypertension developed right-sided
ischemic colitis. There was no evidence
of another cause of vascular
inadequacy. Microscopically, the bowel
showed ischemic alterations of different
stages. The arterial vessels showed
minimal changes. In older lesions,
fibrosis was prominent and the mucosa
was atrophic. In more recent lesions,
some vessels of the submucosa were
plugged with fibrin and the overlying
mucosa was infiltrated by nonorganized
hemorrhage and cellular elements.
Un homme de 48 ans souffrant
d hypertension acceleree a developpe
une colite ischem ique au colon
ascendant. Aucune autre cause que
I'hypotension n'a pu etre trouvee pour
expliquer le probleme. Les changements
histologiques etaient de chronologie
mixte. II y avait peu de changements
dans la paroi des vaisseaux. La fibrose
etait marquee et s'accompagnait
d'atrophie dans les lesions anciennes.
Dans les lesions recentes, les
vaisseaux etaient parfois obstrues par
des bouchons de fibrine et la muqueuse
susjacente etait infiltree d'elements
cellulaires hematologiques.

Six months before admission, he began to
suffer from pain in the epigastrium and
right lower abdominal quadrant, and from
bloodless diarrhea alternating with con
stipation.
On admission he had no fever. The
pulse rate was 88 beats/min and regular.
The blood pressure ranged from 250/170
to 300/200 mm Hg. Cardiac auscultation
was normal. There was abdominal tender
ness, no guarding and diffuse rebound
tenderness. Peripheral pulses were normal.
Fundoscopic examination revealed severe
hypertensive
retinopathy. The leuko
cyte count was 23 X 10V1. Chest and
abdominal roentgenograms appeared nor
mal. The electrocardiogram showed a
transient discrete depressed ST segment.
Proctoscopic examination disclosed no
abnormality but there was a purulent dis
charge from a higher level, without active
hemorrhage.
Intravenous pyelography
yielded normal results.
The hypertension was not treated before
operation. At laparotomy, performed to
ascertain the cause of the abdominal ten
derness and diffuse rebound tenderness,
there was edema and congestion of the
ascending mesocolon. From the middle
of the ascending colon to a distance
10 cm from the splenic flexure, the
gut was contracted and the serosa con
gested. The distal colon was normal.
Arterial pulses were evident at the junc
tion of the mesentery and the colon. The

retroperitoneal area was normal. Through
a transverse colotomy, the mucosa ap
peared cyanotic and hemorrhagic; there
was dark blood in the lumen. A right
hemicolectomy was done.
Postoperatively, the plasma creatinine
concentration and creatinine clearance
were normal. Results of the phentolamine
test for pheochromocytoma were neg
ative. Repeated estimates of vanillylmandelic acid, urinary catecholamines,
total ketogenic steroids, 17-ketosteroids,
and unconjugated corticoids were all
normal. Renal angiography disclosed no
abnormality nor did a skull roentgeno
gram and mediastinal and adrenal tomo
grams. Results of small bowel study were
normal. A renogram obtained using iodohippurate sodium as the contrast medium
and a scan using mercury-197-chlormerodrin showed discrete and not significative
alterations. Treatment instituted for the
symptoms of hypertension consisted of
methyldopa (Aldomet®, Merck, Sharp
and Dohme) and spironolactone hydro
chlorothiazide (Aldactazide®, Searle) and
the patient was observed during 6 years
for blood pressure control. There were no
further intestinal symptoms, and the ro
entgenogram obtained after a barium
enema remained normal. There were no
untoward developments during follow-up.
Pathology (Figs. 1 and 2)
On gross examination of the specimen,

Atheromas of the major or smaller
intestinal vessels may reduce blood
flow and produce ischemic colitis.1^
However, nonocclusive ischemic colitis
may also occur.5
We present evidence that ischemic
colitis may accompany an episode of
accelerated hypertension.
Case R epo rt

A 48-year-old man complained of
severe continuous abdominal pain for 3
days and several episodes of passing bright
red blood by rectum.
He had had headache and vertigo for
many years; hypertension had been dis
covered 2 years before but was not treated.
From the departments of general surgery,
pathology and medicine,
Centre Hospitaller Universitaire,
Universite de Sherbrooke, Sherbrooke, PQ
Reprint requests to: Dr. Ghislain
Devroede, Department of surgery,
Centre Hospitaller Universitaire,
Universite de Sherbrooke,
Sherbrooke, PQ J1H 5N4
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FIG. 1— Photomicrograph showing full thickness of colonic wall. There is atrophic
narrowing of mucosa showing sparse crypts and marked cellular infiltration, prominent
vessels in submucosa with diffuse fibrosis and focal areas of hemorrhage. Mild atrophic
changes are present in muscularis (hematoxylin and eosin, reduced by 30% from X25).
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the mucosal surface showed areas of
hemorrhage and fine granularity but no
frank ulcers. Edema of the submucosa
distended and bulged the overlying mu
cosa in areas. The peritoneal surface had
some areas of granularity and focal
hemorrhage.
Microscopically the bowel showed is
chemic alterations of different stages.6-7
In the older lesions there was thickening
of the wall by fibrosis in the submucosa,
to a much lesser extent in the muscularis
propria and occasionally in the serosa.
The overlying mucosa was frankly
atrophic and there was infiltration of the
lamina propria by plasma cells, lym
phocytes, neutrophils and fibroblasts. The
epithelium was absent in minute focal
superficial areas, in the zones of atrophy.
More recent lesions were recognized
within the areas of prominent, swollen,
bulging submucosa. In some places the
vessels of the submucosa were plugged
with fibrin and their walls infiltrated by
neutrophils; the changes were maximal
near the muscularis mucosae. The overlying mucosa was infiltrated by nonorganized hemorrhage, neutrophils, lym
phocytes and plasma cells.
In the serosa there were zones of
fibrosis adjacent to an atrophic muscularis
and occasional areas of hemorrhage.
There were changes of acute mild
peritonitis at the peritoneal surface.
Throughout the remaining colonic
wall there was edema of the submucosa,
vascular dilatation through all layers and
relatively normal mucosa.
There was no arteritis or thromboembolization. The arterial vessels in the
mesentery and the serosa showed minimal,
if any, histologic changes. There was no
intimal hyperplasia.

D iscussion

Mechanical impairment of the blood
flow to the colon can reproduce a
typical pattern of ischemic colitis in
animals.8 However, the pathogenesis of
the disease is not always clearly de
monstrated in man.5 Distal arterio
sclerosis combined with factors that
decrease blood flow (shock, cardiac
failure,
arrythmia)
may produce
vascular inadequacy without evident
occlusion.1*3’9 A transient decrease
of high blood pressure1 has also
been incriminated but no specific
role assigned. However, ischemic
colitis was attributed to persistent
vasoconstriction in a patient suffering
from hypertension due to a pheochromocytoma.10
The patient reported here had a long
history of uncontrolled hypertension be
fore ischemic colitis developed, and
there was no evidence of arteriosclerosis
or diabetes mellitus. He never took anti
hypertensive drugs. When he suffered
both from a more severe episode of
hypertension and increased digestive
symptoms, there was no evidence of
cardiac failure, hypotension or shock.
The laparotomy excluded an occlusive
process. The origin of the hypertension
was not discovered but a pheochromocytoma was excluded. The only pos
sible remaining mechanism of the
ischemic phenomenon was the existence
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NOTICES
Canadian Lung Association
Asthma, clinical care, community and
governmental education, funding and
life-style smoking are some of the
themes to be discussed at the 79th
annual meeting of the Canadian Lung
Association and its sections.
The meeting will take place at the
Sheraton Centre, Toronto, June 25 to
27, 1979. F or further information con
tact the Canadian Lung Association, 75
Albert St., Ste. 908, Ottawa, Ont. K IP
5E7.

FIG. 2— Prominent crypt atrophy and
intestinal hemorrhage is seen in lamina
propria and submucosa. There is focal
microscopic mucosal ulceration. Prom
inent vascular changes with fibrin plug
ging and cellular infiltration in upper sub
mucosa are demonstrated (hematoxylin
and eosin, reduced by 50% from X63).

celerated episode. Microscopic exam
ination showed no vascular abnormal
ities but did show concomitant chronic
and acute ischemic lesions of the
colon. This correlates well with the
clinical story of repeated episodes of
digestive symptoms for at least 6
months. After surgery, no further in
testinal problem was noted for several
years, when the blood pressure was
controlled. Despite these considera
tions, the evidence provided in this
report for a causative role of hyper
tension in the genesis of ischemic
bowel disease, is at best circumstantial.
Ischemic colitis more often than not
occurs without any identifiable precip
itating event or contributing factor or
condition. Thus, the absence of any
such event or condition does not pro
vide adequate cause for implicating
the hypertension. However, under the
age of 50 years, episodes of colonic
ischemia are extremely rare in the ab
sence of some identifiable cause (e.g.,
collagen disease, operative trauma).
Given the age of our patient, the
causative relationship of the hyper
tension, when all other tests were
normal, is more convincing. How
hypertension may produce vascular
inadequacy in the bowel without
arteriosclerosis or circulatory failure
remains to be determined.
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Symposium on
Skin Microbiology
An international symposium on skin
microbiology and its relevance to clin
ical infection will be held from Aug. 29
to 31, 1979 in San Francisco, Califor
nia. Sponsored by extended programs
in medical education and presented by
the department of dermatology of the
University of California School of Med
icine, the event will be open to interested
parties in all fields of medicine, nursing
and public health.
The symposium will cover clinical
infection in such fields as dermatology,
surgery, infectious diseases and pedi
atrics.
For further information contact:
Extended programs in medical educa
tion, University of California, R. 569 U,
San Francisco, CA 94143.
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To lower
blood pressure
during
anesthesia

reduces excessive
blood loss

Precautions

for controlled hypotension during anesthesia
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
appropriate. Benefit-risk ratio should be carefully considered on an
individual basis.
Contraindications
In the treatment of compensatory hypertension, e.g. arteriovenous
shunt or coarctation of the aorta. It is also contraindicated in physically
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia
or hypovolemia or in those with known inadequate cerebral circulation.
In patients with liver disease, severe renal disease, Leber's optic
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
'Nipride' is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection. Infusion rates
greater than 8 /ig/kg/minute are virtually never required. If at this
rate an adequate reduction in blood pressure is not obtained within
10 minutes, administration of 'Nipride' should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium
nitroprusside administration. One factor is common to all known
cases, namely that large amounts of nitroprusside were infused at
high rates. Since detoxification relies upon enzymatic action, the
rare possibility of deficient or atypical enzymes occurring in humans
should always be considered. Patients most apt to run into difficul
ties are those who are resistant to the hypotensive effect or those
in whom maintenance at the selected blood pressure level is difficult
or impossible.
Constant attention to the patient's dose-response characteristics
is mandatory. If infusion rates are in excess of 8 ftg/kg/minufe deter
mine the nature of the response (effective constant response at
higher dose; tachyphylactic; resistant - none or less than expected).
As soon as either tachyphylaxis or resistance is determined the infu
sion of 'Nipride' should be discontinued immediately. In abnormal
responders it has been noted that metabolic acidosis may occur
at higher doses.
Caution should be exercised in using 'Nipride' in patients with hypo
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g /100 ml, it is
probably safe to continue with the infusion. Peritoneal dialysis can
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concomitant antihypertensive medications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of 'Nipride' should
be adjusted downward accordingly.
The following Warnings apply to the use of 'Nipride' for controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin
ished. If possible, preexisting anemia and hypovolemia should be
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipment and personnel should be available
for frequent and vigilant monitoring of blood pressure. When the infu
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clinical situation, stress induced by pain or manipulation
is reduced or eliminated during ‘Nipride’ infusion, the patient could
experience a greater than expected reduction in blood pressure
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the
infusion bottle should be wrapped with aluminum foil or other opaque
material. Solutions of 'Nipride' should not be kept or used longer
than four hours. 'Nipride' in aqueous solution yields the nitroprusside
ion, which reacts with even minute quantities of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction products (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle twitching, retrosternal discomfort and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and somnolence have been noted with too
rapid reduction in blood pressure. These symptoms rapidly disap
peared with slowing of the rate of infusion or temporary discontinua
tion of infusion and did not reappear with continued slower rate
of administration.
Irritation of the injection site may occur. Methemoglobinemia and
one case of hypothyroidism following prolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
'Nipride' should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml
of sterile dextrose in water without preservatives. No other diluent
should be used. Depending on the desired concentration, all of the
prepared stock solution should be diluted in 500 or 1000 ml of 5 per
cent sterile dextrose in water and promptly wrapped in aluminum
foil or other opaque material. Both stock solution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution for infusion has a very faint brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than four hours from
initial reconstitution. The infusion fluid used for the administration
of 'Nipride' should not be employed as a vehicle for simultaneous
administration of any other drug.
‘Nipride’ dosage varies considerably from patient to patient, hence
the need for individual titration. The infusion should be started at
the lower dosage range, 0.5 jig /kg /m in u te and increased by
0.2 fig/kg/m inute every 5 minutes until the desired reduction in
blood pressure is obtained. The blood pressure usually starts to drop
immediately or at least within a few minutes. Continuous monitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to drop at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
Infusion rates greater than 8 /xg/kg/m inute should rarely be used.
The maximum recommended dose is 800 fig /minute.
'Nipride' should be administered by an infusion pump, micro-drip
regulator or any similar device that will allow precise measurement
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effect, as determined by frequent
blood pressure determinations.
For the use of 'Nipride' in the treatment of hypertensive crises please
refer to the Product Monograph.
Supply
'Nipride' is supplied in 5 ml amber-coloured vials containing the
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
* Reg. Trade Mark for sodium nitroprusside 'Roche'
®Reg. Trade Mark

Can. 8042

(sodium nitroprusside)

Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg
nant has not been established; hence, it should be given only when
the potential benefits have been weighed against possible hazard
to mother and fetus.
Usage in children

Hoffmann-La Roche Limited
Vaudreuil, Quebec
J7V6B3
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PAAB
CCPP

The safety of 'Nipride' in children has not been established. Clinical
experience is limited.
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Intraoperative Blood-Flow Responses in Coronary
Artery Bypass Grafts
T omas A. Salerno, md, frcs[c], D avid S. M ulder,
and R ay C-J. C hiu , md , frcs [c], ph d

Intraoperative graft flow responses
in 15 patients who underwent coronary
artery bypass grafting (CABG) were
studied systematically. The mean
blood flow for 13 left anterior
descending (LAD) coronary artery grafts
was 64 ± 20 m l/m in and for 12 right
coronary artery (RCA) grafts was
53 ± 13 m l/m in. Of these, systolic
flow was dominant in one LAD and
three RCA grafts, suggesting the
perfusion of the right ventricle or the
noncontractile left ventricle segment,
or both. Five LAD and two RCA
grafts had a negligible reactive
hyperemic response, and the underlying
cause for this can be further
examined by observing their phasic
flow patterns. Temporary occlusion of
the coronary artery proximal to the
site of anastomosis produced increased
flow in 8 grafts, indicating the
presence of competitive flow;
decreased flow was observed in 15
grafts, indicating the presence of
proximal retrograde flow which
may play a role in the proximal
occlusion of the bypassed artery later.
Thus intraoperative flow studies
supplement the preoperative
angiographic findings in elucidating
the pathophysiology involved and
are useful in evaluating CABG
operations.
Chez 15 patients qui subirent un
pontage aortocoronarien, le changement
peroperatoire du debit du greffon a
ete etudie systematiquement. Le debit
sanguin moyen pour les 13 greffes
des coronaires descendantes anterieures gauches (CG) etait de 64 ±
20 m l/m in et, pour les 12 greffes des
coronaires droites (CD), de 53 ± 13
m l/m in . Le debit systolique etait

From the division of cardiovascular
and thoracic surgery, the Montreal
General Hospital, McGill University,
Montreal, PQ and the department of
surgery, Queen’s University, Kingston,
Ont.
Reprint requests to: Dr. T.A. Salerno,
Department of surgery, Queen’s
University, Kingston General
Hospital, Kingston, Ont. K7L 2V7
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dominant dans un greffon de CG et dans
trois greffons de CD, ce qui suggere
la perfusion du ventricule droit ou du
segment non contractile du ventricule
gauche, ou des deux. Cinq greffons
de la CG et deux de la CD ont eu une
reaction hyperemique de peu d’importance dont la cause sous-jacente
peut etre examinee de plus pres en
observant revolution caracteristique de
leurs debits. L'occlusion temporaire
de I'artere coronaire proximate au point
d’anastomose a provoque une augmen
tation du debit dans 8 greffons, indiquant
la presence d'un debit concurrent;
une diminution du debit a ete observee
dans 15 greffons, indiquant la presence
d'un debit retrograde proximal qui
pourrait jouer un role dans (’occlusion
proximate ulterieure de I'artere pontee.
Les etudes du debit peroperatoire
completent les observations angiographiques preoperatoires pour
I'elucidation des mecanismes pathophysiologiques impliques et sont utiles
a 1’evaluation des operations de
pontage aortocoronariens.

Detailed intraoperative studies of graft
flow patterns and their responses to
certain maneuvers can elucidate many
salient aspects of pathophysiology
in coronary artery bypass grafting
(CABG). Comparisons of such findings
with the preoperative cardiac catheteri
zation data and angiographic findings
may shed light on a number of clinical
observations and controversies related
to CABG. These include: certain limi
tations of preoperative studies in pre
dicting the outcome of CABG; the
frequent rapid progression of the
stenotic coronary lesion proximal to
the vein-coronary artery anastomotic

md , frcs [c]

site;1-4 the question of “prophylactic”
grafts bypassing a subcritically stenosed coronary artery, and the contro
versy surrounding the value of CABG
in improving left ventricular func
tion.5-9
Patients and Methods

Fifteen consecutive patients who
underwent elective aortocoronary sa
phenous vein bypass grafting were
studied. There were 12 men and 3
women, aged 37 to 68 years. Data
in Table f show the number of coro
nary arteries bypassed and grafts in
serted. Systematic measurements of
graft flow were carried out in 13 left
anterior descending (LAD) coronary
artery grafts and 12 right coronary
artery (RCA) grafts.
Protamine sulfate was given at the
completion of cardiopulmonary bypass
to reverse the effects of heparinization
and the patient was allowed to stabilize
hemodynamically to ensure adequate
systemic blood pressure. A pulmonary
artery (PA) line was inserted and con
nected to a Statham SP 2008 pressure
transducer (Statham Instruments, Ox
nard, CA). Blood flow through the
graft was measured with a Statham
SP 2202 electromagnetic flow probe.
Flow probes 3 mm and 4 mm in
diameter were used depending on the
size of the grafts inserted. Both the
PA pressure and the graft flow were
simultaneously recorded on a twochannel Statham SP 1400 recorder.
Flow Studies (Fig. 1)
The following measurements were
made in succession: (a) basal flow —

Table 1- Aortocoronary Saphenous Vein Bypass Grafts
No. of grafts placed
1
2
3
Single with left ventricular
aneurysmectomy
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Coronary artery bypassed

No. of patients

Left anterior descending
Left anterior descending and right
Left anterior descending, right
and circumflex
Right

3
4
6
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mean flow and phasic (systolic and
diastolic) flow in the graft (Fig. 2);
(b) reactive hyperemia (RH) — mean

and phasic peak graft flows after 5,
10 and 20 seconds of graft occlusion;
(c) changes in graft flow in response
to snare occlusion of the coronary
artery just proximal to the site of veincoronary artery anastomosis.
Correlation with Preoperative
Angiographic Findings

FIG. 1— Site of graft occlusion (A) for
testing reactive hyperemic response. Snare
(B) is placed around the coronary artery
just proximal to site of anastomosis for
temporary occlusion of artery. This
maneuver demonstrates direction of blood
flow in proximal coronary artery.

Data obtained from preoperative left
ventricular (LV) angiography, coronary
angiography and cardiac catheteriza
tion were reviewed and correlated with
the intraoperative flow studies as fol
lows.
1. Dominant systolic patterns of
graft flow were correlated with dyski
nesia and aneurysm of the left ventri
cular wall. Left anterior descending
coronary artery grafts were correlated
with anterolateral LV wall motion,
while the grafts to a dominant RCA
were correlated primarily with poste
rior LV wall movements.
2. The lack of RH was correlated
with preoperative angiographic find
ings of LV dyskinesia, critical stenosis
in the distal coronary artery and the
degree of collateral circulation as
manifested by the retrograde filling
of the coronary artery.

3.
Angiographic estimation of the
severity of coronary artery stenosis and
collateral circulation were also com
pared with the presence of retrograde
flow in the proximal artery and the
competitive flow between the graft and
the proximal artery, as indicated by
changes in the graft flow when the
bypassed artery was subjected to snare
occlusion proximal to the vein-artery
anastomosis.
Results
Flow Studies
In vitro calibration of flow probes
indicated that the error was less than
5% in the range of flow observed. None
of the 13 LAD and 12 RCA grafts had
a mean flow of less than 20 m l/m in.
The flow patterns observed in these
25 grafts are summarized in Table II.
One LAD and three dominant RCA
grafts had systolic flow patterns (Table
III). The maximal peak reactive hype
remic responses were obtained fol
lowing 10 seconds of graft occlusion,
while occlusion of the graft for 20
seconds did not further increase
the magnitude of RH. The LAD
graft with a systolic flow pattern

Table I I — Hemodynamics of Aortocoronary Bypass G raft Flow
Study performed
Basal flow , m l/m in *
Dominant flow patterns, no. of grafts
Systolic
Diastolic
Reactive hyperemic response, no. of grafts
Positive
Negative
Proximal coronary artery occlusion, no. of grafts

LAD

RCA

64 ± 20

53 ± 13

1
12

3
9

8
5

10

T 4, I 7, - 2

-2
T4. 1 8 , - 0

LAD = le ft anterior descending coronary arte ry , RCA = right coronary arte ry , | = increased
graft flow following proximal coronary artery snaring, | = decreased g ra ft flow follow ing proxi
mal coronary artery snaring, - = unchanged g raft flow follow ing proximal coronary a rte ry
snaring.
‘ Mean ± standard error of mean.

Table III- -G ra fts w ith Dom inant Systolic Flow Patterns
Graft flow , m l/m in
Coronary artery
bypassed

FIG. 2—Representative phasic flow
tracings illustrating dominantly diastolic
(a) and systolic (b) flow patterns. PAP =
pulmonary artery pressure.
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Basal

Reactive hyperem ia*

Findings on
preoperative angiogram (le ft
ve nticular dyskinesia)

RCA

26

36

Moderate dyskinesia in distal 1/3 of
in ferio r wall

RCA

22

30

A nterolateral and in fe rio r w all aneurysm

RCA

78

96

Severe dyskinesia of in ferio r w all

LAD

62

68

Severe dyskinesia in an terolateral and
distal 1/3 of in fe rio r w all

‘ A fter 10 seconds of g raft occlusion.

THE CANADIAN JOURNAL OF SURGERY

261

(Fig. 2b) also had a negligible reactive
hyperemic response (i.e., an increase
of less than 10% of basal flow).
Temporary snare occlusion of the
coronary artery just proximal to the
site of vein-coronary artery anastomo
sis resulted in increased flow in eight
grafts, indicating the presence of vein
graft versus proximal coronary com
petitive flow (Figs. 3 and 4). There
was decreased flow in 15 grafts, in
dicating the presence of retrograde
flow from the graft towards the
proximal coronary artery (Fig. 3). No
change was observed in two of the
grafts.
Correlation with Preoperative
Angiographic Findings
On angiography all four grafts with
systolic flow patterns showed moderate
to severe LV dyskinesia (Table III).

However, eight other grafts to areas
with mild to moderate LV wall dyski
nesia, as seen on preoperative angio
grams, had diastolic flow patterns, and
most of them had a positive reactive
hyperemic response. Of the seven
grafts showing a negative reactive
hyperemic response, six had a diastolic
flow pattern while one LAD graft had
dominant systolic flow (Table IV).
Since the combination of diastolic flow
pattern and negative RH may indicate
the absence of myocardial ischemia
during the period of graft occlusion,
evidence of collateral circulation was
sought in the preoperative angiograms.
Of six such grafts, four had retrograde
filling of the distal coronary artery
through the collateral vessels. On the
other hand, the angiographic evidence
of retrograde filling of the distal coro
nary artery does not appear to assure
the presence of adequate collateral
circulation, since four other grafts res
ponded positively to 10 seconds of
graft occlusion with RH.
Discussion

Basal and Phasic Flow Patterns

FIG. 3—Schematic presentation of re
trograde flow in proximal artery from
vein graft (A), which meets antegrade
flow at site of stenosis (S), and of com
petitive flow between vein graft and
proximal coronary artery (B).

Previous studies have demonstrated
that low intraoperative graft flow is as
sociated with a high frequency of early
graft occlusion.10" The phasic flow
pattern, on the other hand, indicates
the flow distribution or the contrac
tility, or both, of the segment of myo
cardium revascularized.12 Because of
the high intramyocardial pressure dur
ing systole in the left ventricle, the
blood flow to the left ventricular mass,
including that of a dominant RCA
which supplies the posteroinferior as
pect of the left ventricle, is predomi
nantly diastolic.13 The predominantly
systolic flow indicates that the blood is
either going to poorly contracting myo
cardium, which fails to generate suffi
cient intramyocardial pressure during
systole, or going predominantly to the
right ventricle which has low systolic

pressure.14 In either case the indication
is that the contracting LV mass has
not been revascularized by such a
graft, and the graft would be unlikely
to improve LV function. As shown
in Table III, of the four grafts with
a systolic flow pattern, three were
RCA grafts, while the one LAD coro
nary artery graft supplied an area with
severe dyskinesia as noted in the LV
angiogram preoperatively.
Reactive Hyperemic Response
The peak reactive hyperemic res
ponse was defined as the greatest in
crease in flow rate over the baseline
flow following a period of flow oc
clusion.14 Experiments with dogs in
dicated that 10-second occlusion of a
coronary artery was sufficient to pro
duce a maximal reactive hyperemic
response in normal canine hearts.15
This figure of 10 seconds might also
be applicable in humans following
CABG. In each of the grafts, the peak
reactive hyperemic response was meas
ured following 5, 10 and 20 seconds
of graft occlusion. In some grafts, 5second occlusion produced maximal
RH, but in others 10 seconds of oc
clusion was required. In none did a
20-second occlusion produce greater
response than that observed after a 10second occlusion. It can therefore be
concluded that 10 seconds of graft
occlusion are indeed adequate to elicit
maximal RH following CABG. The
magnitude of such RH reflects the flow
reserve of the grafted coronary artery
system when the myocardial oxygen
demand is increased.
Failure to observe a reactive hy
peremic response may result from: (a)
perfusion of a nonviable muscle mass,
(b) presence of fixed resistance caused
by flow-limiting stenosis in the grafted
coronary artery system or (c) failure
of graft occlusion to cause myocardial
ischemia because blood flow to the
distal myocardium through collateral

Table IV — Grafts with Negative Reactive Hyperemic Response*
Preoperative angiogram

FIG. 4— Flow tracing demonstrating
competitive flow between vein graft and
proximal coronary artery. Occlusion of
proximal artery caused increase in graft
flow.
262

Coronary artery
bypassed

Dominant
flow pattern

Retrograde fillin g !

LAD
LAD
LAD
LAD
RCA
RCA
LAD

Diastolic
Diastolic
Diastolic
Diastolic
Diastolic
Diastolic
Systolic

2+
2+
0
0
2+
2+
0

___

Site of LV dyskinesia
(degree)
Apical
Anterior wall
Inferior wall
Inferior wall
Inferior wall (m ild)
Inferior wall
Anterolateral wall
(severe)

♦Increase of less than 10% of basal flow.
(Graded 0 to 2 + (0 = no retrograde filling, 1+ = moderate retrograde filling, 2+ = excellent ret
rograd efilling).
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communication or through the parent
vessel is adequate under resting con
ditions.16'19
The combination of a systolic flow
pattern with the absence of RH, as
seen in one of our LAD coronary ar
tery grafts, suggests therefore, the per
fusion of a nonviable myocardial mass.
The lack of RH associated with a
normal diastolic flow pattern suggests
either the lack of myocardial ischemia
under resting conditions or the pres
ence of critical stenosis. Skinner, Elzinga and Matthews14 have suggested
that operative angiography m ay be in
dicated in such cases to detect and
correct, if possible, the critical stenosis
that may be present in the grafted
coronary artery system.
The absence of R H in association
with a diastolic flow pattern may
indicate lack of myocardial ischemia
in the resting state because collateral
circulation is adequate. As shown in
Table IV, however, we were not able
to correlate the results of such flow
studies with the preoperative angio
graphic findings of either collateral
channels or distal artery visualization.
Although preoperative angiography is
essential in delineating the anatomical
lesions, it is of limited value in quanti
tating the collateral circulation. Thus,
intraoperative studies of graft flow can
supplement the angiographic findings
in elucidating the underlying patho
physiology.
Retrograde Flow and
Competitive Flow
The anastomosis between the saphe
nous vein and the coronary artery
is usually made in end-to-side fashion.
The findings in this study indicate that
in more than half the grafts, there is
considerable retrograde blood flow in
the parent coronary artery proximal
to the site of anastomosis. This is
demonstrated by a decrease in the to
tal graft flow when the parent coro
nary artery is occluded by a snare,
placed just proximal to the site of
the anastomosis. This test further de
lineates the distribution of graft flow,
indicating which segments of myocar
dium have been revascularized. F ur
thermore, the frequent occurrence of
retrograde blood flow in the proximal
artery may also explain the rapid
progression and occlusion of the proxi
mal stenotic lesion observed in many
patients following aortocoronary by
pass.1-4 One may surmise that the an
tegrade and the retrograde flows meet
at the site of coronary stenosis, pro
ducing turbulence and stasis which
predispose to thrombosis and progres
sion of the arteriosclerotic lesion at
this site.
VOLUME 22, NO. 3, MAY 1979
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The increase in graft flow which
occurred after snare occlusion of the
proximal parent coronary artery, on
the other hand, indicates the presence
of competitive flow between the
parent artery and the vein graft. This
could happen when the degree of
stenosis in the coronary artery by
passed was subcritical, as in instances
when “incidental” or “prophylactic”
bypass grafts are inserted, or when
there is enough collateral circulation
communicating with the parent artery
proximal to the site of the anastomosis.
We were unable to predict this from
preoperative angiograms. A question
that may arise in such circumstances
is whether it is advisable to ligate the
parent artery proximal to the site of
anastomosis when the resting basal
graft flow is excessively low. The ra
tionale is that ligation of the proximal
artery may increase the basal graft
flow and thus improve its long-term
patency.10,11
It appears from this study that
surgical intervention produces a variety
of hemodynamic changes in the coro
nary arteries, and even when CABG
creates adequate blood flow through
the grafts, which remain patent, some
of these grafts may be of little value
to the myocardium. To be able to
detect these changes may be useful in
reappraising the controversial effects
of CABG on LV function and progno
sis.20,21
The authors appreciate the cooperation
of Dr. E.N. Mercer who performed the
angiographic studies preoperatively, and
Drs. H.J. Scott and P.E. Blundell who
participated in the surgical procedures.
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Propranolol in Thyrotoxicosis:
II. Serum Thyroid Hormone Concentrations
during Subtotal Thyroidectomy
G erald

J.M .

T evaarwerk,

Propranolol alone was used to
prepare 20 thyrotoxic patients,
19 women and 1 man, for subtotal
thyroidectomy. Serum thyroxine (TJ
and triiodothyronine (T3) concentrations
were measured immediately before,
at several stages during and after
the surgical procedure.
A s judged primarily by the
cardiovascular response, an average of
80 mg (range 40 to 120 mg) of
propranolol qid for 8 days (range 3
to 18 days) was required to prepare
the patients. During the various stages
of surgical removal there w as no
change from the initial mean ( ± SEM )
T, concentration of 25.0 ± 2.5 ug/dl
(321.8 ± 32.2 nmol/l) or T, concentration
of 4.2 ± 0.6 pg/l (6.45 ± 0.92 nmol/l)
(P > 0.2). At discharge on the fifth
postoperative day values were
significantly lower, 12.9 ± 1.5 y.g/dl
(166.0 ± 19.3 nmol/l) and 1.9 ± 0.2
p9/1 (2.9 ± 0.31 nmol/l), respectively
(P < 0.001). There were no operative
complications but four patients had
transient hypoparathyroidism. After
1 year 2 of 18 patients had permanent
hypoparathyroidism and 4 of the 18
followed up for 1 year had permanent
hypothyroidism requiring thyroid
hormone replacement. There was no
instance of recurrent thyrotoxicosis.
The authors conclude that during
surgical manipulation of the gland no
release of thyroid hormones into the
circulation was detected and that,
using propranolol as the sole agent,
thyrotoxic patients can be rapidly
and safely prepared for subtotal
thyroidectomy.
From the departments o f medicine
(endocrinology) and nuclear medicine,
St. Joseph’s Hospital, and University of
Western Ontario, London, Ont.
Presented at the 46th annual meeting
o f the Royal College o f Physicians and
Surgeons o f Canada, Toronto, Ont
Jan. 27, 1977
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the departments of medicine and nuclear
medicine, St. Joseph’s Hospital, London
Ont.
Reprint requests to: Dr. G. Tevaarwerk,
Department of medicine (endocrinology),
St. Joseph’s Hospital, 268 Grosvernor
St., London, Ont. N6A 4V2
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md , frcp [ c] and

David Boyd,

Chez 20 patients souffrant de
thyrotoxicose, 19 femmes et 1 homme,
le propranolol a ete utilise comme
seule preparation a une thyroidectomie
sous-totale. Les concentrations seriques
en thyroxine (T4) et en triiodothyronine
(T3) ont ete m esurees immediatement
avant, et a plusieurs reprises durant
et apres ('intervention chirurgicale.
A en juger principalement par la
reponse cardiovasculaire, une moyenne
de 80 mg (avec un ecart de 40 a
120 mg) de propranolol qid administre
pendant 8 jours (entre 3 et 18 jours)
a ete necessaire pour preparer
les patients. Aux divers stades de
I'intervention on n’a constate aucun
changement de la moyenne initiale
f — ecart type) de la concentration de
T4 a 25.0 ± 2 . 5 jxg/dl (321.8 ± 32.2
nmol/l) ou de la concentration de T3
a 4.2 ± 0.6 u.g/1 (6.45 ± 0.92 nmol/l)
(P > 0.2). Au moment du conge
au cinquieme jour postoperatoire, ces
vaieurs avaient baisse de facon
significative a 12.9 ± 1 . 5 [Ag/dl (166 ±
19.3 nmol/l) et a 1.9 ± 0.2 ,j.g/l
(2.9 ± 0.3 nmol/l), soit (P < 0.001).
On n’a observe aucune suite
postoperatoire facheuse mais quatre
patients ont developpe une
hypoparathyroi'die transitoire. Apres 1
an, sur 18 patients, 2 presentaient
une hypoparathyroi'die permanente
et 4 presentaient une hypothroi'die
permanente necessitant une
thyroi'dotherapie. On n’a observe
aucune recidive de la thyrotoxicose.
Les auteurs en concluent que, pendant
la manipulation chirurgicale de la
glande, aucune liberation d'hormones
thyroi'diennes dans la circulation n'a
ete decelee, et que, lorsque le
propranolol est utilise seul, les patients
thyrotoxiques peuvent etre prepares
rapidement et avec securite a une
thyroidectomie sous-totaie.
A s radioactive iodine treatment has
gradually becom e more available, sub
total thyroidectomy as treatment for
thyrotoxicosis is now less commonly
performed.1 The long time necessary
to prepare the patient with medication
and the possibility o f a postoperative
thyroid crisis (storm) are the main
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reasons fo r avoiding surgery. Post
operative thyroid storm is variously
estimated to occur in 1.5% to 10% o f
surgically treated patients.2-3 Its cause
is unknown but a sudden release of
thyroid hormones has been implicated.1
Several recent reports in the literature4-5
have described the successful prepara
tion o f thyrotoxic patients for opera
tion using propranolol as the sole agent.
The duration o f preparation was mark
edly reduced and the operation itself
was reported to be technically easier.
Although no adverse results were en
countered, operation-induced thyroid
crisis remains a possibility.
The rapid turnover o f triiodothyro
nine (T 3) and its low concentration
compared with that o f thyroxine (T .)6
makes the form er a more sensitive in
dicator o f any changes in thyroid
hormone values during surgery. Owing
to the relatively recent development o f
a radioimmunoassay fo r 7a,7 we were
able to study serum T 3 and T 4 concen
trations before, during and after partial
thyroidectomy in 14 o f 20 thyrotoxic
patients prepared for surgery with
propranolol only.

Patients and Method
The diagnosis o f Graves’ disease was
made in 20 patients, 19 women and 1
man, ranging in age from 21 to 68 years.
The clinical and biochemical mani
festations o f their condition have
been described elsewhere.8 Once the
diagnosis was reached all patients were
given propranolol by mouth; the start
ing dose was 20 to 40 mg qid depending
on the clinical severity o f the disease.
The dose was then increased based on
an assessment o f the clinical response,
the greatest emphasis being placed on
heart rate and cardiovascular status.
Other important clinical features moni
tored were tremor o f the extremities,
generalized hyperkinesis, anxiety, nerv
ousness and impaired ability to sleep.
Anesthesia was induced using a nar
cotic, curare, thiopental and a mixture
o f nitrous oxide and oxygen. Atropine
was used in some patients. Peripheral
venous blood samples were drawn im
mediately before, during and imme
diately after the operation by means
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of an indwelling catheter kept open
with a slow normal saline drip. Fur
ther blood samples were drawn on the
day of discharge. The serum was
frozen and stored at -20°C until the
time of assay.
Laboratory Methods

Serum concentrations of T4 were
measured using a commercially avail
able radioimmunoassay (Corning Med
ical Diagnostics, Medfield, MA) and of
serum T3 using a double antibody
solid-phase modification (Organon Can
ada Ltd., West Hill, Ont.) of classic
radioimmunoassay
methods.9 The
normal range for T4 concentration is
4.5 to 11.5 /jlg/dl (57.9 to 148 nmol/1
and for T3 is 0.8 to 2.0 yu.g/1 (1.23 to
3.07 nmol/1). Within and between the
assay, coefficients of variation for the
range of measurements described were,
respectively, 2.4% and 3.7% for T4,
and 3.2% and 7.0% for T3. All sam
ples from a particular patient were
measured by the same assay to mini
mize measurement error.
Student’s r-test for paired groups
was used to determine differences be
tween the successively collected sam
ples. These were grouped according to
the stage of the operation at which
they were collected (Fig. 1).
The operations were performed by
five different surgeons, all using a
standard approach. In all instances the
parathyroid glands were identified and
retained. An estimated 85% of the
thyroid gland was removed.

roidism requiring thyroid hormone re
placement had developed in 4 of the
18 patients whose period of follow-up
was 1 year or longer. There was no
recurrence of the thyrotoxicosis.
The average time required to pre
pare patients for operation, as judged
by a heart rate consistently less than
90 beats/min, a decrease in tremor,
hyperkinesis and anxiety, and im
proved ability to sleep, was 8 days
(range 3 to 18 days). This figure is
somewhat misleading in that it rep
resents our total experience. Initially
the average time was approximately 2
weeks but we are now able to prepare
patients within 3 or 4 days by giving
at the outset a dose of 40 mg qid and
increasing it by that amount on a daily
basis. We found that omission of even
a single dose caused a noticeable in
crease in heart rate and relapse in
other signs and symptoms. The aver
age dose used was 80 mg (range 40 to
120 mg) qid. The drug was well toler
ated and no side effects developed in
any of the patients. Total stay in hos
pital averaged 6 days for the group;
early in the study the average was
10 days, but later patients were ad
mitted on the day before operation and
discharged 4 days afterwards. As a
group, patients were off work for less
than 3 weeks and several for only
2 weeks.
The mean (± SEM) T4and T3 concen
trations immediately before operation
were 25.0 ± 2.5 /rg/dl (321.8 ± 32.2
nmol/1) and 4.2 ± 0.6 yu.g/1 (6.45 ±
0.92 nmol/1), respectively. Neither

hormone showed a significant change
in concentration during operation (for
differences between all groups P >
0.2). The mean ( ± SEM) values
at the end of surgery were 24.9
± 2.7 yu,g/dl (320.5 ± 34.7 nmol/1)
for T4 and 3.9 ± 0.6 yu.g/1 (5.99
± 0.92 nmol/1) for T3. A highly
significant (P < 0.001) decrease oc
curred over the days following opera
tion resulting in mean (± SEM) concen
trations of 12.9 ± 1 . 5 yug/ dl (166.0 ±
19.3 nmol/1) for T4 and 1.9 ± 0.2 yu.g/1
(2.9 ± 0.31 nmol/1) for T3 on the fifth
postoperative day.
Gross and microscopic examination
of the thyroid tissue removed from 19
patients revealed the classic changes
of untreated Graves’ disease but the
hyperplasia was less than in glands
from conventionally prepared patients.
The remaining patient, a 68-year-old
woman with symptoms of laryngeal
obstruction, had an adenomatous
goitre.
Discussion

The results reported here confirm
those of Lee and associates4 and Michie and colleagues,5 namely, that oral
ly administered propranolol makes
possible the safe and rapid preparation
of thyrotoxic patients for subtotal
thyroidectomy. The short preparation
time and hospital stay represent con
siderable savings in hospital and phy
sician utilization as well as a minimal
time loss to the patient. Moreover, the
ability to render the patient euthyroid
within days of making the diagnosis

Results

Surgery in all 20 patients proceeded
uneventfully. At the start the heart
rate was less than 90 beats/min in all
patients and did not vary by more than
10% at any time during the procedure.
Blood pressure in all remained stable
throughout. It was generally agreed
among the surgeons that the gland was
soft, less friable than in conventionally
prepared patients and easy to dissect.
Bleeding was minimal. Three out of
five surgeons thought the gland was
technically easier to remove while two
found no noticeable difference. Re
covery from anesthesia was uneventful
without untoward changes in vital signs.
Five patients were given propranolol
postoperatively for several days because
of heart rates in excess of 120 beats/
min but none required it at the time
of discharge. Clinically four patients
manifested hypoparathyroidism post
operatively; in two the condition was
still present 1 year after surgery and
required vitamin D treatment. No pa
tient sustained injury to the recurrent
laryngeal nerve. Permanent hypothy
VOLUME 22, NO. 3, MAY 1979
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FIG. 1—Serum triiodothyronine (T3) and thyroxine (T„) concentrations before,
at various times during surgery, at end of surgery and at time of discharge. Mean values
± SEM arc given for both hormones. There is no difference in hormone concentrations
of blood samples taken during surgery; at discharge T, and T4 were 51.7% and 45.2%
respectively of preoperative values; differences are significant (P < 0.001).
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may be an important factor in arrest
ing the progress of malignant thyro
toxic exophthalmos.10 A further advan
tage is avoidance of the use of iodine
preoperatively as it may cause the re
lease of thyroid hormones in Graves’
disease (jodbasedow effect).11 If such
release is excessive it may lead to a
thyroid crisis.
We were able to demonstrate that
surgical handling of the gland did not
cause release of thyroid hormones and
is therefore an unlikely cause of thy
roid storm. Bewsher and colleagues12
have previously shown that no eleva
tion of the protein-bound iodine con
centration occurred immediately fol
lowing operation in patients prepared
with a combination of propranolol and
iodine. We believed that it was particu
larly im portant to measure T :) because
of recent evidence13 that this is the
active thyroid hormone. Further, al
though the ratio of T 3 to T4 in serum
is approxim ately 1:70, it is much high
er (1:9) in the thyroid gland itself).7'14
A ny release of thyroid hormone during
surgical handling of the gland would
therefore have a much more pro
nounced effect on the serum concen
tration of T 3 than on that of T4. The
fact that the concentration of neither
horm one became elevated during the
procedure is reassuring. It does not,
however, exclude the possibility that
thyroid storm may be triggered by
some other mechanism that acts during
operation. Conceivably it is caused by a
rapid increase in the conversion of T 4
to T 3.8 This might be mediated by the
increased sympathetic activity associ
ated with surgery. If so, propranolol
may prevent thyroid storm by inhibit
ing the conversion of T4 to T3.8,15
In conclusion, we have demonstrated
that thyrotoxic patients can be success
fully prepared for subtotal thyroidec
tomy by using propranolol as the sole
agent. Preoperative preparation time is
short, postoperative recovery is rapid
and the length of hospitalization and
time off w ork is reduced. Hence this
is a safe alternative form of preopera
tive preparation at decreased cost to
patient and hospital and of greater
convenience to the patient. Failure to
dem onstrate an increase in serum thy
roid horm ones during surgical mani
pulation of the gland after using this
m ethod of preoperative preparation
provides a biochemical basis for the
safety of the procedure.
We are indebted to Drs. T.A. Jory,
D.A. MacKenzie, G.E. Meads, J.P. Swee
ney and J.H. Walker, and to members
of the department of anesthesia, St. Jo
seph’s Hospital, London, Ont., for their
cooperation in carrying out this study.
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Adenocarcinoma of the Trachea:
Palliative Response to Cobalt-60 Irradiation
J

1 ^ RV^EY’ MD’ C.W . Keen , m b , fracr, frcp [c], L. Makowka, md ,
md , frcp [c] and M. G oldberg, md , facs, frcs [c ]

S.C. L uk,

The prognosis of mucus-secreting
adenocarcinoma of the trachea is grim,
its large size and infiltrative nature
prohibit surgical resection and the
response to radiation therapy has
been poor. The authors report a case
in which notable initial palliation was
achieved through cobalt-60 therapy
resulting in regression of the patient’s
tumour and a longer survival than that
previously reported in patients with
this disease.
Le pronostic de I'adenocarcinome a
secretion de mucus de la trachee est
sombre. Son etendue et sa nature
envahissante interdisent la resection
chirurgicale et la reponse a la radiotherapie a ete pauvre. Les auteurs
signalent un cas ou une reponse
palliative initiate remarquable a ete
obtenue grace a un traitement au
cobalt-60, et a entraine une regression
de la tumeur et une survie du patient
plus longue que ce qui a ete rapporte
jusqu'a present chez les patients
atteints de cette maladie.

Mucus-secreting adenocarcinoma of
the trachea is rare. O f the 53 cases of
prim ary carcinoma of the trachea col
lected over a 30-year period (1936 to
1965) at the Mayo Clinic, only 1 was
a case of adenocarcinoma.1 In another
series of 41 tracheal carcinomas seen
over a 33-year interval (1936 to 1968)
at the Memorial Sloan-Kettering Cancer
C enter2 there were four cases of m u
cus-secreting adenocarcinoma. The pa
tient reported in the Mayo Clinic series
died within 1 year and all four from
Memorial Sloan-Kettering Cancer Cen
ter died within 9 months.
There are no reports of a successful
surgical resection of this tumour and
previous investigators have not ob
served any benefit from radiation
therapy during their periods of obser
vation.1-2 The precise nature of radioFrom the departments of surgery and
pathology, Mount Sinai Hospital,
Toronto, and the department of
therapeutic radiology, The Princess
Margaret Hospital, University of Toronto
Toronto, Out.
Reprint requests to: Dr. M. Goldberg,
Ste. 446, 600 University Ave., Toronto
Out. MSG 1X5
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therapy employed by these authors was
not clarified.
The purpose of this report is to add
to the limited clinical and autopsy data
on adenocarcinoma of the trachea and
to call attention to a gratifying pal
liative response obtained from cobalt60 (“"Co) irradiation which resulted
in a longer patient survival than that
previously reported for patients with
this disease.
Case Report

A 33-year-old woman was admitted to

hospital on Oct. 7, 1974 with complaints
of intermittent cough, hoarseness and
dysphagia for 3 months. Aside from be
ing a heavy smoker, her history and
physical examination were unremarkable.
She denied having excessive production
of sputum, hemoptysis, vomiting or
weight loss. At that time she had a laryngoscopic (but not bronchoscopic) exam
ination, the result of which was normal.
A chest roentgenogram appeared normal.
Esophagoscopy and barium swallow
examinations showed a small hiatal her
nia with reflux. She was discharged with
out a diagnosis having been made and
was advised to stop smoking.

FIG. 1— Chest
roentgenogram
ob
tained on June 24, 1975 demonstrates
severe trachea] and bronchial stenosis
(black arrows) due to primary involve
ment of trachea by adenocarcinoma. Tu
mour has produced substantial widening
of superior mediastinum (white arrows).

FIG. 2— Chest roentgenogram, May
19, 1976 demonstrates resolution of
tracheal stenosis (black arrows) and total
resolution o f superior mediastinal mass
(white arrows) after two courses of irra
diation with cobalt-60.
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FIG. 3— Roentgenogram obtained after
barium swaljow on May 21, 1976 shows
extensive stricture of esophagus at thora
cic inlet.
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Her family physician initiated treat
ment with bronchodilators but her symp
toms worsened over the next 8 months.
On June 19, 1975 she was referred to
the Mount Sinai Hospital, Toronto with
respiratory distress. Her blood pressure
was 110/90 mm Hg, pulse rate 120
beats/min and respiratory rate 28/min.
Physical findings included distended veins
of the neck and anterior chest wall and
inspiratory stridor. A chest roentgeno
gram (Fig. 1) showed a large right paratracheal mass with tracheal narrowing
and widening of the mediastinum. Bronchoscopic examination demonstrated an
infiltrating lesion in the trachea originat
ing 2 cm below the vocal cords and ex
tending to the right main bronchus, al
most completely obscuring the tracheal
lumen. Brush biopsies resulted in a diag
nosis of adenocarcinoma of the trachea
being made. Because this was consi
dered an unresectable tumour she
was referred to the Princess Margaret
Hospital, Toronto for radiation therapy.
She was treated with 60Co, 3000 rads,
given in eight fractions over a 2-week
period. Her response was dramatic. She

FIG. 4—Anterior view of trachea
showing tumour (black arrow) which
arose from right posterolateral aspect.
Whitish tissue around trachea at level
of tumour is dense, postirradiation fibro
sis in which thrombosed internal jugular
vein (white arrow) is seen. Bronchi are
not involved by tumour.

became asymptomatic and repeat bronchoscopic examinations showed regres
sion of the tumour. Chest roentgenograms
showed regression of the paratracheal
mass (Fig. 2).
After 10 months her symptoms re
curred. A second course of 60Co, 3000
rads, in 14 daily fractions was given.
Following this progressive dysphagia de
veloped. Roentgenograms obtained after
a barium swallow on May 21, 1976 re
vealed a stricture of the esophagus at
15 to 20 cm (Fig. 3). Esophagoscopic

examination confirmed that there was
marked narrowing but no tumour was
identified grossly and examination of
esophageal biopsy specimens showed no
abnormality. Surprisingly no evidence of
an intrinsic malignant condition was
present on bronchoscopic examination. A
diagnosis of radiation esophagitis was
made and dilatation with a no. 30 Malo
ney bougie accomplished.
Over the next 4 months repeated bou
ginage was required for dysphagia that
prevented the swallowing of secretions.

HI

FIG. 6— (a) Low-power photomicrograph of metastasis to vertebral body (black
arrows) (hematoxylin and eosin, enlarged by 20% from X40). (b) Higher mag
nification demonstrates clearly isolated tumour conglomerate of signet-ring cells
(white arrows) (hematoxylin and eosin, enlarged by 20% from X200).

FIG. 5—Oval ulcer with everted edge
(open arrow) 3 cm in length is present
in esophagus. Trachea and dense fibrosis
are designated by closed arrow.

FIG. 7__Photomicrograph of poorly differentiated adenocarcinoma of trachea
taken at autopsy from nonirradiated site (adrenal gland). Gland formation (G) is
present and individual tumour cells demonstrate signet-ring characteristics (black
arrow). Nuclear pleomorphism, presence of signet-rings and of mucin (periodic acidSchiff positive, diastase resistant) differentiate this adenocarcinoma from adenoid
cystic carcinoma (hematoxylin and eosin, reduced by 28% from X300).

VOLUME 22, NO. 3, MAY 1979

THE CANADIAN JOURNAL OF SURGERY

/

269

On Aug. 18, 1976 a retrosternal reverse
gastric tube esophageal bypass was per
formed, but the patient continued to have
dysphagia and progressive obstruction of
the superior vena cava.
By the first week of September stridor
had recurred and by the second week she
was very weak and lethargic. She died
on Sept. 12, 1976, 26 months after the
onset of symptoms and 15 months after
the first course of 60Co irradiation.
At autopsy a necrotic sessile tumour,
3.1 cm in diameter, was present on the
right posterolateral aspect of the trachea
between the middle and lower thirds
(Fig. 4). It had extended into the adjacent
esophagus resulting in the formation of
an oval ulcer measuring 3 cm in its great
est diameter (Fig. 5). Severe postirradia
tion fibrosis was evident in the neck
tissues with bilateral thrombosis of the
internal jugular veins (Fig. 4). The gas
tric tube—esophageal anastomosis was pa
tent and intact. Distant metastases were
present in the upper pole of the right
kidney, both adrenal glands and the sixth
thoracic vertebral body. Microscopic
examination showed poorly differentiated
adenocarcinoma with diffuse sheets of
signet-ring cells (Fig. 6). In focal areas
glandular formation was present with
lumina filled with mucin (Fig. 7).

Discussion

diation therapy in this disease1'2'6 their
reports dealt with experiences gained
before e°Co was available and their
patients may well have received a less
than adequate dosage of radiation.7
Our experience supports the use of
60Co in the management of patients
with adenocarcinoma of the trachea.

It is not unusual for patients with
tracheal tumours to be symptomatic
for more than a year before the diag
nosis is made. Often in that time they
have been treated for bronchospasm.1-4
Surgical excision offers the best chance
of cure of tracheal tumours and has
been employed with success in the
management of adenoid cystic carci
noma.5 Far less satisfactory results
have been obtained in the treatment
of squamous cell carcinomas and no
mucus-secreting adenocarcinoma has
yet been reported to be resectable due
to its large size and infiltrative na
ture.1'2
Like most other patients with tra
cheal tumours, our patient was symp
tomatic for a year before the diagnosis
was made. It was only when severe
stridor and superior venal caval ob
struction had developed that she was
referred for bronchoscopic examina
tion. However, she was treated by 60Co
irradiation and survived for 15 months
following this treatment.
Though previous authors have been
pessimistic regarding the value of ra

f
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Squamous Cell Carcinoma Arising
in Chronic Osteomyelitis
A.M.

I nglis,

Analysis of three cases and a review
of the recent literature on squamous
cell carcinoma arising in osteomyelitis
confirm that this is an uncommon
condition which may run a less benign
course than was earlier believed.
The disease affects chiefly middle-aged
and older men, usually involves the
lower extremity and most often occurs
in the tibia. Development of a malignant
tumour is heralded by increased
pain and foul-smelling drainage in the
presence of a fungating ulcer.
Increased bone destruction is seen
on the roentgenograms. A consistent
finding is the long duration of infection
but the authors stress that sinus
drainage of long duration is not
essential: the carcinoma can arise in
scar overlying quiescent osteomyelitis
as is occasionally seen in burn scars.
Amputation is the treatment of choice.
L’analyse de trois cas et la revue de
la litterature recente sur les cas
d'epitheliomas malpighiens de la peau
survenant au cours d'une osteomyelite,
confirment la rarete de cette affection
dont 1'evolution peut etre moins
benigne qu'on ne le croyait anterieurement. Cette maladie affecte
principalement les hommes d’age
moyen ou plus ages, implique habituellement un membre inferieur et touche
le plus souvent le tibia. L'apparition
d'une tumeur maligne est annoncee par
une augmentation de la douleur et un
ecoulement nauseabond en presence
d'un ulcere envahissant. A la radiographie, on note une augmentation de
la destruction osseuse. La longue
duree de I’infection est une observation
constante mais les auteurs notent
qu'un ecoulement prolonge n'est pas
essentiel: le carcinome peut apparaitre
sur le tissu cicatriciel recouvrant une
osteomyelite quiescente comme on le

From the division of orthopedics,
University of British Columbia,
Vancouver General Hospital and
St. Paul’s Hospital, Vancouver, BC
Reprint requests to: Dr. K.S. Morton,
Division of orthopedics, Department of
surgery, Udiversity of British Columbia,
2740 Heather St.,' Vancouver, BC
V5Z 3J4
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voit occasionnellement sur les cicatrices
de brulures. L'amputation est le
traitement de choix.

Squamous cell carcinoma arising in an
area of chronic osteomyelitis is un
common. Gillis and Lee1 pointed out
that Hawkins in 1835 in his article
“Warty tumours in cicatrices” was
the first to describe the condition, and
Horn and Templeton2 noted that the
condition was first confirmed histolo
gically by Dittrich in 1847. Sedlin and
Fleming3 reviewed 90 published case
reports since 1940 and added 13 new
ones. Vishniavsky4 mentioned 112 re
ported cases up to 1966 and added
another of his own. Most recently,
Fitzgerald, Brewer and Dahlin5 have
reported the largest single experience
with this lesion, 28 cases.
Recent experience of one of us
(A.M.I.) with such a case provided the
stimulus to review the records of the
University of British Columbia Bone
Tumour Registry from 1956. Two other
cases were found and these three form
the basis of this report.
Case Reports
Case /.—On Oct. 28, 1974, a 49-year-

Roentgenograms of the tibia (Fig. 2)
showed irregular destruction of the ante
rior portion of the proximal half of the
tibia with some sclerosis distally but
porosis proximally.
Biopsy specimens of the margin and
floor of the ulcer revealed well-differen
tiated squamous cell carcinoma (Fig. 3)
infiltrating the tibia.
Above-knee amputation was carried out
on Jan. 30, 1975. Popliteal lymph nodes
were found to be free of metastases as
were sections from the margins of the
amputation.
His subsequent course was satisfactory
until August 1976 when he was readmitted
with a 3-week history of an enlarging red,
warm, tender mass in the right inguinal
region. Open biopsy of the mass was done
on Aug. 6, 1976. Examination of the
biopsy specimen confirmed a diagnosis of
squamous cell carcinoma metastatic to
the inguinal lymph nodes. Irradiation of
the local lesion controlled it for a time
but he eventually required repeated intra
arterial infusion of methotrexate and
bleomycin plus vincristine which gave
some relief of symptoms and signs. He
had one further course of irradiation to
the area of persistent ulceration but it
continued to grow and he died of his
disease in May 1978. No autopsy was
performed.
Comment This was a typical case in
that the patient was a middle-aged man
with a history of osteomyelitis involving
the tibia 40 years earlier, but was atypical
in that there had been no sinus drainage
.—

old man scraped and bruised his right
shin over a distance of 8 cm. The abrasion
failed to heal and after 2 months, when
the lesion became painful and began to
discharge pus, he reported to his family
physician.
Forty years earlier he had suffered from
hematogenous osteomyelitis involving his
right tibia, right femur and right ilium;
this had resulted in sinus drainage for
about 4 years. He was left with a wide,
depressed scar of thin skin adherent to
almost the whole length of the underlying
anteromedial aspect of the tibia.
When he presented on Jan. 13, 1975, he
had a painful limp on the right side. There
was a large fungating ulcer on the anterior
aspect of the upper third of his right leg.
The ulcer (Fig. 1) measured 8 X 10 cm.
It was 4 cm deep and had a rolled irreg
ular edge with yellow and black slough in
the base. The adjacent skin was scarred
and adherent to the tibia. There was a
deep older scar over the lower, inner
thigh from earlier operative treatment of
FIG. 1—Case 1. Fungating ulcer of
the femoral infection. There was no
right mid-leg with adjacent scar.
regional lymphadenopathy.
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for 34 years. The complication of
squamous cell carcinoma appeared within
2V4 months of a minor injury to the
chronically infected limb.
Case 2.—At the age of 12 years, this
73-year-old man had what appeared to
be acute hematogenous osteomyelitis
of the right tibia with spontaneous
discharge, which was treated by saucerization. Discharge, though it varied in
amount, had persisted from that date.
A second saucerization had been done in
1943.
In March 1956 he was admitted for
treatment of his chronic osteomyelitis.
The area was saucerized and skin grafted
even though the excised scar was con
firmed histologically as squamous cell
carcinoma. A fungating ulcerated mass
quickly reformed. The area was irradiated
but foul discharge continued. Roentgeno
grams of the tibia obtained on Mar. 29,
1957 showed distortion of the tibia with
areas of sclerosis and osteolysis and evid
ence of previous operative treatment by
saucerization. The central area of osteo
lysis showed cortical destruction and
strongly suggested a pathologic fracture,
clearly demonstrating that considerable
bone destruction had occurred during the
year of observation.
Physical examination of the area on
Apr. 4, 1957, revealed a fungating ulcer
ated mass with several smaller similar
lesions involving the larger part of the
anterior aspect of the right leg. Culture
of material from the lesion grew Staphyl
ococcus aureus (coagulase positive), Pseu
domonas aeruginosa and Proteus vulgaris.
Open-flap amputation of the right iower
thigh through the femoral condyles was
carried out on Apr. 11, 1957 and was con
verted to a Gritti-Stokes amputation 1
week later.
Fig. 2a
Fig. 2b
In April 1958 tumour masses were
FIG. 2— Case 1. (a) Anteroposterior view of right tibia showing irregular destruc
noted in the right thigh stump and in tion in its proximal half, (b) Lateral view of right tibia showing extensive bone destructhe inguinal region. These were treated
by irradiation but the patient died on July
10, 1958, 2 years from the time of diag
nosis of squamous cell carcinoma, which •tfW
VST-At', - A
.....
occurred in association with chronic
osteomyelitis of 60 years’ duration.
Comment.—This represents a classic
case of squamous cell carcinoma arising
in an older man in association with
long-standing chronic osteomyelitis of the
tibia.
Case 3.—This 79-year-old man presented
in September 1972 with pain, ulceration
and drainage on the plantar aspect of his
left heel resulting from an injury sus
tained in 1926. Initial treatment had been
by partial excision of the left os calcis
and he was able to continue working
satisfactorily for 27 years, until his retire
ment. However, in 1965 he suffered fur
ther injury to the left foot which caused
opening of the old wound and continued
drainage. The chronic ulcer was treated
in 1968 by debridement, saucerization and
sequestrectomy but the excised tissues
were not examined. Roentgenograms at
that time showed evidence of old injury
and superimposed infection.
When he returned for examination in
272

,iif ( J .! o i\ , 3T CaSe K Ph»‘om 'crograph of tissue excised from ulcer showing* wellc e lls
carcinoma on left, lying in area of chronic inflammatory
cells and dense fibrous tissue (hematoxylin and eosin, reduced by 22% from X125).
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case 1 illustrates a feature not pre ulcer. Roentgenograms show increased
viously emphasized. Browne,6 Lidgren7 destruction of bone. Prognosis must be
and Marks and Turner8 all stated that guarded. The treatment of choice is
malignant changes occur in draining amputation. A feature not previously
sinuses of long duration. However, in appreciated is the possibility of dev
our case 1 (and, indeed, in case 5 and elopment of squamous cell carcinoma
possibly case 7 of Sedlin and Fleming3) in osteomyelitis of long duration but
the osteomyelitis had been quiescent without a long period of sinus drainage.
without sinus drainage for 36 years
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50%. They found the average duration foul-smelling discharge and a fungating
of infection prior to the development
of carcinoma to be approximately 30
years but the latent period could be
much shorter.
More recently, Fitzgerald, Brewer
and Dahlin5 reporting on 28 patients
from the Mayo Clinic, confirmed these
Kanamycin is one of several antibiotics which may produce nephrotoxicity.
observations. The average age of the
Profound respiratory depression is another serious complication resulting
patients in their series was 57 years
and the average duration, 42 years.
from its use.
Twenty-one of the 28 were men and
Hepatitis is an unusual but important complication of isoniazid therapy.
the tibia was involved in 14.
Isoniazid should be used with caution in patients with a history or symptoms
The development of a malignant
of liver disease.
lesion in an area of chronic osteomy
elitis is heralded clinically by increased
Erythromycin frequently causes diarrhea, nausea, and vomiting, and,
pain and foul-smelling drainage in the
occasionally, severe, crampy, abdominal pain.
presence of a fungating ulcer. Roent
Anaphylactic reaction is a rare but catastrophic complication of
genograms show evidence of increased
penicillin
therapy. A generalized skin rash occurs much more frequently,
destruction of bone.
and the rash is sometimes serious. A patient who reacts to penicillin is
Sedlin and Fleming3 stated that 20%
also likely to react to the synthetic penicillins and cephalosporins.
to 30% of these squamous cell carci
nomas will metastasize and suggested
Pancytopenia secondary to bone marrow depression as a complication
a guarded prognosis. In the Mayo
of chloramphenicol has been publicized out of proportion to its frequency.
series,5 10 patients remained alive and
However, it can be fatal. Therefore, this agent should be used when it is
well at follow-up 1 to 35 years later
specifically required on the basis of sensitivity testing.
and 9 died of unrelated causes. Both
reports agreed that earlier statements
272 [ a ]
271
270 E
269 D
of a relatively benign course for the
disease cannot be confirmed and re
commended amputation as the treat
ment of choice. The Mayo report
Reference
stated that regional lymphadenectomy
269-272/1. Neu HC: Antimicrobial agents— mechanisms of action and
is not necessary.
clinical usage. Curr Probl Surg, June, 1973, pp 34-49
Our three reported cases follow the
typical pattern of age, sex and site but
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1972, development of squamous cell carci
noma in the persisting sinus was suspect
ed, but he refused treatment. In 1974, at
81 years of age, he accepted the offered
mid-thigh amputation. Histologic examina
tion of the ulcer showed a well-differenti
ated, infiltrating squamous cell carcinoma.
Three days after the amputation he suf
fered a massive cerebrovascular accident
and died. At autopsy no metastases from
the squamous cell carcinoma were found.
Comment.—Although in this instance
the involved bones were in the foot, this
case again demonstrated the long duration
of chronic osteomyelitis and persistent
drainage in an elderly man. The case
illustrates the need for routine examina
tion of tissues excised from any long
standing osteomyelitic lesion.

Critique of Items 269-272 (SESAP II)
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Nephrotoxicity and Ototoxicity following Irrigation
of Wounds with Neomycin
M .A . M a n u el , M B , CH B, F C P ( S A ) , F R C P jc ] , F A C P ,* I . K U R T Z , M D ,t
C.S. S a iphoo , MD, FR CP[C]J AND J.M . NEDZELSKI, MD, FRCS[c ]§

Renal failure and ototoxicity developed
in two patients following wound
irrigation with neomycin. In both
patients the renal failure was reversible,
but the deafness was progressive
despite withdrawal of the neomycin.
In one patient the serum neomycin
concentration was still markedly
elevated (42 p.g/ml) 2 days after use
of the drug was discontinued. The
authors suggest that irrigation of large
open wounds with neomycin is dan
gerous since toxic blood concentrations
may ensue. The benefits conferred by
neomycin irrigation should be weighed
against the possible danger of
permanently impaired hearing.
Une insuffisance renale et une
ototoxicite sont apparues chez deux
patients a la suite de I'irrigation d'une
plaie avec de la neomycine. Chez les
deux patients, I’insuffisance renale
a ete reversible mais la surdite s'est
developpee malgre le retrait de la
neomycine. Chez un patient la concen
tration serique en neomycine etait
encore remarquablement elevee
(42 ug/ml) 2 jours apres I’interruption
de son emploi. Les auteurs suggerent
que I'irrigation de plaies etendues avec
la neomycine est dangereuse puisque
des concentrations sanguines toxiques
peuvent en resulter. Les benefices
escomptes de I'irrigation a la neomycine
devraient etre evalues en tenant
compte du danger possible d’atteinte
permanente de I'ouie.

spectrum antibiotic. Susceptible micro
organisms are inhibited at a concen
tration of 5 yug/ml to 10 /xg/ml or
less.1 Currently, it is administered top
ically, orally and during irrigation of
the pleura, peritoneum, bowel, bladder,
joints and wounds. Its widespread use
in irrigations indicates that it is gener
ally considered to be harmless when
used locally. The following case re
ports emphasize that neomycin ab
sorption is increased when tissues are
inflamed and that absorption may
occur sufficient to cause renal toxicity
and ototoxicity.
Case Reports
Case 1.—A 55-year-old quadriplegic
man was admitted to hospital on Apr. 6,
1977 for treatment of pressure ulcers. He
had suffered a fracture of his cervical
spine 29 years before admission resulting
in quadriplegia and a neurogenic bladder.
Recurrent urinary tract infections had
been treated with various antibiotics. His
serum creatinine and blood urea nitrogen
concentrations were always normal. The
patient had required insertion of a Foley
catheter for 4 months prior to admission.
On physical examination the patient
was pale but in no distress. There was
spastic paralysis of the lower limbs,
grade 4 to 5 power (Medical Research
Council of England classification: grade
0, complete paralysis; grade 5, normal
power) in the upper limbs and bilateral
flexion contractures of the fingers. De
cubitus ulcers were present on the left
elbow and the sacrum and in the
trochanteric regions.

Pertinent laboratory findings included
the following: hemoglobin value 10.4 g/dl,
hematocrit 33%, leukocyte count 10.2 X
109/1, blood urea nitrogen value 12 mg/dl
(4.28 urea, mmol/1) and serum creatinine
value 0.9 mg/dl (79.6 p.mol/1); electrolyte
values and urinalysis were normal.
The appearance of an intravenous
pyelogram was compatible with chronic
pyelonephritis, more marked on the left.
Roentgenograms showed osteoarthritic
changes in the right hip and superior
subluxation of the left femur with marked
deformity of the femoral head suggesting
a Charcot’s joint or osteomyelitis.
The patient’s course in hospital is sum
marized in Table I. On Apr. 11, 1977, he
received three doses of gentamicin (1 mg/
kg body weight, intramuscularly, q8h)
and underwent repair of the left elbow
pressure ulcer with a rhomboid flap. On
Apr. 26 the left trochanteric area was
drained and the left femoral head was
removed with curettage of the left aceta
bulum. He was again given gentamicin
(1.3 mg/kg body weight q8h for 5 days).
On May 31 the left trochanteric pres
sure ulcer was debrided and drains were
inserted. The wound was continuously
irrigated with 3 1/d of a neomycin-saline
solution (neomycin 5 g/1) for 4 days. The
dose was then decreased to 5 g/d for 4
days, and 1.5 g /d for 2 days. By the
fourth postoperative day the patient
began to experience nausea and vomiting.
On June 6, 6 days after starting the neo
mycin irrigation the serum creatinine
value was 1.5 mg/dl (132.6 u.mol/1) and
it gradually rose to reach a peak of 5
mg/dl (442.0 u.mol/1) on June 17 (Fig. 1).
Over the next 5 weeks his renal function
gradually improved and the serum

Neomycin sulfate is a potent broad
From the division of nephrology,
Sunny brook Medical Centre, University
of Toronto, Toronto, Ont.
*Assistant professor, faculty of medicine,
University of Toronto
t Medical resident, University of Toronto
*Associate professor, faculty of medicine,
University of Toronto; head, division of
nephrology, Sunnybrook Medical Centre
§Lecturer, department of otolaryngology,
University of Toronto, Sunnybrook
Medical Centre
Reprint requests to: Dr. M.A.
Division of nephrology, Rm.
Sunnybrook Medical Centre,
Bayview Ave., Toronto, Ont.
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Manuel,
2039,
2075
M4N 3M5

Serum electrolytes, mmol/l
Date

Na+

K+

CD

HCCF

Apr. 7-IVIay 27 138
3.4
93
30
May 31-June 3 Neomycin irrigation 15 g/d
June 4-8
Neomycin irrigation 5 g/d
6
135
2.3
87
30
8-10
Neomycin irrigation 1.5 g/d
9
134
2.4
81
31
13
17
29
30
July 21

128
2.6
81
Audiogram obtained
134
3.3
91
135
3.9
99
Audiogram obtained
134
4.1
101
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9
16

0.8
0.9

18

1.5

Intake,
ml/d

Urine
output,
ml/d

1430

1690

25

2.3

31

32

3.1

1560

1330

27
22

47
37

5.0
3.5

1630

2100

26

18

1.5

1530

1350

10

11

Blood urea
Serum
nitrogen, creatinine,
mg/dl
mg/dl
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creatinine value returned to 1.5 mg/dl
(132.6 ij.mol/1) by July 21. At no time
was there a decrease in the urine volume.
On June 10 the patient first noticed a
hearing abnormality associated with in
creasing lethargy and headaches. Audio
metry on June 13 revealed bilateral sen
sorineural hearing loss (Fig. 2).
Caloric testing showed a marked loss of
vestibular function bilaterally. On Aug. 3
the right trochanteric ulcer was closed by
covering it with a rhomboid flap. At the
time of discharge, July 21, 1977, the pa
tient’s serum creatinine value was 1.5
mg/dl (132.6 p.mol/1) and the blood
urea nitrogen was 18 mg/dl (6.43 urea,
mmol/1), but he remained clinically deaf.
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Case 2.—This 69-year-old man was
admitted to Sunnybrook Medical Centre
on Mar. 4, 1974, with a history of inter
mittent claudication. During the 3 months
before admission pain had increased in
severity and had restricted his ability to
walk. There was no history of diabetes
mellitus, hypertension or coronary artery
disease.
Physical examination revealed a healthy
man in no distress. Cardiovascular exami
nation disclosed bruits audible over both
carotid arteries. A bruit, which radiated
to both femoral arteries, was also heard
over the abdominal aorta. The left foot
was cold and blue and a 3- to 4-cm ulcer
was present on the medial aspect of the
first metatarsophalangeal joint.
Relevant laboratory findings included a
blood urea nitrogen value of 15 mg/dl
(5.36 urea, mmol/1) and a serum creat
inine value of 1 mg/dl (88.40 ^mol/1).
Urinalysis was normal.
Aortograms demonstrated complete oc
clusion of both superficial femoral ar
teries. The patient underwent a lumbar
sympathectomy and subsequently had an
above-knee amputation. The wound was
irrigated with 3 1/d of a neomycin-saline
solution (neomycin 5 g/1) from Mar. 15
to 19.
At the end of the period of irrigation
the patient’s serum creatinine value was
6.9 m g/dl (609.96 p.mol/1) and the blood
urea nitrogen value was 66 mg/dl (23.56
urea, mmol/1). Peritoneal dialysis was
started on Mar. 24. The serum electrolyte
values were: sodium 129 mmol/1, potas
sium 3.9 mmol/1, chloride 90 mmol/1,
bicarbonate 20 mmol/1. The serum neo
mycin concentration 2 days after discon
tinuing the medication was 42 u.g/ml.
Despite peritoneal dialysis the patient’s se
rum creatinine value continued to increase
to a peak of 11.1 m g/dl (981.24 p.mol/1).
Subsequently, his renal function improved
but he became confused and he began to
complain of difficulty in hearing. A hip
disarticulation was performed because of
an infected stump wound. He had a
stormy course postoperatively and died of
cardiopulmonary complications.

30 JUNE 1977
F ig .

2b

FIG. 2__Case 1. (a) Bilateral moderately severe symmetric sensorineural hearing
loss documented 3 days after neomycin irrigation was discontinued, (b) Bilateral total
hearing loss documented 20 days after neomycin was discontinued. Note progressive
hearing loss despite withdrawal of antibiotic. dB = decibels, AC _ air conduction,
BC = bone conduction.
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Discussion

These two case reports emphasize
the danger that neomycin wound irri
gation may produce ototoxicity and
renal impairment. This irrigation tech-
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nique is still widely used by orthopedic
surgeons to prevent wound infections
by organisms such as Escherichia coli,
Klebsiella sp., Proteus sp. and Enterobacter which are usually sensitive to
the drug.
Of all the aminoglycosides (strepto
mycin, kanamycin, gentamicin, tobra
mycin and amikacin) neomycin is the
most toxic, and commonly causes mid
dle ear and kidney damage after pa
renteral injection. For this reason its
use is confined to topical application
and oral administration, but the latter
has been shown to result in high
enough blood concentrations of the drug
to produce ear damage in some pa
tients; Kunin2 showed that plasma con
centrations, approximating those fol
lowing parenteral injection, can occur
when 4 to 8 g of neomycin daily is
administered orally to cirrhotic patients
with poor renal function. Deafness
may even occur when renal function is
normal.3 There have been only a few
case reports of kidney and ear damage
following neomycin wound irrigation
despite frequent use of this technique.
As with other nephrotoxic drugs pre
vious renal damage predisposes to the
development of both kidney and ear
damage. It is therefore imperative that
creatinine clearance studies be done
before wounds are irrigated with neo
mycin since the serum creatinine value
alone will not detect mild degrees of
renal impairment. Absorption can be
monitored by determining serum neo
mycin concentrations during the irriga
tion. However, measurement of the
urinary enzyme N-acetyl-/)-o-glucosaminidase value may be useful in
monitoring kidney damage since this
enzyme is elevated long before the
other indices of renal function become
abnormal in patients receiving genta
micin.4 The enzyme is easy to measure
and a single spot urine sample is all
that is needed for the assay.
The mechanism whereby aminogly
cosides cause kidney damage is not
known. These antibiotics bind very
avidly to renal parenchymal proteins.5
The cells of the proximal renal tubule
are mainly affected.6,7 Cortical accu
mulation of gentamicin is now a welldocumented phenomenon and it is
interesting to note that those amino
glycosides that are least nephrotoxic
(e.g., streptomycin) also have the least
affinity for renal cortical tissue.8
It is noteworthy that both of our
patients had normal serum creatinine
values but neither underwent creatinine
clearance testing. The intravenous
pyelogram, however, did show evidence
of chronic pyelonephritis in the first
patient. One of the patients (case 2)
became oliguric and thus drew our
attention to the abnormal kidney func
276

tion. However, as frequently occurs, tinger1' showed that neomycin, strep
the renal failure secondary to nephro tomycin and dihydrostreptomycin sul
toxic drugs, such as neomycin, is often fate produced competitive blockade at
of the nonoliguric variety and unless the myoneural junction.
renal function is monitored daily, kid
The mechanism of competitive
ney damage may be missed until it has blockade induced by antibiotics ap
become great enough to cause irre pears to involve depression of the
versible damage to the inner ear. As calcium ion concentration at the myo
demonstrated in both these patients, neural
junction.16,18 Neurohumoral
kidney function frequently is reversible transmission at this site is normally
but the onset of deafness is often irre dependent on release of acetycholine
versible and progressive despite with by the nerve endings into the synaptic
drawal of the drug. As noted by space. The amount released depends
others,912 high frequency deafness ap on the concentration of calcium ions
peared first (Fig. 2a) and later, long and varies inversely with the concen
after the drug was discontinued, low tration of magnesium ions. Substances
frequency hearing was also affected that lower calcium ion concentration
(Fig. 2b). Hearing loss has also been would therefore depress neurohumoral
reported several days, weeks or months transmission. Hava, Sobek and Mikulaafter stopping the drug. Vestibular in skova19 demonstrated that neomycin
volvement is unusual but may occur in lowers the concentration of ionized cal
association with auditory involvement cium but not of total serum calcium.
as seen in our case 1.
The above mechanisms are impor
Neurologic damage has also been tant therapeutically since antibiotics
reported.13 In both our patients leth that produce competitive blockade can
argy was an initial symptom. Sub be reversed by the administration of
sequently the first patient experienced calcium and an anticholinesterase
headaches and the second patient con agent. Craig and associates20 have
fusion and marked disorientation. The shown that calcium chloride is the
patients reported by Masur, Whelton drug of choice.
and Whelton13 complained of progres
Antibiotics such as kanamycin sul
sive lethargy and dizziness during irri fate and polymyxin B produce non
gation of the hip with neomycin. competitive blockade and neostigmine
Gruhl7 reported that a 16-year-old is contraindicated since it may make
boy who underwent mediastinal irriga the block worse. The role of calcium
tion subsequently had renal failure and in this situation has not been clearly
brain lesions. The patient became coma defined.
tose and was responsive only to painful
The two cases we have described
stimuli. Despite hemodialysis, he even serve as a reminder that wound irriga
tually lapsed into a coma. Small hemor tion with neomycin should be used
rhagic areas were found scattered bi with the utmost caution. Studies of
laterally throughout the basal ganglia, renal function and audiometry should
thalamus and hippocampus. One of our be performed before and during the
patients had proteinuria, a development wound irrigation. The development of
that was confusing since glomerular proteinuria should alert the physician
damage has not been associated with to the possibility of neomycin nephro
neomycin toxicity. However, the pre toxicity. Measurement of the urinary
sence of proteinuria can be explained enzyme N-acetyl-/J-D-glucosaminidase
by inhibition of proximal tubular ab may help in detecting early renal dam
sorption of albumin since it is now age because gentamicin nephrotoxicity
known that about 1.8 g to 3.6 g/24 h can be indicated by the finding of an
of albumin are filtered through the elevated urinary concentration of the
glomeruli of normal kidneys.14 This enzyme. By the time the serum creati
protein is then reabsorbed by the nine value rises there may already be
tubule by a process of pinocytosis.15 a 50% reduction in the creatinine
While the mechanisms of ototoxicity clearance and sufficient accumulation
are uncertain it is interesting that in of neomycin in the blood stream to
experimental models neomycin is produce toxic damage in the ear. High
selectively concentrated and retained frequency hearing loss should prompt
in the endolymph of the inner ear. It immediate withdrawal of the drug since
appears that, just as in the kidney, the the deafness that ensues is often irre
severity of ototoxicity of some amino versible. The value of prophylactic
glycoside antibiotics correlates with neomycin wound irrigation is in doubt
the degree of antibiotic accumulation and can also result in the emergence of
in the inner ear.
resistant organisms.15 Moreover, it has
Aminoglycoside antibiotics may also been demonstrated that deafness may
be toxic to nerves and muscles by develop in patients receiving prolonged
producing blockade of the neuro- oral neomycin therapy with blood con
humoral transmission at the myoneural centrations of neomycin as low as 0.4
junction.1* Timmerman, Long and Pit- /xg/ml.3,21
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Indications de rectotomie posterieure
pour tumeurs villeuses
D enis B ernard,

Douze patients ont subi une rectotomie
posterieure pour exerese de tumeurs
villeuses, situees entre 6 et 12 cm de
I’anus. Un malade est decede en
postoperatoire et six autres ont eu
des complications significatives dont
quatre infections de plaie, une
hemorragie rectale mais aucune fistule.
La procedure operatoire n’est pas
difficile e t est bien toleree en general
par les patients. Malgre un taux de
morbidity significatif, I’approche
posterieure du rectum represente un
heureux compromis pour les tumeurs
inaccessibles (i.e., trop basses pour
subir une resection anterieure avec
anastomose, et trop hautes ou trop
volumineuses pour une approche
transanale ou endoscopique). Autant
que possible, seules les tumeurs
benignes devraient etre enlevees par
cette voie et le moyen le plus fiable
de prevoir la benignite est la palpation.
Le diagnostic definitif commande
toutefois I'examen histopathologique
de toute la lesion.
The posterior (Kraske) approach to the
surgical management of villous tumours
of the rectum was used in 12
patients. One patient died in the
postoperative period and in six others
there w ere complications (wound
infection in three, wound infection and
rectal hemorrhage in one, wound
dehiscence in one and cellulitis in one),
but there was not a single fistula.
This approach represents an easy
and well-tolerated operation especially
in older patients who are otherwise
poor operative risks. The posterior
approach is also excellent for excising
lesions of the mid-rectum that may be
too bulky for endoscopic removal and
too proximal for their excision through
the dilated anus. The procedure is not
appropriate for malignant tumours and
the benign nature of these tumours is
best appreciated preoperatively by digital

md, frcs[c]*

palpation; however, confirmation of
their exact nature requires microscopic
examination of the whole lesion.

Les tumeurs villeuses continuent de
presenter occasionnellement un dilemme pour le chirurgien.
Certaines lesions rectales de grande
taille et avec une large base d’implantation peuvent poser des problemes
techniques a l’exerese. De plus, le
risque de recidive locale et le taux
relativement eleve de transformation
maligne au moment du diagnostic
commandent une excision complete,
sans toutefois sacrifier la fonction
sphincterienne pour une tumeur tout a
fait benigne.
Le chirurgien doit pouvoir recourir
a plusieurs precedes selon le site et la
morphologie de la lesion. Generalement les tumeurs du tiers inferieur du
rectum sont enlevees par voie anale.
Pour les lesions plus proximales, la
voie endoscopique est utilisee pour les
tumeurs petites ou pediculees, et une
resection segmentaire pour les plus
grosses lesions situees au tiers superieur du rectum ou plus haut.
II existe toutefois une “zone grise”,
le tiers moyen du rectum, principalement a l’union des tiers moyen et superieur, surtout lorsque la tumeur est
volumineuse, le patient obese, age ou
dont l’etat general est trop mauvais
pour subir une chirurgie majeure. Dans
ces cas, la tumeur n’est pas accessible
“confortablement” par les voies anales
et endoscopiques et la voie d’acces appropriee est la face posterieure du
rectum par approche trans-sacrococcygienne.
Le but de notre expose est de vous
faire part de notre experience de cette
voie chez 12 malades, en mentionnant quelques points techniques, nos
resultats, une etude comparative de la
litterature et nos conclusions personnelles en regard de cette technique.
Les patients

*Professeur agrege, departement de
chirurgie, Universite de Montreal, et
service de chirurgie digestive,
Hopital Saint-Luc, Montreal, PQ
Les demandes de tires a part doivent
etre adressees au Dr Denis Bernard,
235, est bold Dorchester, S. 101,
Montreal, PQ H2X 1N8
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En 1977 nous avions fait une etude
de notre serie personnels de 33 mala
des porteurs de tumeurs villeuses du
rectum.1 Huit malades de cette serie
avaient subi une approche rectale pos
terieure. Nous avons maintenant traite
45 malades parmi lesquels 12 ont subi
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une rectotomie posterieure, entre le
1" septembre 1974 et le 31 aout 1978.
Trois de ces 12 malades avaient en
plus une petite lesion satellite de meme
nature histologique. La taille des le
sions variait de 1 a 9.5 cm dans leur
plus grand diametre (les lesions satel
lites etant celles qui mesuraient 1 cm).
Elies etaient toutes situees a entre 6 et
12 cm de l’anus, distance prise a la
rectoscopie au moment du diagnostic
Clinique.
Chez sept malades, les lesions principales s’implantaient sur la paroi ante
rieure ou anterolaterale du rectum.
Quant aux cinq autres patients, les
lesions etaient situees sur la face poste
rieure (trois cas), sur la face laterale
gauche (un cas) et circonferentielle
(un cas).
Cette serie se compose de six hommes et de six femmes dont l’age moyen
est de 63 ans (ecart de 52 a 86 ans).
Le detail de chacun de ces malades est
resume dans la moitie gauche au
Tableau I.
Technique chirurgicale

La meilleure description de l’anatomie chirurgicale de l’approche poste
rieure est celle d'Adloff et Kohler.2
Quelques points pratiques cependant
meritent d’etre soulignes. L’examen
endoscopique minutieux et la palpation
de la tumeur immediatement apres
l’anesthesie du patient permettent d’estimer attentivement la lesion par rap
port a la voie d’acces, les points de
repere osseux pour ce qui est de la
hauteur et la paroi rectale posterieure
pour ce qui est de l’implantation de la
tumeur. Ceci permet de determiner a
l’avance si la coccygectomie sera suffisante ou s’il sera necessaire d’enlever la
derniere vertebre sacree. II est impor
tant aussi de planifier le site de la rec
totomie. Idealement, elle doit etre mediane, longitudinale posterieure mais il
faut prevoir un leger decalage vers la
gauche ou la droite si la tumeur s’implante sur la face posterieure du
rectum.
La mobilisation verticale et laterale
du rectum par dissection mousse le
degage plus facilement dans l’incision.
De meme l’utilisation d’environ six fils
de traction sur les bords de la recto-
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Tableau 1— Rectotomie posterieure: detail de 12 patients
Date de
I’operation

Siege, cm
de I’anus

Diam etre, cm

Sexe

Age, an

1
2
3
4

F
M
F
M

73
52
58
53

Sept.
Dec.
Jan.
Jan.

1974
1974
1975
1975

5
6
7
8
9

F
M
M
M
M

63
54
86
60
62

Avril
Juin
Dec.
Nov.
Fev.

1975
1975
1975
1976
1977

9
9
9 ,7
9
9

5.5
5
5 ,1
3 ,1
9.5, 1

10

F

79

Sept.

1977

6

11
12

F
F

58
60

Dec.
Juin

1977
1978

12
10

Cas no.

7
8
12
8

Complications
postoperatoires

Histologie*
B
B
B
M

5.5

—
—
Infection (p la ie)
Hemorragie rectale, dehiscence
plaie, hemorragie gastrique,
coma hepatique, insuffisance
renale
Infection (p laie)
—
Infection (p la ie)
—
Infection (p la ie ), hem orragie
rectale
Cellulite

9
3

Dehiscence plaie
—

B
B

4
2.5
4
4

B
B
B
B
B
M

Evolution)
Deces, 2 ans.
0
0
Deces postop.

0
0
Deces, 1 an (?)
0
0
Resection,
approche posterieure
nov. 1977
0

*B = benigne, M = maligne.
sans recidive.

to =

Quant au drainage de l’espace peri
tomie aide a l’exposition de la tumeur
rectal il n’est pas toujours necessaire.
rectale.
La dissection et l’excision de la L’espace "mort” est habituellement
tumeur villeuse doivent etre adequates comble par le rectum s’il a ete suffien profondeur et en peripherie. Les samment mobilise. II est essentiel celimites acceptables sont le plan sous- pendant si l’hemostase n’est pas parmuqueux en profondeur et une colle- faite, surtout en raison d’un saignement
rette de 1 cm de muqueuse saine. Une persistant de la tranche de section
certaine mobilite de la sous-muqueuse osseuse. L’accumulation d’hematome
aide a l’exteriorisation de la lesion par peut etre un facteur nocif a la guerison
la rectotomie; ce qui permet d’abaisser du rectum et conduire a une fistule.
certaines d’entre elles lorsqu’elles sont Nous utilisons deux petits catheters
implantees proximalement au site de pluri-orificiels de polyethylene relies
a une succion continue Hemo-Vac
rectotomie.
L’infiltration genereuse de la sous- (Snyder Laboratories, New Philadel
muqueuse avec une solution d’epine- phia, OH) qui sont gardes 48 a 78
phrine diluee dans du salin normal heures.
Nous n’avons pas encore resolu le
(concentration 1/300 000) facilite enormement la recherche du plan de dis probleme de l’infection du tissu soussection sous-muqueux, de meme que cutane. Presentement notre attitude est
l’hemostase des arterioles par electro de fermer la peau en y laissant un petit
coagulation. L’utilisation d’autres fils drain tubulaire pendant 24 a 48 heures
de traction en peripherie de la lesion, pour empecher l’accumulation de serosont egalement indispensables pour sites.
1’exposer, pour verifier l’hemostase
apres son excision et pour aider a
Resultats
refermer le site de l’excision avec un
Nous allons presenter les resultats
surjet de materiel resorbable.
Cette fermeture n’est pas essentielle sous trois aspects: (a) complications
et parfois ne peut se faire si la surface
d’excision est large. Nous avons l’impression qu’elle facilite l’hemostase et
Tableau I I — Complications postoperatoires
nous la pratiquons lorsqu’elle est
(12 patients)
petite, facile et qu’elle ne risque pas
de compromettre le calibre du rectum.
No. de
Nous sommes egalement d’avis que
Type de complication
complications
la rectotomie doit etre fermee en deux
Aucune complication
5
plans dans le meme sens que son ouInfection de plaie (abces)
5
verture. La fermeture paradoxale reC ellulite
1
commandee par certains auteurs3'4 ne
Dehiscence (peau
et aponevrose)
2
peut etre faite qu’avec une certaine
Hemorragie rectale
2
tension et n’est pas necessaire pour
Deces postoperatoire
1
s’assurer d’un calibre suffisant dans la
2
malades
ont
eu
2
complications
et
1
malade
lumiere rectale.5 Nous suturons en plus
a eu 3 complications et deces.
le fascia perirectal sur lui-meme ce qui
equivaut a un troisieme plan.
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postoperatoires, (b) histologie des le
sions et (c) evolution subsequente des
patients.
Le detail de ces trois points figure
a la moitie droite du Tableau I.

Complications postoperatoires
(Tableau II)
Un patient (cas no. 4) est decede
dans les suites operatoires de coma
hepatique et d’insuffisance renale, 38
jours apres l’operation. Chez ce malade
cirrhotique l’hemorragie repetee de la
tumeur nous a force a intervenir apres
l’administration de 9 unites de sang,
malgre les contre-indications relatives
imposees par son mauvais etat general.
Nous deplorons cinq infections de
plaie avec suppuration qui sont entrees
dans l’ordre apres evacuation de l’abces. Un cas d’infection des tissus souscutanes sans suppuration a repondu a
l’administrattion par voie systemique
d’antibiotiques a large spectre. Deux
malades, incluent notre deces postope
ratoire, ont presente une hemorragie
rectale post operatoire. Le second (cas
no. 9) a presente un saignement continu, a bas bruit pendant 3 jours, qui
s’est tari spontanement apres avoir
necessite l’administration de 2 unites
de sang. Un malade dont nous avions
laisse la peau ouverte a presente une
desunion de l’aponevrose du sacrum a
la partie superieure de la plaie.
Aucun de ces malades, malgre les
problemes d’infection, d’hemorragie
ou de desunion de plaie, n’a presente
en aucun moment de dehiscence du
rectum avec fistule.

Histologie des lesions
Les trois lesions satellites etaient
toutes benignes. Toutes les lesions principales se sont montrees benignes a
l’histopathologie sauf deux.
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Un de ces cas est notre malade
decede en periode postoperatoire; il ne
fut jamais candidat a une rechirurgie.
L’autre (cas no. 10) merite d’etre
detaille.
Histoire de cas.—II s’agit d’une vieille
dame de 79 ans, a qui son chirurgien
avait pratique 2 mois auparavant une
exerese endoscopique jugee adequate avec
fulguration de la base d’une lesion semicirconferentielle de 5 cm, situee a 6 cm
de l’anus. Tout le materiel tumoral enleve
fut examine microscopiquement et ne
revela aucun signe de malignite. Une
recidive precoce fut a nouveau fulguree
1 mois plus tard. Devant une nouvelle
recidive, et en raison de la fibrose exten
sive de la zone fulguree, nous optons
pour une excision large par approche
posterieure de toute la recidive avec
fibrose sous-jacente, compte tenu du probleme de la recidive, de l’age et du siege
de la lesion. L’examen histopathologique
de ce nouveau specimen a revele la pre
sence d’un adenocarcinome mucipare et
infiltrant. Cette malade a eu des suites
postoperatoires faciles mais a du subir
apres un delai planifie de 2 mois, une
resection abdominoperineale de son rec
tum. Nous avions commis l’erreur de nous
fier aux constatations de la premiere
exerese qui manifestement n’etait pas in
toto; la base d’implantation qui fut
fulguree montrait surement de l’envahissement que nous avons interprete erronement 2 mois plus tard comme du tissu
cicatriciel. Nous aurions du auparavant
rebiopsier en profondeur de la lesion.
Evolution subsequente des malades
Outre notre malade qui est decede
des suites postoperatoires, deux autres
malades sont decedes (cas no. 1 et 7):
1’un 2 ans plus tard d’autre cause et
sans recidive locale, l’autre 8 mois
plus tard de defaillance cardiaque globale sans que son rectum ne fut re
examine.
Tous les autres malades ont ete
suivis avec des rectoscopies a intervalles de 3 a 6 mois et aucun n’a demontre de recidive de la tumeur primitive.
Une malade par ailleurs (cas no. 12)
a ete operee trop recemment pour etre
evaluee.

Europe2'8'11 et en Amerique1,3"5,1215 avec
comme principale indication l’excision
des tumeurs villeuses inaccessibles par
d’autres voies.
Selon les donnees de plusieurs series
de la litterature recente1,10,16-23 entre 4%
et 52% de ces tumeurs ont d’emblee
un foyer de transformation maligne au
moment de leur decouverte (Tableau

etre evaluee par palpation ou par biop
sie selective ou meme par exerese in
toto au prealable. La resection segmentaire et anastomose s’impose et
garantit un traitement adequat quelque
soit 1’histologie definitive de la lesion.
Par ailleurs, 1’abouchement terminal
naturel du rectum a l’anus permet un
double acces: (a) endoscopique pour
IIji,io,16-23) pjans piusjeurs cas> ce f0yer
des tumeurs pediculees ou de petite
de transformation sera evident a l’ob- dimension (2.5 cm ou moins), et (b)
servateur qui palpera une zone induree transanal pour la majorite des lesions,
d’infiltration ou qui visualisera une memes volumineuses, de sa moitie
ulceration. La biopsie selective de ces distale (0 a 7.5 cm) en permettant leur
zones suspectes confirmera alors la prolapsus per anum apres traction ou
malignite de la lesion et la conduite a leur accessibilite a travers un anus
tenir sera alors toute tracee dans le dilate.18’22 Nous rencontrons occasionsens d’une intervention radicale selon nellement certains cas ou il n’est pas
les principes de la chirurgie anti- vraiment possible d’utiliser aucun des
cancereuse.
precedes ci-haut. Ce sont egalement
Dans la majorite des cas cependant,
des tumeurs larges, situees entre 8 et
le clinicien ne peut se garantir aussi
12 cm de l’anus. La resection antefacilement d’une pareille Certitude rieure basse peut s’averer risquee en
quant a la nature de la tumeur. Les raison d’age ou d’etat general mauvais
lesions apparaissent souples a la palpa et difficile chez un sujet obese. De
tion, sans aucun foyer suspect ou en meme une tentative d’exerese endosco
core s’implantent trop proximalement pique d’une telle tumeur est souvent
pour etre entierement evaluees par une entreprise considerable, sanglante,
palpation. Les biopsies multiples, frag- aveugle et comportant des risques de
mentaires et au hasard sont peu ins- perforation. L’exerese endoscopique
tructives et peu fiables, la majorite des dans ces cas est fragmentee et habi
histopathologistes hesitant ou meme tuellement completee d’une fulguration
refusant de se prononcer en ayant sous de la base. L’histologie des fragments
leurs yeux que des fragments de tu peut nous induire en erreur, nous
meurs. Plusieurs auteurs ont deplore procurer une fausse securite jusqu’a ce
l'incidence des faux negatifs dans que nous assistions a une recidive
1’ordre de 11% a 50%
locale, comme dans 1’exemple de
Tous les auteurs s’entendent pour notre cas no. 10.
affirmer que l’exerese in toto de la
L’approche transanale popularisee
tumeur doit etre pratiquee afin par Parks et Stuart21 est un excellent
d’assurer un diagnostic histologique precede d’exerese locale totale, tres
exact.4'8,12,17
confortable et tres bien toleree par les
La localisation anatomique pelvienne patients de tout age. Elle permet d’enet extraperitoneale du rectum rendent lever un tres grand nombre de lesions
son acces peu commode par les pre rectales. Plus la tumeur est haute ce
cedes conventionnels de chirurgie intra- pendant, plus les difficultes sont
abdominale. Une approche abdominale grandes, et il existe des cas, ou l’anus
est cependant habituellement requise est tout simplement non dilatable sans
et recommandable pour les tumeurs entrainer une rupture des sphincters.
villeuses de son tiers superieur et de la
La voie posterieure represente une
jonction rectosigmoidienne. Une lesion situation de compromis, entre une ap
a ce niveau est toujours de diagnostic proche simple (endoscopique ou trans
incertain puisqu’elle peut rarement anale) et un precede majeur (voie abdo-

Discussion

T a b le a u I I I - - T u m e u r s v ille u s e s : ta u x de c a n c e r

La technique de rectotomie poste
rieure n’est pas nouvelle, elle a pres
d’un siecle. On la designe souvent
selon le nom de son auteur, Kraske,
chirurgien allemand, qui l’a decrite
pour la premiere fois en 1885.6 Au
debut, on l’utilisa pour traiter de fa§on
palliative les cancers rectaux. Le nombre imposant de recidives et de fistules
et l’adoption de la technique de re
section abdominoperineale classique7
en ont force l’abandon. Depuis 10 ans,
elle est redecouverte a la fois en
280

A u te u r
B a c o n e t E is e n b e rg , 197123
Q u a n e t C a s tro , 197120
O r r in g e r e t E g g le s to n , 197219
IVIcCabe e t c o lle g u e s , 1 9 7 3 17
N iv a tv o n g s e t c o lle g u e s , 1 9 7 3 18
P a rk s e t S tu a rt, 197322
H o lle n d e r e t c o lle g u e s , 197510
J a h a d i e t B a ile y , 1 9 7 5 16
W e lc h e t H e d b e rg , 197521
B e rn a rd e t M o rg a n , 1 9 7 7 ’
T o ta l

VOLUME 22, NO. 3, MAY 1979

/

N o . de
cas

P o u rc e n t

222
215
69
169
72
30
32
185
214
33

30
52
26
29
4
17
6
30
28
15

1241
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minale). Ses elements de morbidite
sont, une plaie cutanee, une coccygectomie, une rectotomie et le lit de la
tum eur elle-meme.
Si on analyse les series rapportees
de rectotom ies posterieures,3'5'811'15 on
y retrouve les complications semblables a celles de notre etude mais dont
les auteurs ont vite fait d’en minimiser
1’im portance dans leur enthousiasme
pour cette technique. Les fistules occu
pant une place significative dans presque toutes les series (Tableau IV3-58-n,i5,26^ jj faut avouer que ces fistules
peuvent etre breves et sans risque
majeur. Certaines peuvent necessiter
une colostomie proximale de deriva
tion.
L ’hem orragie rectale est le resultat
d’un defaut d’hemostase locale et peut
survenir apres n’importe quel precede
d ’excision locale. N otre principale difficulte fut 1’infection de plaie. Tous
nos malades avaient subi une prepara
tion intestinale mecanique adequate.
De plus, une instillation rectale de 5 g
de neomycine au moment de l’asepsie
cutanee, une antibioprophylaxie parenterale de courte duree a la cephaloridine selon Polk et Lopez-Mayor27 et
une application topique, dans la plaie,
de neomycine, bacitracine et polymyxine en aerosol dans presque tous
les cas, n ’ont pas reussi a prevenir une
suppuration dans 50% de nos cas,
malgre l’absence de fistule.
Par contre, la voie posterieure fournit un acces au moyen rectum facile
pour le chirurgien et bien tolere par le
malade. Elle permet un traitement
adequat des tumeurs villeuses selon les
criteres enonces par Crowley et Davis12
et repris par Adloff, Arnaud et Miclo,8
(a) excision totale de la tumeur avec
marges de securite, (b) controle ade
quat de l’hemorragie et de Pintegrite
de la paroi rectale, (c) respect de la
fonction sphincterienne et de l’innervation et (d) ne pas compromettre ou
gener une reintervention plus radicale.

Conclusion
L ’epoque de la chirurgie radicale
inconsideree avec excision de tout le

rectum pour les tumeurs villeuses du
rectum est revolue. La chirurgie radi
cale doit s’appliquer au cancer prouve.
Toutes les autres lesions doivent etre
enlevees dans leur totalite par une
technique d’excision locale qui permet
1 examen histologique et ainsi un
diagnostic precis. Ces precedes sont
habituellement curatifs pour les lesions
benignes.
L ’excision des lesions villeuses pre
s u m e s benignes du tiers moyen du
rectum se fait tres facilement par voie
posterieure, lorsqu'elle risque d’etre
complexe par une autre voie. L ’intervention est habituellement bien toleree
du cote general en depit des difficultes
que l’on peut rencontrer du cote local.
Le taux de recidive est bas et si un
diagnostic definitif d’adenocarcinome
envahissant est pose, une reintervention
radicale subsequente est toujours reali
sable.
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Selective Superior Mesenteric Embolization
for Small Intestinal Hemorrhage
T.R.J. T odd, m d , frcs [c ], G. W einm an , m d , D. M c I n t y r e , m d ,
J.B. Sim o n , md , f r c p [ c ], A . G ro ll m b , ch b , f r c p [c ] and R.O. W est ,

A 25-year-old white woman who had
previously undergone two operations for
peptic ulcer disease, and was addicted
to drugs and alcohol, had massive
hemorrhage from the small intestine.
Angiography pinpointed the jejunum as
the source of bleeding. Because the
patient had a coagulopathy she was
considered a poor risk for surgery.
Bleeding was controlled by
embolization with sterile, commercially
available Gelfoam® (Upjohn) which
was injected into the offending branch
of the superior mesenteric artery. This
is believed to be only the third
documented case of embolization of
small intestinal vessels. A review of the
available literature is presented and
the value of Gelfoam® embolization as
an adjunct in the control of hemorrhage
in selected patients is stressed.
Une caucasienne de 25 ans ayant deja
subi deux operations pour ulcere
gastro-duodenal et s'adonnant a I’usage
des drogues et de I’alcool, a eu une
hemorragie massive du petit intestin.
L'angiographie a identifie le jejunum
comme etant la source du saignement.
La patiente souffrant d’une coagulopathie, le risque d'une chirurgie a ete
juge trop considerable. L'arret du
saignement a ete effectue par
embolisation; du Gelfoam® (Upjohn)
sterile du commerce a ete injecte dans
la branche hemorragique de I'artere
mesenterique superieure. L'on croit
qu'il s’agit du troisieme cas documents
d'embolisation d'un vaisseau du petit
intestin. On presente une revue des
etudes disponibles et on souligne
I’interet de I’embolisation au Gelfoam®
comme mesure d'appoint dans le
controle de I’hemorragie chez certains
patients.

Angiography has been widely used to
identify the source of bleeding in cases
From the departments of surgery and
medicine, Queen’s University and
Kingston General Hospital, Kingston, Ont.
Reprint requests to: Dr. T.R.J. Todd,
Rm. 107, University Wing, Toronto
General Hospital, Toronto, Ont.
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of gastrointestinal hemorrhage. Since
its original description,1'2 pharm acol
ogic agents, specifically epinephrine
and vasopressin, have been infused
through angiographic catheters in an
effort to control hemorrhage in the
upper gastrointestinal tract by nonop
erative means in patients at high risk.3
In 1972, Rosch, Dotter and Brown4
initiated the concept of obliterating
bleeding gastric vessels by embolization
with autologous clot or foreign m a
terial introduced through the angio
graphic catheter. A number of similar
series followed5'14 but these have con
cerned the therapy of gastric and duo
denal bleeding.
The case we report concerns the
embolization of terminal branches of
the superior mesenteric artery to con
trol massive small intestinal hem or
rhage. A review of the literature in
dicated that this technique for control
ling bleeding from the small intes
tine has been reported on only two
previous occasions.7,9
Case R eport

A 25-year-old white woman was trans
ferred to the Kingston General Hospital
on June 22, 1977 because of uncontrolled
gastrointestinal hemorrhage.
She had become addicted to codeine
at 14 years of age and to alcohol by 17
years. Two gastric operations had been

Measurement
Hemoglobin, g/dl
Leukocyte count, X 10°/l
Platelet count, X 109/l
Prothrombin time, s/control
Partial thromboplastin time, s/control
Thrombin time, s/control
Fibrin degradation products
Fibrinogen, g/dl
Serum
bilirubin, mg/dl
alkaline phosphatase, IU (normal <90)
glutamic oxaloacetic transaminase, IU
(normal <60)
albumin, g/dl
salicylate, mg/dl

md

performed for peptic ulcer disease, one
at age 18, the other 15 months before
this admission. She had also been a fre
quent patient in the Kingston Psychiatric
Hospital because of emotional problems
and drug addiction. On June 15, 1977
she was admitted to another hospital
because she had peripheral edema, a
subcutaneous abscess of the right ankle,
a chronic burning sensation in the epi
gastrium, weakness and fatigue. On June
18 she was given a 1 day pass and re
portedly had consumed a minimum of
20 acetylsalicylic tablets and an unde
termined amount of alcohol. Forty-eight
hours later, buccal mucosal bleeding and
a melenic stool were noted. She began
to pass large quantities of dark blood
per rectum. The results of laboratory in
vestigations (Table I) indicated a sig
nificant coagulopathy, so she received
fresh frozen plasma, vitamin K and plate
lets in addition to whole blood. The find
ings on endoscopic examination of the
esophagus, stomach and duodenum were
normal. Bleeding continued and after
receiving 13 units of blood she was
transferred to the Kingston General Hos
pital.
On arrival at the Kingston General
Hospital the patient appeared pale and
lethargic and was passing large quantities
of dark blood clot per rectum. Blood
pressure and heart rate were normal. She
vomited clear bile-stained material on
two occasions shortly after arrival. A
grade II /IV systolic ejection murmur
was present parasternally; she had normal
sinus rhythm and the chest was clear.
The abdomen was soft and nontender;

At the
referring
hospital

On admission to
Kingston General
Hospital

On discharge from
Kingston General
Hospital

9.5

9.7
8.3
191
16/13
50/33
18.6/15.2
Negative
0.1

14.1
6.2
—
11/12
35/33
—
—
0.2

380
24/11
162/33
—

Negative
—
0.5

0.4
29
21

2.8
___
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1.4

—

86
61
2.74
—
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there were no masses or palpable organs.
in whom surgical intervention is un
Bowel sounds were hyperactive. There suitable. Rosch, Dotter and Brown4
were no signs of liver disease.
and Prochaska, Flye and Johnsrude5
Sigmoidoscopic examination to 25 cm have used autologous blood clot to
revealed no mucosal lesion. A nasogastric
obstruct left gastric or right gastro
tube returned bile-stained material and
the laboratory findings (Table I) con epiploic vessels. However, they noted
tinued to indicate a coagulopathy. Blood difficulties with clot fragmentation and
drawn into a test tube did not clot after dissolution. These problems, of course,
25 to 30 minutes.
are magnified in the patient with im
paired coagulation. In such cases other
Hemorrhage continued and a further
11 units of blood were required to main substances have been added to the pa
tain perfusion. In order to localize the tient’s blood to enable a strong and
site of bleeding she was subjected to stable clot to form. Reuter, Chuang
angiography. This was performed transand Bree6 have added epsilon-aminobrachially employing a no. 7 French
Cordis multipurpose catheter (Cordis caproic acid and Bookstein and assoCorp., Miami, FL) and meglumine diatrizoate (Renografin®, Squibb) as the
contrast medium. The initial superior me
senteric flush (Fig. 1) demonstrated an
area ot extravasation of dye in the dis
tribution of the third jejunal branch.
Because of her coagulopathy, surgical in
tervention presented a major risk. We
therefore decided to attempt Gelfoam®
(The Upjohn Company of Canada, Don
Mills, Ont.) embolization of the bleeding
vessels. The catheter was advanced deep
ly into the offending vessel and supraselective films were obtained which ve
rified the site of extravasation (Fig. 2).
Sterile Gelfoam® plugs measuring ap
proximately 5 x 3 mm were injected in
a 10-ml bolus of 25% saline and 75%
Renografin®. A repeat angiogram was
obtained, which demonstrated that bleed
ing at the point described above had
stopped but indicated a second source
of bleeding (Fig. 3). As a result Gelfoam®
was injected a second time in the same
manner. Subsequent angiography verified
that all bleeding had ceased (Fig. 4).
No further bleeding was noted during
FIG. 1—Initial
superior
mesenteric
the remainder of the patient’s hospital
revealed area o f dye extravasation
stay and she was discharged 7 days after flush
(arrow).
admission. The coagulopathy resolved
spontaneously (Table I); we believe it was
related to the ingestion of acetylsalicylic
acid. The source of the jejunal hemor
rhage remains in doubt. It was believed
to be due to mucosal erosions secondary
to the. dumping of large quantities of
acetylsalicylic acid through the gastro
enterostomy. On subsequent radiologic
examination the small bowel appeared
normal.

ciates7 routinely used oxidized cellulose
(Oxycel®, Parke-Davis).
Carey and Grace8 reported a case
of successful Gelfoam® embolization
of the left gastric artery. Further in
vestigations in their institution led to
the creation of an animal model of
gastric hemorrhage and subsequently
to safe and effective Gelfoam® em
bolization of the left gastric artery in
these animals." Cyanoacrylate has also
been used successfully in clinical ex
perimental situations.10 This substance
polymerizes rapidly on contact with
blood to form a homogeneous sponge

*

1

rm

*

FIG. 3— Angiogram taken after first
embolization. Initial bleeding has ceased
and vessel no. 4 is occluded. Second area
of extravasated dye is indicated (arrow).

Discussion
This patient presented a difficult
problem for the surgeon in that she
had undergone two previous laparoto
mies and had a significant coagulo
pathy. Selective angiography was in
valuable in identifying the jejunum
as the site of hemorrhage but even
with this foreknowledge the surgeon’s
task in localizing the lesion during
laparotom y would have been difficult.
As a result, Gelfoam® embolization
appeared to be a reasonable alternative.
Various agents have been used to
produce embolic occlusion of gastro
intestinal vessels in poor-risk patients
284

FIG. 2—Supraselective angiogram in
third branch of superior mesenteric ar
tery. Extravasated dye is visible at bot
tom of film (arrow). Hemorrhage was
believed to have arisen from vessel no. 4.
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FIG. 4— Final angiogram fails to show
any further extravasation of contrast ma
terial. Newly occluded vessel is indicated
by arrow.
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which will occlude the offending ves
sel, so it requires careful injection to
prevent proximal thrombosis.
There are only two other reported
cases concerning embolization of small
intestinal vessels. Katzen and McSweeney11 reported occlusion of distal
ileal vessels with autologous clot to con
trol hemorrhage that occurred 10 days
after the patient had undergone laparo
tomy for a traumatic injury. Using
autologous clot with Oxycel® added,
Bookstein and associates7 managed to
control bleeding from the terminal
ileum due to regional enteritis.
There are five reported cases of gas
tric or intestinal infarction following
embolization. Reuter, Chuang and
Bree6 described gastric mucosal necro
sis seen on endoscopic examination in
one patient. Prochaska, Flye and
Johnsrude5 and Goldman and col
leagues12’13 have each reported a single
case of fatal gastric infarction follow
ing embolization with Gelfoam® and
autologous clot, respectively. Finally,
Bookstein and associates7 noted one
case of necrosis of the duodenal m u
cosa discovered on endoscopic exam
ination and a second of afferent loop
infarction. Except for the case reported
by Reuter, Chuang and Bree6 these case
reports have all involved either the
concomitant use of intra-arterial vaso
pressin or a previous laparotomy which
resulted in interruption of collateral
blood supply. It appears, therefore,
that this procedure should be under
taken with caution in patients who
have already undergone recent gastro
intestinal surgery with interruption of
collateral blood supply. In addition,
once embolization has been instituted,
vasopressin infusion should probably
be stopped. Finally, in order to pre
serve collateral circulation it is logical
to assume that the angiographic cathe
ter should be advanced as far into the
offending vessel as possible to avoid
showering multiple vessels with em
bolic material.
The precise indications for trans
catheter embolic occlusion to control
gastrointestinal hemorrhage have not
been defined. However, it can be ef
ficacious in poor-risk patients, such as
ours, or in those in whom coagulo
pathy presents a complicating problem.
Gelfoam® cut from commercially
available blocks appears to provide a
suitable material. Care and the abovenoted precautions are indicated when
there is doubt about the adequacy of
the collateral circulation. However,
with these provisions Gelfoam® em
bolization of gastric or indeed distal
superior mesenteric branches appears
a worthwhile adjunct in the control
of small intestinal hemorrhage in se
lected patients.
VOLUME 22, NO. 3, MAY 1979
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when shock
threatens the lung
helps reduce pulmonary
damage and increase ^
survival rates.

• preserves lysosome and cell membranes, thereby preventing the release of destructive
lysosomal enzymes3
• preserves platelets thereby reducing the risk of intravascular coagulation 1
0 preserves leukocyte integrity thereby helping to maintain the pulmonary architecture 1

The recovery of patients in shock is often complicated by a pattern of deteriorating pul
monary function, commonly described as shock lung. This pulmonary insufficiency
progresses despite restoration of haemodynamic balance and apparent stabilization of
the acute episode.
Under conditions of prolonged shock, lack of oxygen at the cellular level causes
alterations in the oxygen-carbon dioxide exchange m echanism . These
changes in cell metabolism lead ultimately to interstitial oedema and peri|||
vascular haemorrhage .1Polymorphonuclear leukocytes aggregate in
jjjljragk w
the pulmonary capillaries and obstruct the pulmonary vascular
bed. As these trapped cells break down, they release lyso-

Prescribing information on page288.
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A N N U A L REVIEW OF BIRTH
D E
FECTS, 1976. Part A. Numerical Tax
onomy of Birth Defects and PolygenicDisorders. Sponsored by The National
Foundation— March of Dimes at the
University of British Columbia, Van
couver. Edited by Daniel Bergsma and
R. Brian Lowry. 163 pp. Illust. Alan R.
Liss, Inc., New York, 1977. $20. ISBN
0-8451-1010-1.
A N N UA L REVIEW OF BIRTH
D E
FECTS, 1976. Part B. New Syndromes.
Sponsored by The National Founda
tion— March of Dimes at the University
of British Columbia, Vancouver. Edited
by Daniel Bergsma and R. Brian Lowry.
268 pp. Illust. Alan R. Liss, Inc., New
York, 1977. $32. ISBN 0-8451-1011-X.
A N N U A L REVIEW OF BIRTH D E
FECTS, 1976. Part C. Natural History
o f Specific Birth Defects. Sponsored by
The National Foundation— March of
Dimes at the University of British Co
lumbia, Vancouver. Edited by Daniel
Bergsma and R. Brian Lowry. 257 pp.
Illust. Alan R. Liss, Inc., New York,
1977. $30. ISBN 0-8451-1012-8.
A NN UA L REVIEW OF BIRTH D E
FECTS, 1976. Part D. Embryology and
Pathogenesis and Prenatal Diagnosis.
Sponsored by The National Foundation
— March o f Dimes at the University of
British Columbia, Vanvouver. Edited
by Daniel Bergsma and R. Brian Low
ry. 298 pp. Illust. Alan R. Liss, Inc.,
New York, 1977. $30. ISBN 0-84511013-6.

These volumes encompass four different
aspects of birth defects. They are part of
a continuing series of original articles
published by the National Foundation—
March of Dimes at the University of
British Columbia in Vancouver and are
almost indispensable for persons engaged
in the diagnosis of syndromes, in genetic
counselling or in certain types of clinical
research. However, these volumes may
have limited appeal.
In Part A an attempt is made in the
early chapters to set forth a classification
that would lead to grouping of syndromes
“sharing a large proportion of their
principal properties”. This classification
could help to distinguish syndromes that
appear to be variations of each other
from those that are truly different enti
ties. Not only would it be easier to fit
patients into the correct syndrome pat
tern, but it could also be helpful in search
ing for possible etiologic agents.
Part B presents a series of articles re
porting new and very rare syndromes,
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some associated with unusual chromo
somal rearrangements. Such a book can
be an interesting and useful reference for
diagnostic purposes.
Part C starts with an interesting
chapter entitled “Time in syndrome analy
sis,” which could almost be regarded as
compulsory reading for students of re
medial surgery. It discusses conditions
that improve with time (e.g., Pierre Robin
syndrome), conditions whose severity in
creases with time (e.g., Apert’s syndrome)
and conditions in which the degree of
severity remains the same. It is essential
to know these distinctions and natural
histories when planning remedial ther
apy. One unusual article is on medical
and social adaptation in dwarfing condi
tions and is a very thoughtful presenta
tion of some of the problems faced by
midgets and dwarfs.
Part D is devoted to embryology and
pathogenesis, and prenatal diagnosis.
Pathologic embryogenesis, for example
the anomalies of the aortic arch system,
is discussed at length and may help
readers to understand the various present
ing abnormalities. There are some in
teresting chapters on the causes of de
fects. The first is a discussion of gene ex
pression in different conditions. Several
chapters on reduction deformities of limbs
and amniotic band syndromes present in
teresting theories for the production of
these unusual deformities. The final sec
tion on prenatal diagnosis is a useful re
view of the present state of the art. Some
recently adopted techniques and their in
creasing use are discussed: this section ap
pears to be valuable for persons involved
in genetic counselling services. Obstetri
cians and gynecologists also will find this
section of considerable interest.
M a u r e e n R o b e r t s , m b , f r c p [c ]

Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
THE CARE OF CONGENITAL HAND
ANOMALIES. Adrian E. Flatt. 371 pp.
Illust. The C.V. Mosby Company, Saint
Louis, 1977. $36.25. ISBN 0-80161586-0.

Congenital malformations of the hand
represent some of the most difficult and
complex problems confronting the sur
geon. Because a properly functioning hand
is essential, adequate treatment of mal
formations is of paramount importance to
the afflicted child and to the child’s
parents. Flatt has offered his philosophy
of care and surgical approach in dealing
with these problems by summarizing his
experience in treating more than 1400
patients with malformed hands.
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The style of writing and the general
format of the book are similar to that in
the author’s previous publications. The
text is divided into four sections.
Section one explores the genetic and
functional aspects of the malformed hand
and discusses the appropriate timing of
the surgical procedures. Included is the
new classification on congenital anomalies
of the upper extremity recently adopted
by the American Society of Surgery of the
Hand.
The remainder of the volume is con
cerned with reconstructive surgery from
the author’s viewpoint and details condi
tions involving the thumb, the fingers and
the hand as a whole. Each topic is
discussed in an orderly fashion giving the
author’s preferred method of manage
ment when surgery is involved. Obviously
Flatt has not intended this volume to
be an encyclopedia on the treatment of
all hand malformations but he has
stressed the more commonly encountered
conditions and explained them in detail.
Several roentgenograms and photographs
appropriately complement the conditions
discussed. Associated with these condi
tions are details of recommended pro
cedures in illustrated form. A healthy re
ference section, a useful glossary and a
syndrome index as applied to hand
anomalies are included at the end of the
book. Flatt has succeeded in making the
subject easily understood for all persons
responsible for the initial care of chil
dren affected with hand malformations.

This is a book not only for hand surgeons
but for all those involved with the early
care of children.
D.J. C la ssen , m d , dds, frcs [c ]
704 CN Towers,
Saskatoon, Sask.
FARQUHARSON’S TEXTBOOK
OF
OPERATIVE SURGERY. 6th ed.
Edited by R.F. Rintoul. 963 pp. Illust.
Churchill Livingstone, Edinburgh; Long
man Canada Limited, Don Mills, 1978.
$64. ISBN 0-443-01363-2.

Previous personal use of this textbook as
a junior surgical resident made this review
an interesting and easy task. The text was
always considered as a handbook or “how
I do it” manual for the junior surgical
resident. Farquharson’s original text con
tained a wealth of material on surgical
technique, particularly details of minor
surgery which are often taken for granted
or are poorly taught. This feature is con
tinued in the sixth edition.
The textbook makes no pretence of
being a comprehensive surgical encyclo
pedia but instead emphasizes technical
aspects of surgery. The outstanding fea
ture of Rintoul’s revision is the solid
embryologic and anatomical basis for each
operative procedure discussed. A brief
historical perspective of many procedures
will interest all surgical students. The
book contains many details which are

particularly valuable for examination pur
poses such as the anatomical basis for the
treatment of hand space infections, Lud
wig’s angina, branchial cleft cysts and
other examination favourites. The chapter
on amputations is a classic and provides
much information that is not found in
standard textbooks, particularly for the
surgical resident who is approaching his
first amputation. Many unusual amputa
tions are presented and the indications are
related to neoplasm, trauma or amputa
tions as a consequence of arterial in
sufficiency. The section on vascular sur
gery contains all the essential principles of
arterial reconstruction, but does not in
clude a comprehensive preoperative as
sessment as might be provided in a vascu
lar laboratory setting. Little emphasis is
placed on extra-anatomic arterial re
constructions. Surgical principles related
to many of the subspecialties are men
tioned superficially but are by no means
comprehensive.
The major shortcomings of this book
are lack of basic surgical physiology and a
bibliography which in many instances is
out of date. The emphasis on anatomy
frequently excludes important physiologic
aspects which have to be considered for
pre- and postoperative care as well as in
planning an effective surgical procedure.
The bibliography requires up-dating; for
example, the discussion of malignant
melanoma makes no mention of a
Mimms-Clark or Breslow classification
which relates histologic grading to the clin-

CANADIAN ASSOCIATION OF GENERAL SURGEONS
RESIDENT RESEARCH CONTEST
The Canadian Association of General Surgeons is sponsoring an annual award for achievement in
research by a surgical resident. Residents are encouraged to submit abstracts of research work
they have done. The research may be basic or applied but should be related to general surgery and
suitable for presentation at the annual meeting of the Association.
AWARD

(1) An all expense paid trip to the annual meeting of the Canadian Association of General Surgeons.
(2) $500
ELIGIBILITY

Any resident in general surgery who has conducted research during his residency training at a
Canadian University.
ABSTRACT

The abstract, without identification, should be confined to two typewritten pages. Tables and
illustrations may be extra. A separate sheet should identify the authors, institution of origin and
whether or not an abstract of the work has been submitted as well for the Royal College programme.
The latter is necessary to avoid duplication at the Royal College meeting. The original and four copies
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Department of Surgery,
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ical management of malignant melanoma.
The book is extremely easy to read and
is well illustrated. The major role for this
textbook will continue to be as an oper
ative handbook for the junior surgical
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M ANUAL OF SURGICAL INTENSIVE
CARE. The Committee on Pre and
Postoperative Care. American College
of Surgeons. Editorial Subcommittee —
John M. Kinney, Henrik H. Bendixen
and Samuel R. Powers, Jr. 335 pp.
Iilust. W.B. Saunders Company, Phila
delphia; W.B. Saunders Company Can
ada Limited, Toronto, 1977. $14.85.
ISBN 0-7216-1180-X.

This short and easily read manual on
surgical intensive care is written by con
tributors recognized in the field of critical
care.
Part I of the text discusses the devel
opment of surgical intensive care and is
the most interesting section. It deals with
all aspects of the facility: design, admi
nistration, personnel, equipment, monitor
ing and oriented data collection. Chapter
8 considers the cost of surgical intensive
care and poses the provocative question,
Can one identify the patient who may
survive when given the best treatment?
General aspects of surgical intensive
care are covered in Part II which tends
to be too general a survey. There is
nothing new in some of the chapters
and possibly these should have been de
leted or shortened. The chapter on infec
tion hazard is of special interest and
certain requirements are emphasized, such
as a leader, an ambience, surveillance, the
physical set-up, traffic control, housekeep
ing, education and a personnel health
program. The chapter on psychiatric con
siderations covers an aspect of intensive
care that is frequently overlooked and
poorly understood. The discussion in
chapter 14 on ethical and legal considera
tions is most provocative and emphasizes
the problems of life-support systems
and the ethics of their use. As the author
states, “when such devices are used to
support a patient who has no expectation
of survival, the utilization of the facility
cannot be justified. The most difficult
aspect of this problem is that it is fre
quently impossible to make that distinc
tion with medical certainty.”
The third part of the text considers
management of specific conditions and
contains expositions on control of infec
tion, ventilatory complications, peripheral
circulatory failure, cardiac problems, re
nal failure and! the burned patient. In
general these are excellent summaries of
the state of intensive care as applied to
ventilatory and renal failure and to the
burned patient.
This is a useful, though not a compre
hensive manual, with several provocative
VOLUME 22, NO. 3, MAY 1979
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chapters. It serves best those setting up
a surgical intensive care facility. Unfor
tunately, in attempting to touch on all
the aspects of surgical intensive care the
effect of the manual is diluted. The lack
of a chapter on nutrition is particularly
noteworthy.

THE PATIENT’S GUIDE TO SUR
GERY. How to Make the Best of Your
Operation. Lawrence Galton. 468 pp.
Avon Books, New York, 1977. $2.50,
paperbound. ISBN 0-380-00683-9.

This paperback has been written to en
lighten prospective surgical patients about
possible pitfalls and to provide a fore
knowledge of the surgical procedure they
may have to undergo. The intriguing
introduction contains
some general
thoughts about what is required to
prepare an adult or child for an oper
ative procedure and deals with anticipa
tions, beliefs and fancies. It also describes
sources of support and help which are
available. In part one, dealing with 200
operative procedures, the indications for
the operation and the anatomy involved
are described and a brief description of
the operation, its purposes and expected
results are given in layman’s terms.
The second portion of the book is
basic; general information is included on
the nature of surgery, its extent and its
volume in the United States. This section
discusses problems, risks versus gains and
the necessity for an accurate definition
of the need for the operative procedure.
The author provides the reader with
some rational techniques for choosing a
surgeon or a hospital, by discussing
training qualifications, titles and prestige.
Not essential to the Canadian scene are
the paragraphs on fees and insurance, but
these are followed by a fair discussion
of preoperative and postoperative care,
and the anesthetic procedure with its ad
vantages and disadvantages.
In a more descriptive fashion, the au
thors then discuss the role in surgery
played by roentgenography, scanning and
nuclear medicine; they describe the nature
and purpose of laboratory tests, and name
at least 25. They conclude with some gen
eral comments on the state of the art of
surgery.
This book should be of interest to all
surgeons because it touches so many facets
of surgery; it does so from the eyes of the
surgeon attempting to talk to the patient.
It should be of value to many individuals
for it conveys information that may be
important and useful to the prospective
patient.
C.B.

M u e l l e r , m d , f r c s [c ]

Department of surgery,
McMaster University,
Hamilton, Ont.
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